10.02.2013 Views

Directory of Cyclotrons used for Radionuclide Production in Member ...

Directory of Cyclotrons used for Radionuclide Production in Member ...

Directory of Cyclotrons used for Radionuclide Production in Member ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IAEA-DCRP/2006<br />

<strong>Directory</strong> <strong>of</strong> <strong>Cyclotrons</strong> <strong>used</strong> <strong>for</strong><br />

<strong>Radionuclide</strong> <strong>Production</strong> <strong>in</strong><br />

<strong>Member</strong> States<br />

2006 Update<br />

October 2006


The orig<strong>in</strong>at<strong>in</strong>g Section <strong>of</strong> this publication <strong>in</strong> the IAEA was:<br />

Industrial Applications and Chemistry Section<br />

International Atomic Energy Agency<br />

Wagramer Strasse 5<br />

P.O. Box 100<br />

A-1400 Vienna, Austria<br />

DIRECTORY OF CYCLOTRONS USED FOR<br />

RADIONUCLIDE PRODUCTION IN MEMBER STATES:<br />

2006 UPDATE<br />

IAEA, VIENNA, 2006<br />

IAEA-DCRP/2006<br />

ISBN 92-0-111506-7<br />

© IAEA, 2006<br />

Pr<strong>in</strong>ted by the IAEA <strong>in</strong> Austria<br />

October 2006


FOREWORD<br />

The present directory <strong>of</strong> cyclotron facilities <strong>used</strong> <strong>for</strong> the production <strong>of</strong> radionuclides <strong>in</strong> <strong>Member</strong><br />

States is an update <strong>of</strong> the one compiled by the International Atomic Energy Agency (IAEA) <strong>in</strong> late<br />

2001 and published <strong>in</strong> 2002. This directory was prepared through <strong>in</strong><strong>for</strong>mation collected by<br />

questionnaires that the IAEA sent to known <strong>in</strong>stitutions operat<strong>in</strong>g cyclotrons <strong>for</strong> radionuclide<br />

production. Technical as well as adm<strong>in</strong>istrative data supplied to the IAEA as <strong>of</strong> November 2005 were<br />

taken <strong>in</strong>to account.<br />

The directory is considered to <strong>in</strong>clude most <strong>of</strong> the cyclotrons <strong>of</strong> the world that are <strong>used</strong> at least<br />

partially <strong>for</strong> radionuclide production. There are 262 entries <strong>for</strong> cyclotrons operat<strong>in</strong>g <strong>in</strong> 39 <strong>Member</strong><br />

States <strong>of</strong> the IAEA. This is an <strong>in</strong>crease <strong>of</strong> 7% over the 246 reported <strong>in</strong> the 2002 cyclotron directory.<br />

This can be compared to the 350 or so cyclotrons believed to be presently operat<strong>in</strong>g <strong>in</strong> the world,<br />

which are <strong>in</strong>volved <strong>in</strong> some aspects <strong>of</strong> radionuclide production. The <strong>in</strong>crease has been <strong>in</strong> the number<br />

<strong>of</strong> cyclotrons <strong>in</strong> developed countries, but even more so <strong>in</strong> the develop<strong>in</strong>g countries. The <strong>in</strong>crease <strong>in</strong><br />

number dur<strong>in</strong>g the last four years was driven by several factors, i.e. advent <strong>of</strong> advances <strong>in</strong> medical<br />

imag<strong>in</strong>g, <strong>in</strong>troduction <strong>of</strong> compact, user friendly medical cyclotron, and a recent decision that costs <strong>for</strong><br />

15 O-oxygen position emission tomography (PET) studies <strong>in</strong> Japan and 18 F-FDG PET studies <strong>in</strong><br />

Germany and the United States <strong>of</strong> America are eligible <strong>for</strong> reimbursement by government or health<br />

<strong>in</strong>surance companies. There is no doubt that the fastest grow<strong>in</strong>g segment <strong>of</strong> the market is <strong>in</strong> the<br />

commercial distribution <strong>of</strong> FDG to local hospitals.<br />

The IAEA is promot<strong>in</strong>g cyclotron technology as applied to nuclear medic<strong>in</strong>e. Requests <strong>for</strong><br />

cyclotron technology is steadily <strong>in</strong>creas<strong>in</strong>g; many develop<strong>in</strong>g <strong>Member</strong> States are <strong>in</strong>terested <strong>in</strong> this<br />

technology. There is need to stimulate, build and ma<strong>in</strong>ta<strong>in</strong> consult<strong>in</strong>g capability <strong>in</strong> <strong>in</strong>terested<br />

develop<strong>in</strong>g <strong>Member</strong> States. There are good reasons to believe that the number <strong>of</strong> cyclotron facilities<br />

dedicated to the production <strong>of</strong> PET tracers will cont<strong>in</strong>ue to grow <strong>in</strong> the near future, so the need to<br />

further update the directory will be assessed <strong>in</strong> due course, depend<strong>in</strong>g on comments and suggestions<br />

receiv<strong>in</strong>g from users <strong>of</strong> the directory. This directory will help decision makers and specialists <strong>in</strong><br />

<strong>Member</strong> States to draft mid and long term strategies regard<strong>in</strong>g the implementation <strong>of</strong> cyclotron<br />

technology <strong>for</strong> radioisotope production and their medical applications, as well as <strong>for</strong> selection <strong>of</strong> the<br />

most suitable alternative.<br />

The IAEA wishes to thank D.J. Schlyer <strong>of</strong> the Brookhaven National Laboratories, USA, <strong>for</strong> his<br />

analysis <strong>of</strong> the data. The IAEA <strong>of</strong>ficer responsible <strong>for</strong> the compilation <strong>of</strong> the directory was M. Haji-<br />

Saeid <strong>of</strong> the Division <strong>of</strong> Physical and Chemical Sciences.


EDITORIAL NOTE<br />

This CD-ROM has been prepared from the orig<strong>in</strong>al material as submitted by contributors. Neither the<br />

IAEA nor its <strong>Member</strong> States assume any responsibility <strong>for</strong> the <strong>in</strong><strong>for</strong>mation conta<strong>in</strong>ed on this CD-<br />

ROM.<br />

The use <strong>of</strong> particular designations <strong>of</strong> countries or territories does not imply any judgement by the<br />

publisher, the IAEA, as to the legal status <strong>of</strong> such countries or territories, <strong>of</strong> their authorities and<br />

<strong>in</strong>stitutions or <strong>of</strong> the delimitation <strong>of</strong> their boundaries.<br />

The mention <strong>of</strong> names <strong>of</strong> specific companies or products (whether or not <strong>in</strong>dicated as registered) does<br />

not imply any <strong>in</strong>tention to <strong>in</strong>fr<strong>in</strong>ge proprietary rights, nor should it be construed as an endorsement<br />

or recommendation on the part <strong>of</strong> the IAEA.


CONTENTS<br />

SUMMARY ............................................................................................................................................ 1<br />

1. Argent<strong>in</strong>a......................................................................................................................................... 7<br />

2. Australia........................................................................................................................................ 11<br />

3. Austria........................................................................................................................................... 17<br />

4. Belgium......................................................................................................................................... 21<br />

5. Brazil............................................................................................................................................. 37<br />

6. Canada........................................................................................................................................... 41<br />

7. Ch<strong>in</strong>a............................................................................................................................................. 59<br />

8. Czech Republic ............................................................................................................................. 77<br />

9. Denmark........................................................................................................................................ 81<br />

10. Egypt........................................................................................................................................... 85<br />

11. F<strong>in</strong>land ........................................................................................................................................ 87<br />

12. France.......................................................................................................................................... 95<br />

13. Germany.................................................................................................................................... 107<br />

14. Hungary..................................................................................................................................... 153<br />

15. India .......................................................................................................................................... 155<br />

16. Indonesia................................................................................................................................... 159<br />

17. Iran, Islamic Republic <strong>of</strong>........................................................................................................... 161<br />

18. Israel.......................................................................................................................................... 163<br />

19. Italy ........................................................................................................................................... 167<br />

20. Japan ......................................................................................................................................... 193<br />

21. Kazakhstan................................................................................................................................ 265<br />

22. Korea, Republic <strong>of</strong>.................................................................................................................... 267<br />

23. Mexico ...................................................................................................................................... 297<br />

24. Netherlands ............................................................................................................................... 299<br />

25. Norway...................................................................................................................................... 319<br />

26. Philipp<strong>in</strong>es................................................................................................................................. 321<br />

27. Poland ....................................................................................................................................... 323<br />

28. Romania .................................................................................................................................... 327<br />

29. Russian Federation.................................................................................................................... 329<br />

30. Saudi Arabia.............................................................................................................................. 347<br />

31. Slovakia..................................................................................................................................... 349<br />

32. South Africa.............................................................................................................................. 351<br />

33. Spa<strong>in</strong> ......................................................................................................................................... 353<br />

34. Sweden...................................................................................................................................... 363<br />

35. Switzerland ............................................................................................................................... 365<br />

36. Syrian Arab Republic................................................................................................................ 371<br />

37. Turkey....................................................................................................................................... 373<br />

38. United K<strong>in</strong>gdom........................................................................................................................ 377<br />

39. United States <strong>of</strong> America .......................................................................................................... 391


SUMMARY<br />

The directory <strong>of</strong> cyclotrons <strong>used</strong> <strong>for</strong> radionuclide production <strong>in</strong> <strong>Member</strong> States conta<strong>in</strong>s<br />

technical, utilization and adm<strong>in</strong>istrative <strong>in</strong><strong>for</strong>mation supplied to the IAEA as <strong>of</strong> November 2005. It<br />

was prepared through <strong>in</strong><strong>for</strong>mation collected by questionnaires sent to <strong>in</strong>stitutions that either have a<br />

cyclotron or were identified to be <strong>in</strong> the process <strong>of</strong> <strong>in</strong>stall<strong>in</strong>g a cyclotron.<br />

Included <strong>in</strong> the directory are a significant fraction <strong>of</strong> the cyclotrons <strong>of</strong> the world that are <strong>used</strong> at<br />

least <strong>in</strong> part <strong>for</strong> radionuclide production. If replies were not received from <strong>in</strong>stitutions, it was assumed<br />

that the cyclotron is still be<strong>in</strong>g <strong>used</strong> <strong>for</strong> similar tasks as it was at the time <strong>of</strong> the last survey. Some<br />

<strong>in</strong>stitutions reported that older cyclotrons had been shut down and replaced with newer cyclotrons. The<br />

questionnaire was, <strong>in</strong> general, not completed by <strong>in</strong>stitutions that have cyclotrons dedicated to physics<br />

and/or material science activities. Certa<strong>in</strong> <strong>of</strong> the <strong>in</strong>stitutions construct<strong>in</strong>g superconduct<strong>in</strong>g cyclotrons<br />

<strong>for</strong> medical and nuclear physics applications responded even though they are not yet <strong>in</strong>volved <strong>in</strong><br />

radionuclide production <strong>in</strong>itiatives.<br />

The directory is organized alphabetically by <strong>Member</strong> States and by <strong>in</strong>stitutes. There are<br />

<strong>in</strong>dividual entries <strong>for</strong> each cyclotron even <strong>for</strong> <strong>in</strong>stitutions hav<strong>in</strong>g more than one cyclotron. The names,<br />

title/position <strong>of</strong> the persons listed <strong>in</strong> position <strong>in</strong> the entries <strong>for</strong> <strong>in</strong>dividual countries were taken directly<br />

from the answers <strong>in</strong> the questionnaires.<br />

There are 262 entries <strong>for</strong> cyclotrons operat<strong>in</strong>g <strong>in</strong> 39 <strong>Member</strong> States <strong>of</strong> the IAEA. This is an<br />

<strong>in</strong>crease <strong>of</strong> 7% over the 246 reported <strong>in</strong> the 2002 cyclotron directory. This can be compared to the 350<br />

or so cyclotrons believed to be presently operat<strong>in</strong>g <strong>in</strong> the world, which are <strong>in</strong>volved <strong>in</strong> some aspects <strong>of</strong><br />

radionuclide production. The <strong>in</strong>crease has been <strong>in</strong> the number <strong>of</strong> cyclotrons <strong>in</strong> developed countries, but<br />

even more so <strong>in</strong> the develop<strong>in</strong>g countries. Large concentrations <strong>of</strong> cyclotrons <strong>for</strong> radionuclide<br />

production are located <strong>in</strong> the United States <strong>of</strong> America, Japan and Germany. The largest number <strong>of</strong><br />

cyclotrons <strong>for</strong> a s<strong>in</strong>gle country is <strong>in</strong> the United States <strong>of</strong> America. However, taken collectively there<br />

are more cyclotrons located <strong>in</strong> the European Union countries that are <strong>used</strong> <strong>for</strong> medical radionuclide<br />

production.<br />

The number <strong>of</strong> <strong>in</strong>stitutions which distribute radiopharmaceuticals and 18 F-FDG, <strong>in</strong> particular, is<br />

significant and grow<strong>in</strong>g. In this sample, 75% <strong>of</strong> the cyclotrons are be<strong>in</strong>g <strong>used</strong> to produce FDG, either<br />

<strong>for</strong> <strong>in</strong>ternal use or <strong>for</strong> distribution. This is certa<strong>in</strong>ly an underestimate as the commercial suppliers are<br />

under represented <strong>in</strong> this survey.<br />

The expansion <strong>in</strong> the number <strong>of</strong> cyclotrons dur<strong>in</strong>g the last 10 years has been driven by the<br />

advent <strong>of</strong> advances <strong>in</strong> medical imag<strong>in</strong>g <strong>in</strong>strumentation (PET, SPECT and more recently PET/CT);<br />

<strong>in</strong>troduction <strong>of</strong> user friendly compact medical cyclotrons from several companies that manufacture<br />

cyclotrons; and recent decisions that some PET radiopharmaceuticals are eligible <strong>for</strong> reimbursement<br />

by government or <strong>in</strong>surance companies. There is no doubt that the fastest grow<strong>in</strong>g segment <strong>of</strong> the<br />

market is <strong>in</strong> the commercial distribution <strong>of</strong> 18 F-FDG to local hospitals. Many centers have begun<br />

distribut<strong>in</strong>g FDG and at present at least 36% <strong>of</strong> the centers produc<strong>in</strong>g FDG are distribut<strong>in</strong>g it. Aga<strong>in</strong><br />

this is a lower limit rather than an accurate assessment. The satellite approach is cost-effective<br />

because it is not necessary <strong>for</strong> every medical imag<strong>in</strong>g centre to own a cyclotron as a source <strong>of</strong> shortlived<br />

radiopharmaceuticals. 18 F-FDG is ga<strong>in</strong><strong>in</strong>g widespread cl<strong>in</strong>ical acceptance <strong>for</strong> a variety <strong>of</strong> disease<br />

states.<br />

The number <strong>of</strong> types <strong>of</strong> cyclotrons available commercially is quite large and grow<strong>in</strong>g. The<br />

energies range from a few MeV <strong>for</strong> only PET isotope production to a few hundreds MeV <strong>for</strong> proton<br />

therapy or production <strong>of</strong> radioisotopes requir<strong>in</strong>g these high energies. The beam currents range upwards<br />

from 40 µ to over 1 mA. The characteristics <strong>of</strong> the mach<strong>in</strong>es available <strong>for</strong> commercial acquisition are<br />

shown <strong>in</strong> Table I.<br />

1


TABLE I. CHARACTERISTICS OF COMMERCIAL CYCLOTRONS<br />

Company Model Description Oper. Plan<br />

CTI, Inc. RDS 111 11 MeV H - , 60µA 44 10<br />

RDS 112 11 MeV H - , 60µA 30<br />

Ebco Technologies TR 14 11-14 MeV H - , 100µA 2<br />

TR 19 14-19 MeV H - , 160µA 2<br />

TR 19/9 19 MeV H - , 9 MeV D - , 160µA 1 3<br />

TR30 30 MeV H - , 100µA 2<br />

TR30/15 30 MeV H - , 15 MeV D - , 160µA 1<br />

D.V. Efremov Institute MGC-20 18 MeV H - , 10 MeV D - , 160µA 4 2<br />

General Electric M<strong>in</strong>iTrace 9.6 MeV H - , 50µA 2<br />

PETrace 16.5 MeV H - , 8.6 MeV D - , 80µA 16<br />

Ion Beam Applications Cyclone 3 3.8 MeV D - , 60µA 2<br />

Cyclone 10/5 10 MeV H - , 5 MeV D - , 60µA 3<br />

Cyclone 18/9 18 MeV H - , 9 MeV D - , 80µA 15 5<br />

Cyclone 18+ 18 MeV H - , 80µA 1<br />

Cyclone 30 30 MeV H - , 15 MeV D - , 400µA 16 2<br />

Cyclone 235 240 MeV H - 1<br />

Japan Steel Works BC168 16 MeV H + , 8 MeV D + , 50µA 2<br />

BC1710 17 MeV H + , 10 MeV D + , 60µA 7<br />

BC2010N 20 MeV H - , 10 MeV D - , 60µA 2<br />

BC2211 22 MeV H + , 11 MeV D + , 60µA 1<br />

BC3015 30 MeV H + , 15 MeV D + , 60µA 1<br />

Ox<strong>for</strong>d Instrument Co. OSCAR 12 12 MeV H - , 60µA 5<br />

Scanditronix Medical AB MC17 17.2 MeV H + , 8.3 MeV D + , 60µA 13<br />

12 MeV 3 He ++ , 16.5 4 He ++ , 60µA<br />

MC30 30 MeV H + , 15 MeV D + , 60µA<br />

MC32NI 15-32 MeV H - , 8-16 MeV D - , 60µA 3<br />

11-23 MeV 3 He ++ , 15-31 4 He ++ , 60µA<br />

MC40 10-40 MeV H + , 5-20 MeV D + , 60µA 6<br />

13-53 MeV 3 He ++ , 10-40 4 He ++ , 60µA<br />

MC50 18-52 MeV H + , 9-25 MeV D + , 60µA 1<br />

24-67 MeV 3 He ++ , 18-50 4 He ++ , 60µA<br />

MC60 50 MeV H + , 60µA 1<br />

K130 6-90 MeV H - , 10-65 MeV D - , 60µA<br />

16-173 MeV 3 He ++ , 20-130 4 He ++<br />

Sumitomo Heavy Industries CYPRIS 325 16 MeV H + , 8 MeV D + , 60µA 1<br />

CYPRIS 370 16 MeV H + , 10 MeV D + , 60µA 4<br />

HM 18 18 MeV H - , 10 MeV D - , 60µA 7<br />

HM 12 12 MeV H - , 6 MeV D - , 60µA 1<br />

480 AVF 30 MeV H + , 60µA 1<br />

AVF 680 40 MeV H + , 60µA 1<br />

AVF 715 50 MeV H + , 60µA<br />

AVF 750 70 MeV H + , 60µA 1<br />

AVF 930 90 MeV H + , 60µA 2<br />

AVF 1000 80 MeV H + , 60µA<br />

R<strong>in</strong>g Cyclotron 400 400 MeV H + (K=400), 60µA 1<br />

R<strong>in</strong>g Cyclotron 540 240 MeV H + (K=540), 60µA 1<br />

C235 240 MeV H - , 60µA 1<br />

KIRAMS Kirams-13 13 MeV H + , 100 µA 3<br />

2


Of the respondents to the survey, the number <strong>of</strong> exist<strong>in</strong>g cyclotrons broken down by energy<br />

level is given <strong>in</strong> Fig. 1.<br />

Number <strong>of</strong> <strong>Cyclotrons</strong><br />

180<br />

160<br />

140<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

100 MeV<br />

Energy Distribution<br />

FIG. 1. Distribution <strong>of</strong> proton energies as reported by respondents to the IAEA survey.<br />

The preponderance <strong>of</strong> low energy cyclotrons can be clearly seen from the distribution which is<br />

very similar to the distribution from the 2002 edition <strong>of</strong> the directory. Another <strong>in</strong>terest<strong>in</strong>g aspect is the<br />

distribution <strong>of</strong> time be<strong>in</strong>g devoted to radioisotope production. This distribution is shown <strong>in</strong> Figure 2.<br />

Number <strong>of</strong> Instutions<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

100 hrs<br />

Radioisotope <strong>Production</strong> Hours per week<br />

FIG. 2. Distribution <strong>of</strong> hours <strong>of</strong> radioisotope production from the respondents to the IAEA survey.<br />

3


One <strong>in</strong>terest<strong>in</strong>g aspect <strong>of</strong> this distribution is that many <strong>in</strong>stitutions are spend<strong>in</strong>g a very small<br />

fraction <strong>of</strong> the available time <strong>in</strong> radioisotope production. The cyclotron is idle <strong>for</strong> a significant fraction<br />

<strong>of</strong> the week. This implies that the cyclotron is not the slow step <strong>in</strong> cl<strong>in</strong>ical applications and that a<br />

s<strong>in</strong>gle cyclotron can support several PET or PET/CT cameras.<br />

The other <strong>in</strong>terest<strong>in</strong>g trend is <strong>in</strong> the compounds that are be<strong>in</strong>g synthesized with these<br />

radioisotopes. A graph <strong>of</strong> the number <strong>of</strong> centres that responded synthesiz<strong>in</strong>g these compounds is given<br />

<strong>in</strong> Fig. 3.<br />

Number <strong>of</strong> Instutions<br />

250<br />

200<br />

150<br />

100<br />

50<br />

0<br />

FDG FLT FDOPA Methon<strong>in</strong>e Ammonia Water<br />

Compound<br />

FIG. 3. Number <strong>of</strong> report<strong>in</strong>g <strong>in</strong>stitutions that use a particular compound.<br />

This figure clearly shows that 18 F-FDG is the most widely produced compound at cyclotron<br />

facilities world wide. It is now <strong>used</strong> <strong>in</strong> many applications <strong>in</strong> diagnostic nuclear medic<strong>in</strong>e.<br />

TABLE II. EXPECTED PRODUCTION YIELDS (MCI) OF SYNTHETIC PRECURSORS OF PET<br />

RADIOPHARMACEUTICALS WITH SELECTED PROTON AND DEUTERON ENERGIES AND<br />

IRRADIATION AT 20 TO 35 ΜA AS RECOMMENDED BY THE MANUFACTURER OF VARIOUS<br />

CYCLOTRONS.<br />

Precursor 12 MeV p only 10 MeV p + 5 MeV d 18 MeV p + 9 MeV d<br />

11 CO2 1500 1000 2800<br />

11 CO 1000 350 1400<br />

11 CO 1250 350 700<br />

11 CO 750 250 1200<br />

13 NH3 200 100 450<br />

15 O2 1000 >150/m<strong>in</strong>. 1200<br />

15 OC 500 >75/m<strong>in</strong>. 700<br />

15 OCO 500 >150/m<strong>in</strong>. 700<br />

15 OH2 750 200 1000<br />

18 F - 700 >500 800<br />

18 FF 300<br />

4


One <strong>of</strong> the areas <strong>of</strong> current research is on the development <strong>of</strong> very high current targets that can<br />

produce several curies <strong>of</strong> fluor<strong>in</strong>e-18 <strong>for</strong> synthesis <strong>of</strong> 18 F-FDG. This type <strong>of</strong> target is advantageous <strong>for</strong><br />

production facilities where distribution <strong>of</strong> 18 F-FDG is be<strong>in</strong>g carried out on a rout<strong>in</strong>e basis.<br />

5


1. ARGENTINA<br />

2005 COUNTRY: ARGENTINA ARG-1<br />

[1] INSTITUTE: Comisión Nacional de Energia Atómica (CNEA)<br />

Avenida del Libertador 8250<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

[3]<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

TYPE OF<br />

Isochronous,<br />

CYCLOTRON: negative ion<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

MODEL: CP - 42<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

1429 Buenos Aires<br />

+54 11 4379 8250<br />

rocco@cae.cnea.gov.ar<br />

+54 11 4480 0615<br />

Mr. Carmelo Rocco<br />

Head <strong>of</strong> the Facility<br />

Mr. Ortega Daniel, <strong>in</strong> charge <strong>of</strong> Operation and Ma<strong>in</strong>tenance<br />

Mr. Guevara Ernesto, <strong>in</strong> charge <strong>of</strong> Radiochemistry<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

1994<br />

(II) UPGRADE: Beam current <strong>in</strong>crease<br />

Dual Beams<br />

Beam energies (MeV) 25/42 Yes No<br />

Maximum beam available (µA) 150<br />

Typical beam employed (µA) 100<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research ma<strong>in</strong>tenance applications<br />

29 22 - 7 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

123 123 67 111<br />

I, I iodide and other compounds, Ga, In<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s and how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals<br />

carried out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

71


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

2<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2?<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18 O (p, n) 18 F 25 95 1.7 45 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/ Price/<br />

(list)<br />

(GBq) production<br />

Sales<br />

GBq<br />

18<br />

FDG 15 4 weekly Yes No Yes No U$S 392<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price<br />

(list)<br />

(GBq) production<br />

Sales<br />

/GBq<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield<br />

on batch, GBq<br />

Frequency <strong>of</strong><br />

production<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

OTHER ISOTOPES PRODUCED<br />

Typical yield on batch<br />

(GBq)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

Sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq) production<br />

Sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 37 2 monthly Yes No Yes No US$ 324<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g<br />

produced)<br />

The production <strong>of</strong> high purity 123 I is a project that was carried out under the IAEA’s Technical Co-operation<br />

Programme (ARG/4/085). The IAEA supported the CNEA ef<strong>for</strong>ts to set up required facilities <strong>in</strong>clud<strong>in</strong>g different<br />

system provision <strong>of</strong> expert and personnel tra<strong>in</strong><strong>in</strong>g.<br />

8


2005 COUNTRY: ARGENTINA ARG-2<br />

[1] INSTITUTE: Fundación Escuela de Medic<strong>in</strong>a Nuclear<br />

Garibaldi 405, CP 5500<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Mendoza 1429<br />

+54 261 4201 615 ( 1 ext. 564; 2 ext. 562; 3 ext. 508)<br />

enoya@fucsmen.edu.ar<br />

+54 261 4203 288<br />

Ing. Enrique R. Noya<br />

Electronic Eng<strong>in</strong>eer – Head <strong>of</strong> Operation and Ma<strong>in</strong>tenance<br />

Dr. Fernando Spigat<strong>in</strong> 2 , Head <strong>of</strong> Radiochemical Laboratory<br />

Ing. Norma Acosta 3 , Head <strong>of</strong> Radiological Security<br />

YEAR OF:<br />

CYCLOTRON:<br />

Negative ion hospital<br />

cyclotron<br />

(I) INSTALLATION<br />

1997<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

This cyclotron is not self-shielded. This is <strong>in</strong>stalled <strong>in</strong>side a bunker. All the support equipment is located <strong>in</strong><br />

different rooms.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 8 2 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

15 11<br />

O, C<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera 1<br />

S<strong>in</strong>gle photon tomography (SPET) 1<br />

Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

93


4<br />

18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 20 >97 0.330 100 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

(list)<br />

(GBq)<br />

production<br />

Used on site Distribution/sales Price/<br />

GBq<br />

18 FDG 10 5/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4 6/week p+ H20 Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

10<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2. AUSTRALIA<br />

2005 COUNTRY: AUSTRALIA AUL-1<br />

[1] INSTITUTE: Aust<strong>in</strong> and Repatriation Medical Centre<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Studley Road, Heidelberg, VIC 3084<br />

+61 3 9496 3995<br />

htd@aust<strong>in</strong>.unimelb.edu.au<br />

+61 3 9496 5892<br />

Dr. Henri Tochon-Danguy<br />

Senior Radiochemist<br />

Dr. John Sach<strong>in</strong>idis, Radiochemist<br />

Dr. Uwe Ackermann, Radiochemist<br />

Mr. Stan Poniger, Cyclotron/Robotic Eng<strong>in</strong>eer<br />

YEAR OF:<br />

1992<br />

CYCLOTRON:<br />

Negative ion<br />

accelerator<br />

(I) INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE: 1996 (new sources)<br />

MODEL: Cyclone 10/5 2001 (remote start-up &<br />

control)<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 10 5 Yes No<br />

Maximum beam available (µA) 50 20<br />

Typical beam employed (µA) 25 8<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

25 25 1 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

124 I,<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

4<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

115


6<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 37 90 1 200 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

Sales<br />

18<br />

FDG 24 7/week Yes No Yes No<br />

18<br />

F MISO 2 1/week Yes No Yes No<br />

18<br />

FLT 2 2/month Yes No Yes No<br />

18 FA85380 2 1/week Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq) production<br />

Sales<br />

PIB 2 2/week Yes No Yes No<br />

SCH23390 2 1/month Yes No Yes No<br />

Ro151788 2 2/month Yes No Yes No<br />

Chol<strong>in</strong>e 2 2/month Yes No Yes No<br />

PK11195 2 2/month Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

Sales<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 1/m<strong>in</strong> 1/week<br />

14 15<br />

N[d, n] O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

Sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

12<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: AUSTRALIA AUL-2<br />

[1] INSTITUTE: Australian Nuclear Science & Technology Organization<br />

(ANSTO)<br />

Radiopharmaceutical Division<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

New Illawarra Road<br />

+61 2 9717 9079<br />

stuart.carr@ansto.gov.au<br />

POSITION:<br />

Dr. S. Carr<br />

Director, Radiopharmaceuticals<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

D. Arnott<br />

[3] TYPE OF<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1991<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE: 1997<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

140 90 60 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

137


8<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Y<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

Sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

Sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

Sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

Sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

14<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: AUSTRALIA AUL-3<br />

[1] INSTITUTE: Peter MacCallum Cancer Institute<br />

12 Cathedral Place<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

East Melbourne 3002, Victoria<br />

Superconduct<strong>in</strong>g YEAR OF: (I)<br />

INSTALLATION<br />

+61 3 9656 1852<br />

peu@petermac.unimelb.edu.au<br />

+61 3 9656 1826<br />

Dr. Rodney J. Hicks<br />

Associate Pr<strong>of</strong>essor/Director, PET Centre<br />

Mr. Peter Eu, Radiochemist<br />

MANUFACTURER: Ox<strong>for</strong>d (II) UPGRADE:<br />

MODEL: 12 MeV<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 12 Yes N<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

13 12 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

18 18<br />

F-AZA, F-LT<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F, Wesley Private Hospital/ 2-3<br />

times/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

2<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

1 (Jan. 2002 delivery)<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1998<br />

159


10<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 55 95 5 500 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 6.5 1-2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

16<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


3. AUSTRIA<br />

2005 COUNTRY: AUSTRIA AUS-1<br />

[1] INSTITUTE: ARGOS Zyklotron<br />

Betriebs-Ges.m.b.H.<br />

LKH Klagenfurt, PET-Zentrum NMSE<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

St. Veiter Str. 47, A-9026 Klagenfurt<br />

+43 (0) 463 500 705<br />

+43 (0) 463 500 705 14<br />

Dr. Dirk W. Becker<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

Dipl. Ing. Mustafa Skenderi, QC<br />

NAME/POSITION<br />

Stefan Weber, Lead<strong>in</strong>g Technician<br />

[3] TYPE OF<br />

PT YEAR OF:<br />

1999<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: GE Medical Systems (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16 8.5 Yes N<br />

Maximum beam available (µA) 75 60<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

32 30 1 1 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Isotope<br />

production<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

( 18 F) FLT, 124 I, 86 Y<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

17<br />

11


12<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 120 95-96 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 65 Yes No Yes No<br />

DOPA 10 Yes No Yes No<br />

MISO 30 Yes No Yes No<br />

Fluoride 150 Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong> Yes No Yes No<br />

Chol<strong>in</strong> Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

18<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price<br />

/GBq<br />

Price/<br />

GBq


2005 COUNTRY: AUSTRIA AUS-2<br />

[1] INSTITUTE: Österreichisches Forschungszentrum Seibersdorf<br />

Department <strong>of</strong> Radiopharmaka<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

A-2444 Seibersdorf<br />

+43 0 50 550 3470<br />

Peter.Angelberger@arcs.ac.at<br />

+43 0 50 550 3473<br />

Dr. Peter Angelberger<br />

Department Head<br />

Dr. Herbert Kvaternik, Deputy<br />

Negative ion YEAR OF:<br />

1999<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: GE Uppsala (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes N<br />

Maximum beam available (µA) 75 60<br />

Typical beam employed (µA) 40 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15 10 4 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

Further 18 F radiopharmaceuticals<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

19<br />

13


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

14<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 130 95 250 Yes<br />

No<br />

20 Ne (d, α) 18 F 20<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 65 5/week Yes No Yes No<br />

FDOPA 2 2/month Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

20<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


4. BELGIUM<br />

2005 COUNTRY BELGIUM BEL 1<br />

[1] INSTITUTE: ULB/Erasme hospital<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Negative ion<br />

IBA<br />

Cyclone-30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

808 Lennik street, B-1070 Brussel<br />

00.32.2.555.47.10<br />

sgoldman@ulb.ac.be<br />

00.32.2.555.47.01<br />

Dr. S.Goldman<br />

Doctor <strong>in</strong> medic<strong>in</strong>e<br />

M.Monclus (PhD, radiochemist)<br />

M.Kadiata (PhD, radiochemist)<br />

J.Van Naemen (cyclotron eng<strong>in</strong>eer)<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

3 He<br />

4 He<br />

1990<br />

1999-2006<br />

Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 200<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

<strong>for</strong> radio. product<br />

ma<strong>in</strong>tenance applications<br />

20 3 2.5 1 0<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: 20 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18<br />

F labeled am<strong>in</strong>o acid and derivatives<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence 0<br />

Gamma camera 4<br />

S<strong>in</strong>gle photon tomography (SPET) 4<br />

Positron emission tomography (PET) 2<br />

- Cl<strong>in</strong>ical 2<br />

- Small animal 0<br />

- Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

21<br />

15


16<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 111 95 1.5 ml 600 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 67 254/year Yes No Yes No<br />

18<br />

F MPPF 2 10/year Yes No Yes No<br />

18<br />

F F- 2 5/year Yes No Yes No<br />

18<br />

F<br />

phenylalan<strong>in</strong>e<br />

2 5/year Yes No Yes No<br />

18<br />

F FET 2 10/year Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C methion<strong>in</strong>e 8 154 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N radiopharmaceuticals produced<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N NH3 3 10<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O H2O 3 10/year<br />

16 15<br />

O(p,pn) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu 0 Yes No Yes No<br />

67<br />

Ga 0 Yes No Yes No<br />

86<br />

Y 0 Yes No Yes No<br />

94m<br />

Tc 0 Yes No Yes No<br />

103<br />

Pd 0 Yes No Yes No<br />

111<br />

In 0 Yes No Yes No<br />

123<br />

I<br />

0 Yes No Yes No<br />

124<br />

I<br />

0 Yes No Yes No<br />

201<br />

Tl 0 Yes No Yes No<br />

211<br />

At 0 Yes No Yes No<br />

22<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 Country: BELGIUM BEL-2<br />

[1] Institute: Institute <strong>of</strong> Nuclear Sciences<br />

University <strong>of</strong> Ghent<br />

Telephone no.:<br />

E-mail address:<br />

Fax No.:<br />

[2] Person <strong>in</strong> charge:<br />

Position:<br />

Proeftu<strong>in</strong>straat 86, B-9000 Gent<br />

+32 9 264 6616<br />

karel.strijckmans@rug.ac.be<br />

+32 9 264 6699<br />

Pr<strong>of</strong>essor Dr. Karel Strijckmans<br />

Pr<strong>of</strong>essor<br />

Other senior staff:<br />

Name/Position<br />

[3] Type <strong>of</strong> cyclotron: Isochronous Year <strong>of</strong>: (i) <strong>in</strong>stallation 1977<br />

Manufacturer: CGR-MeV (France) (ii) upgrade: 1982<br />

Model: 520<br />

[4] Cyclotron characteristics:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 2.5 – 24 3 – 14.5 6 – 32 10 – 29 Yes No<br />

Maximum beam available (µA) 100 100 60 60<br />

Typical beam employed (µA) 20 5 - -<br />

[5] Cyclotron operation:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20-30 10 10-20


18<br />

18 F <strong>Radionuclide</strong> production<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15 97 0.8 50 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F radiopharmaceuticals produced<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 4 3-4/week Yes No Yes No<br />

seronot<strong>in</strong><br />

receptor<br />

antagonist<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C radiopharmaceuticals produced<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

PK 11195 4


2005 COUNTRY: BELGIUM BEL-3<br />

[1] INSTITUTE: MDS Nordion S.A.<br />

Zone Industrielle<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

B-6220 Fleurus<br />

+32 10 829 211<br />

+32 10 829 696<br />

Dr. Claude Pirarat<br />

Manager, Radiochemical <strong>Production</strong><br />

Isochronous YEAR OF:<br />

1992<br />

CYCLOTRON: Cyclotron H- (I) INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15 - 30 Yes No<br />

Maximum beam available (µA) 400<br />

Typical beam employed (µA) 400<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

160 160 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions? If yes and available, name <strong>of</strong><br />

<strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Bulk 201 Tl – Europe, North and South America, 123 I, 201 Tl – Europe (OEM manufactur<strong>in</strong>g)<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

25<br />

19


20<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

123<br />

I 100 – 250 4/week Yes No Yes No<br />

201<br />

Tl 150 - 300 5/week Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

26<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


-<br />

2005 COUNTRY: BELGIUM BEL-4<br />

[1] INSTITUTE: Universite catholique de Louva<strong>in</strong><br />

Centre de Recherches du Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Compact H- YEAR OF: (I)<br />

INSTALLATION<br />

2, Chem<strong>in</strong> du Cyclotron, B-1348 Louva<strong>in</strong>-la-Neuve<br />

+32 10 472 998<br />

ryckewaert@cyc.ucl.ac.be<br />

+32 10 452 183<br />

Mr. Guido Ryckewaert<br />

Director<br />

Mr. Daniel Labar – Head <strong>of</strong> Radiochemistry<br />

MANUFACTURER: UCL/IBA, s.a. (II) UPGRADE:<br />

MODEL: Prototype<br />

Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 15 – 30 Yes No<br />

Maximum beam available (µA) 350<br />

Typical beam employed (µA) 50/300<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 - 4 15<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: 15 Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1987<br />

27<br />

21


22<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 80 95 2 200 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 40 daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 5 monthly Yes No Yes No<br />

Methion<strong>in</strong>e 5 weekly Yes No Yes No<br />

Flumazenil 5 monthly Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

NH4OH 5 weekly<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 10 2/week<br />

16 15<br />

O (p, pn) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 1 weekly Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

28<br />

Price/G<br />

Bq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: BELGIUM BEL-5<br />

[1] INSTITUTE: Universite catholique de Louva<strong>in</strong><br />

Centre de Recherches du Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Isochronous<br />

multiparticle variable<br />

energy<br />

2, Chem<strong>in</strong> du Cyclotron, B-1348 Louva<strong>in</strong>-la-Neuve<br />

+32 10 472 998<br />

ryckewaert@cyco.ucl.ac.be<br />

+32 10 452 183<br />

Mr. Guido Ryckewaert<br />

Director<br />

Mr. Daniel Labar – Head <strong>of</strong> Radiochemistry<br />

YEAR OF: (I)<br />

INSTALLATION<br />

1969-1972<br />

MANUFACTURER: Thomson – CSF. (II) UPGRADE:<br />

MODEL: Cyclone<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 20 – 85 10 – 55 15 – 145 20 - 110 Yes No<br />

Maximum beam available (µA) 30 20 5 20<br />

Typical beam employed (µA) 20 10 5 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

150 8 - 4 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? To two centres, sporadically.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Number<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

29<br />

23


24<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

28<br />

Mg 20 MBq Al (100%) Yes No Yes No<br />

52<br />

Fe 0,2 – 2 MBq Mn (100%) Yes No Yes No<br />

94,95,96<br />

Tc 0,1 – 0,01 MBq Mo (nat) Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

30<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: BELGIUM BEL-6<br />

[1] INSTITUTE: Universite de Liege<br />

Centre de Recherches du Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Sart Tilman, B-4000 Liege<br />

+32 4 366 2360<br />

cyclotron@ulg.ac.be<br />

+32 4 366 2946<br />

Dr. A. Luxen<br />

Director<br />

C. Brihaye, Senior Radiochemist<br />

G. Del Fiore, Senor Radiochemist<br />

C. Lemaire, Senior Radiochemist<br />

A. Plenevaux, Senior Radiochemist, Aerts/Pharmacist<br />

H-/D- YEAR OF:<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1999<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 50 35<br />

Typical beam employed (µA) 50 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 10 20 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) PET/30<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

Several radiopharmaceuticals specific <strong>for</strong> receptoe and gene expression imag<strong>in</strong>g.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Number<br />

Positron emission tomography (PET) 1<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

31<br />

25


26<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 4 Ci 95 2 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 75 250/year Yes No Yes No<br />

FTyros<strong>in</strong>e 11 12/year Yes No Yes No<br />

FDopa 11 12/year Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 0.37 4000/year<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

32<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: BELGIUM BEL-7<br />

[1] INSTITUTE: University <strong>of</strong> Leuven (KUL)<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e, U.Z. Gasthuisberg<br />

Herestraat 49<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

B-3000 Leuven<br />

+32 16 34 3715<br />

luc.mortelmans@UZ.kuleuven.ac.be<br />

+32 16 34 3759<br />

Luc Mortelmans, MD, PhD.<br />

Head <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Negative ion YEAR OF: (I) INSTALLATION 1990<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 10/5<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 10 5 Yes No<br />

Maximum beam available (µA) 70 50<br />

Typical beam employed (µA) 45 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5 4 0 1 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 0<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 0<br />

– Small animal 0<br />

– Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

33<br />

27


28<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F #1 — 20 GBq 97 #1 — 0,5 mL<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

#2 — 70 GBq<br />

#2 — 2 mL<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

18<br />

FDG 350 GBq 1-2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

Methion<strong>in</strong>e 2 1/week Yes No Yes No<br />

Acetate 2 0,5/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

13<br />

N H3 2 3/week<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

sales<br />

sales<br />

sales<br />

16 O(p,x) Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2 15 O 2 2-3/week<br />

14 N(d,n)<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

34<br />

Yes<br />

No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: BELGIUM BEL-8<br />

[1] INSTITUTE: Vrije Universiteit Brussels<br />

Eenheid Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Laarbeeklaan 103, B-1090 Brussels<br />

+32 2 4774 864 or +32 2 477 4860<br />

pvdw<strong>in</strong>k@vucy.vub.ac.be<br />

aherman@vucy.vub.ac.be<br />

+32 2 477 4855<br />

Pr<strong>of</strong>essor A. Hermanne<br />

Head, Cyclotron Department<br />

Pr<strong>of</strong>essor P. Van den W<strong>in</strong>kel<br />

Pr<strong>of</strong>essor J. Mertens<br />

AVR YEAR OF:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1983<br />

MANUFACTURER: CGR France (II) UPGRADE:<br />

MODEL: 560<br />

[4] CYCLOTRON CHARACTERISTICS: All beams are extracted with an electrostatic deflector – average 50%.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 5-42 10-22 20-50 20-43 Yes No<br />

Maximum beam available (µA) 100 100 10 20<br />

Typical beam employed (µA) 2-30 8<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

2 3 2 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 7 Proton therapy:<br />

Physics: 3 Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No En > 25 MeV. Th<strong>in</strong> targets<br />

neutron TOF spectroscopy<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

Neurotens<strong>in</strong> analogues; 18 F peptides and aromatic am<strong>in</strong>o acids; Pd- 103 <strong>for</strong> research labell<strong>in</strong>g and rodent studies;<br />

188 186<br />

Rh Rh<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? RUG , SCK<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site? In academic hospitals – Nuclear Medic<strong>in</strong>e<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera > 3<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

1<br />

–Cl<strong>in</strong>ical From June 2001<br />

–Small animals<br />

–Plant biochemistry<br />

collaboration with RUG<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience Yes No<br />

35<br />

29


30<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 16 95 0.45 40 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 8 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/GBq<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 37 2-4 /week Yes No Yes No Stopped <strong>in</strong><br />

1996<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Additional labelled compounds:<br />

77 Br, 56 Co, 123 I , 111 In, 206 Tl neurotens<strong>in</strong> analogues, 123 I peptides and aromatic am<strong>in</strong>o acids<br />

36


5. BRAZIL<br />

2005 COUNTRY: BRAZIL BRA-1<br />

[1] INSTITUTE: Instituto de Engenharia Nuclear (IEN)<br />

Caixa Postal 68550, Cidade Universitária S/N – Ilha do Fundão<br />

21945-970 – Rio de Janeiro – RJ<br />

TELEPHONE NO.:<br />

+55 21 560-4113 ext. 2184<br />

E-MAIL ADDRESS:<br />

suita@cnen.gov.br<br />

[2] PERSON IN CHARGE:<br />

Dr. Julio Cezar Suita<br />

POSITION:<br />

Head, Radiopharmaceutical Division<br />

OTHER SENIOR STAFF:<br />

Ana Maria Silveíra Braghirolli<br />

NAME/POSITION<br />

José Antônio Dias Furlaneto<br />

NAME/POSITION<br />

Jackson Louis Queiroz de Britto<br />

Migual Ângelo Valle Bastos<br />

[3] TYPE OF<br />

Isochronous YEAR OF:<br />

1975<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

(II) UPGRADE:<br />

MODEL: CV-28<br />

[4] CYCLOTRON CHARACTERISTICS: Variable energy and multiparticle<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 24 14 36 28 Yes No<br />

Maximum beam available (µA) 50 75 30 25<br />

Typical beam employed (µA) 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

32 20 4 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No Occasionally<br />

Mössbauer sources? (specify which & quantity) Yes No Occasionally<br />

X ray sources? (specify which & quantity) Yes No Occasionally<br />

Intense neutron beam? (specify average En = ?) 17 MeV Yes No Occasionally<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

n-isopropyl para-iod<strong>in</strong>e anphetam<strong>in</strong>e labelled with 123 I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

37<br />

31


32<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 11 96 0.3 30 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α, d) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

18 FDG 6 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

15 3/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Meta – iod<strong>in</strong>ebenzilguan<strong>in</strong>e labelled with 123 I has also been produced.<br />

38<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: BRAZIL BRA-2<br />

[1] INSTITUTE: Instituto de Pesquisas Energéticas e Nucleares – IPEN/CNEN-<br />

SP<br />

Travesa , R, 400, Cidade Universitária<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

CEP – 05508-900, São Paulo, SP<br />

+55 11 3816 9275/ 9265<br />

wdelima@net.ipen.br<br />

+55 11 3816 9263<br />

Dr. Wanderley de Lima<br />

Head, Cyclotron Laboratory<br />

Dra. C. Pagano G. da Silva, Head – Radioisotope Department<br />

Uylton Matsoda<br />

[3] TYPE OF<br />

Fixed field, fixed<br />

Valdir Sciani<br />

YEAR OF: (I)<br />

1998<br />

CYCLOTRON: frequency<br />

INSTALLATION<br />

MANUFACTURER: TBA, S.A. (II) UPGRADE:<br />

MODEL: Cyclone - 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15-30 Yes No<br />

Maximum beam available (µA) 500<br />

Typical beam employed (µA) 200<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 18 - 2 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

201 111<br />

Tl, In<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Hospitals and medical centers/<br />

weekly<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

39<br />

33


34<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 37 94 2 200 Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 500 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Nuclear reaction <strong>used</strong> Distribution/sales Price/G<br />

Bq<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/G<br />

Bq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/G<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Bq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 50 1/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

20 1/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

As <strong>of</strong> June 2001, MIBG 123 I, HEPPURAN 123 I and radiopharmaceutical <strong>for</strong> neuroreceptors are produced.<br />

40


6. CANADA<br />

2005 COUNTRY: CANADA CAN-1<br />

[1] INSTITUTE: Clark Institute <strong>of</strong> Psychiatry<br />

250 College Street<br />

Toronto, ON M5T 1R8<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 416 979 4651<br />

FAX NO.:<br />

+1 416 979 4656<br />

[2] PERSON IN CHARGE:<br />

Dr. Sylva<strong>in</strong> Houle<br />

POSITION:<br />

Head, PET Centre<br />

OTHER SENIOR STAFF:<br />

Allan A. Wilson<br />

NAME/POSITION<br />

Jean Da Silva<br />

[3] TYPE OF<br />

Fixed energy YEAR OF: (I)<br />

1991<br />

CYCLOTRON: isochronous<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 8.5 Yes No<br />

Maximum beam available (µA) 15-60 20-25<br />

Typical beam employed (µA) 10-40 10-12<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20-25 20-22 2-3 (additional 1weekma<strong>in</strong>tenance/y)<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

41<br />

35


36<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F-FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-raclopride Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

15 O-water<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/G<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Bq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

42


2005 COUNTRY CANADA CAN -2<br />

[1] INSTITUTE: Edmonton PET Centre, Cross Cancer Institute<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Negative ion<br />

Advanced Cyclotron<br />

Systems<br />

TR19/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Edmonton, AB, T6G 1Z2, Canada<br />

780-989-4311<br />

stevemcq@cancerboard.ab.ca<br />

780-432-8483<br />

Steve McQuarrie, PhD<br />

Director, Cyclotron Operations and<br />

Pr<strong>of</strong>essor, Faculty <strong>of</strong> Medic<strong>in</strong>e, University <strong>of</strong> Alberta<br />

John Wilson, PhD<br />

Sr. Cyclotron Operator<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 19 9 Yes x No<br />

Maximum beam available (µA) 200 100 200<br />

Typical beam employed (µA) 75 20 75<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

30 30 1<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (Medical research) 30<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No X<br />

Mössbauer sources? (specify which & quantity) Yes No X<br />

X ray sources? (specify which & quantity) Yes No X<br />

Intense neutron beam? (specify average En = ?) Yes No X<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

<strong>Radionuclide</strong>s: 124 I, 64 Cu, 86 Y<br />

Radiopharmaceuticals: Development <strong>of</strong> new tracers to study metabolic processes <strong>in</strong> cancer.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Foothills Hospital, Calgary. 3 – 4/week<br />

Health Sciences Centre, W<strong>in</strong>nipeg. 3 -4/week<br />

Yes X No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes X No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number <strong>of</strong><br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

3<br />

–Cl<strong>in</strong>ical 3<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

3 He<br />

4 He<br />

2001<br />

N/A<br />

43<br />

37


38<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 180 95 2 Yes X<br />

No<br />

Ne (d, α) 18 F 0<br />

16 O (α, x) 18 F 0<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 50 - 100 3/day Yes X No Yes X No<br />

18<br />

FES 2 - 10 1/week Yes X No Yes No X<br />

18<br />

FLT 2 - 10 1/week Yes X No Yes No X<br />

18<br />

FAZA 2 - 10 3/week Yes X No Yes No X<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-chol<strong>in</strong>e Yes X No Yes No X<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

< 0.05 1 – 4 /month Yes X No Yes No X<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

The Edmonton PET centre is a basic science and translational research centre whose mission is the discovery,<br />

elucidation and cl<strong>in</strong>ical evaluation <strong>of</strong> the molecular mechanisms associated with cancer.<br />

44


2005 COUNTRY: CANADA CAN-3<br />

[1] INSTITUTE: Hamilton Health Sciences Corporation<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Mc Master Site, 1200 Ma<strong>in</strong> Street West, Room 1 P 6<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Hamilton, ON L8N3Z5<br />

+1 905 521 2100 ext. 76893/73025<br />

chiraklr@mcmaster.ca<br />

+1 905 546 1125<br />

Dr. Raman Chirakal<br />

Radiochemist<br />

Jia Juen Chen<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

RDS 112 YEAR OF: (I)<br />

1990<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

CTI, Inc. (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS: Negative ion cyclotron<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 10 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5 3 2 1 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 3 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Research - 2<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Ottawa Heart Institute, 1/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

45<br />

39


40<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 18.5 94 0.8 14 200 10 Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 10 6/week Yes No Yes No<br />

J6 – F MT 1.12 1/week Yes No Yes No<br />

J6 - FDOPA 0.3 2/month Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

ACETATE 0.3 2/month Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

AMMONIA 0.8 4/week<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

WATER 5.6 9/month<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

46<br />

18 OH2<br />

?<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CANADA CAN-4<br />

[1] INSTITUTE: Montreal Neurological Institute<br />

McGill University<br />

3801, University Street<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Montreal, Quebec H3A2BA<br />

+1 514 398 8526<br />

mirko@pet.mni.mcgill.ca<br />

+1 514 398 8540<br />

Pr<strong>of</strong>. Mirko Diksic<br />

Dean Jolly<br />

Negative ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 100 60<br />

Typical beam employed (µA) 30-40 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20-30 20-30 2-3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Number<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1993<br />

47<br />

41


42<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F-FDG Yes No Yes No<br />

18<br />

F-DOPA Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-RO Yes No Yes No<br />

Deprenyl Yes No Yes No<br />

α-methyl-<br />

L-trypotophan<br />

Yes No Yes No<br />

Bensotrop<strong>in</strong>e Yes No Yes No<br />

PK-11195 Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

48


2005 COUNTRY: CANADA CAN-5<br />

[1] INSTITUTE: TRIUMF<br />

4004 Westbrook Mall<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Vancouver, BC V6T 2A3<br />

+1 604 222 1047<br />

Zeisler@triumf.ca<br />

+1 604 222 1074<br />

Dr. Stefan K. Zeisler<br />

Manager, Applied Technology Groups<br />

Mr. R. Van Den Elzen<br />

H- / sector-foc<strong>used</strong> YEAR OF: (I)<br />

INSTALLATION<br />

1990<br />

MANUFACTURER: EBCO (II) UPGRADE: 1995<br />

MODEL: TR30<br />

[4] CYCLOTRON CHARACTERISTICS<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 1200<br />

Typical beam employed (µA) 1000<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

168 148 - 20 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

49<br />

43


44<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd ~7/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

3/week Yes No Yes No<br />

201<br />

Tl ~5/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Yields and prices <strong>of</strong> commercial products are confidential and cannot be reported.<br />

50<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CANADA CAN-6<br />

[1] INSTITUTE: TRIUMF<br />

4004 Wesbrook Mall<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER: EBCO<br />

MODEL: TR30-2<br />

[4] CYCLOTRON CHARACTERISTICS<br />

1 H<br />

Vancouver, BC V6T 2A3<br />

+1 604 222-7364<br />

Zeisler@triumf.ca<br />

+1 604 221-0436<br />

Dr. Stefan K. Zeisler<br />

Manager, Applied Technology Group<br />

Mr. R. van den Elzen<br />

H- / sector-foc<strong>used</strong> YEAR OF: (I)<br />

INSTALLATION<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 1200<br />

Typical beam employed (µA) 1000<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

168 148 - 20 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

3 He<br />

4 He<br />

2002<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

51<br />

45


46<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd ~7/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

3/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may <strong>in</strong>clude names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Yields and prices <strong>of</strong> commercial products are confidential and cannot be reported.<br />

52<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CANADA CAN-7<br />

[1] INSTITUTE: TRIUMF<br />

4004 Wesbrook Mall<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Vancouver, BC V6T 2A3<br />

+1 604 222-7364<br />

zeisler@triumf.ca<br />

+1 604 221-0436<br />

Dr. Stefan K. Zeisler<br />

Manager, Applied Technology Group<br />

Mr. R. van den Elzen<br />

520 MeV H-/ YEAR OF: (I)<br />

1962<br />

CYCLOTRON: sector-foc<strong>used</strong> INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

TRIUMF (II) UPGRADE: 1997<br />

[4] CYCLOTRON CHARACTERISTICS: Isotope production beam l<strong>in</strong>e only<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 500 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 70<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

144 4 months/year<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

53<br />

47


48<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

82 Sr/ 82 Rb, Mo(p, spall) — ~ 8 targets/year<br />

54<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CANADA CAN-8<br />

[1] INSTITUTE: TRIUMF<br />

4004 Wesbrook Mall<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Vancouver, BC V6T 2A3<br />

+1 604 222-7364<br />

zeisler@triumf.ca<br />

+1 604 221-0436<br />

Dr. Stefan K. Zeisler<br />

Manager, Applied Technology Group<br />

Mr. R. van den Elzen<br />

H-/sector-foc<strong>used</strong> YEAR OF:<br />

INSTALLATION<br />

(I)<br />

1980<br />

(II) UPGRADE: 1991<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

MODEL: CP42<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 42 Yes No<br />

Maximum beam available (µA) 200<br />

Typical beam employed (µA) 180<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

168 158 1 9 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? University <strong>of</strong> British Columbia,<br />

Botany Department, 1-2 times/week<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

55<br />

49


50<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

13 N – NO3 7 1/week<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16<br />

O(p, α) Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 5/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 1/month Yes No Yes No<br />

123<br />

I<br />

3/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Yields and prices <strong>of</strong> commercial products are confidential and cannot be reported.<br />

56<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CANADA CAN-9<br />

[1] INSTITUTE: UBC/TRIUMF PET Programme<br />

4004 Wesbrook Mall<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Vancouver, BC V6T 2A3<br />

+1 604 222 1047<br />

truth@triumf.ca<br />

+1 604 222 1074<br />

Dr. Thomas Ruth<br />

PET Director/Senior Research Scientist<br />

Ken Buckley, PET Project Eng<strong>in</strong>eer<br />

Negative ion, YEAR OF: (I)<br />

1994<br />

CYCLOTRON: sector foc<strong>used</strong><br />

INSTALLATION<br />

MANUFACTURER: EBCO (II) UPGRADE:<br />

MODEL: TR13<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 13 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

25 15 10 4 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: 2 Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

Same as below.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Various, on request<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET) 3<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

57<br />

51


52<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F F 2 – 18.5 >90 0.5 500 50 1 Ye<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

F -26<br />

No<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 3.7 1/week Yes No Yes No<br />

18<br />

F SETOPERONE 1.8 1/week Yes No Yes No<br />

18 F DOPA 0.8 2/week Yes No Yes No<br />

18 F EF5 0.8


7. CHINA<br />

2005 COUNTRY: CHINA CPR-1<br />

[1] INSTITUTE: Ch<strong>in</strong>a Institute <strong>of</strong> Atomic Energy<br />

P.O. Box 275 (99)<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Beij<strong>in</strong>g 102413<br />

+86 01 69358090<br />

+86 01 69357195<br />

Dr. Li Da Kang<br />

OTHER SENIOR STAFF:<br />

Zhao Gui Zhi; Zhao Zhen Lu<br />

NAME/POSITION<br />

Shen de Heng Xu Shu He<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1995<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA sa (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

15-30 Yes No<br />

Typical beam employed (µA) 100-220<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

4 days/week 4 days/week 1 day/week<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

123 186<br />

I, Re<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 57 Co to USA 1 per month<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET) 2<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

59<br />

53


54<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

60<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CHINA CPR-2<br />

[1] INSTITUTE: Guangdong Prov<strong>in</strong>ce People's Hospital<br />

96 Dong Chuan Road<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Guangzhou 5 10 100<br />

+11 86 20 8382 7812<br />

+11 86 20 8382 5453<br />

Dr. Tang Au-Wu<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11.1 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 38.5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

18 12 2 2 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

3 He<br />

4 He<br />

1999<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

61<br />

55


56<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 1.2 260 Yes<br />

No<br />

Ne (d,α) 18 F<br />

16 O (α , d) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 30 4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

Frequency <strong>of</strong><br />

production<br />

AMMONIA 4 1/week<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 O (p , α ) 13 N Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 22 3/month<br />

15 15<br />

N (p , n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

62<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CHINA CPR-3<br />

[1] INSTITUTE: Hong Kong Sanatorium & Hospital, Ltd.<br />

Department <strong>of</strong> Radiology & Radiotherapy<br />

2 Village Road, Happy Valley<br />

Hong Kong<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+11 852 2835 8989<br />

FAX NO.:<br />

+11 852 2835 8825<br />

[2] PERSON IN CHARGE:<br />

Dr. C.L. Ho<br />

POSITION:<br />

Director, Department <strong>of</strong> Nuclear Medic<strong>in</strong>e and PET<br />

OTHER SENIOR STAFF:<br />

Dr. David W.C. Young, Deputy Director<br />

NAME/POSITION<br />

Mr. Steve H.Q. Sitt, Manager<br />

Dr. M.K. Cheung, Radiochemist<br />

[3] TYPE OF<br />

- YEAR OF: (I)<br />

1998<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE: -<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

6 5 – 18 F; 1 – 11 C 1 6<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

15 18 18 18 18<br />

O-oxygen; F-Fluoroestradiol, F-chol<strong>in</strong>e, F-fluoro-α-methyltyros<strong>in</strong>e, F-DOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

63<br />

57


58<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F ~ 37 95 1100 Y<br />

No<br />

Ne(d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG ~ 15 5 batches/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate ~ 3.7 1-2/week Yes No Yes No<br />

Chol<strong>in</strong>e ~ 3.7 1/month Yes No Yes No<br />

Methion<strong>in</strong>e ~ 3.7 1/ month Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia ~ 1.8 1/month O(p, α) 13 N Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

64<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CHINA CPR-4<br />

[1] INSTITUTE: Key Laboratory <strong>of</strong> Radiopharmaceuticals (Beij<strong>in</strong>g Normal<br />

University), M<strong>in</strong>istry <strong>of</strong> Education <strong>of</strong> Ch<strong>in</strong>a<br />

Beij<strong>in</strong>g Normal University<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Beij<strong>in</strong>g ,100875 , P. R. Ch<strong>in</strong>a<br />

+86-01-6220 7786<br />

zhul<strong>in</strong>@bnu.edu.cn<br />

+86-01-62207786<br />

Pr<strong>of</strong>essor L<strong>in</strong> Zhu<br />

Zhi-Gang Tang/senior Eng<strong>in</strong>eer<br />

Zheng-Hao Liu/Pr<strong>of</strong>essor<br />

M<strong>in</strong>g-Da Hua/Pr<strong>of</strong>essor<br />

Positive ion YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: TCC (II) UPGRADE:<br />

MODEL: CS-22<br />

[4] CYCLOTRON CHARACTERISTICS: Our CS-22 will be <strong>used</strong> to produce radiopharmaceuticals <strong>in</strong> 2002.<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 22 11 29 Yes No<br />

Maximum beam available (µA) 50 50 50<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1997<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 67 111 18 18<br />

F, Ga, In, FDG, F - DOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

microSPECT 1 Next year<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

65<br />

59


60<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 95 0.3 Yes<br />

No<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

18<br />

F - DOPA Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

66<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CHINA CPR-5<br />

[1] INSTITUTE: Institute <strong>of</strong> Applied Chemistry<br />

Beij<strong>in</strong>g Normal University<br />

Bej<strong>in</strong>g Cyclotron Produced Radiopharmaceutical Laboratory<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

100875 Beij<strong>in</strong>g, Ch<strong>in</strong>a P.R.<br />

+86 01 6220 7786 or 8396<br />

Liuboli@bnu.edu.cn<br />

+86 01 6220 0567<br />

Pr<strong>of</strong>essor Bo Li Liu<br />

Dean <strong>of</strong> Radiochemistry<br />

Huang Zheng X<strong>in</strong>g<br />

Pr<strong>of</strong>essor Liu Zheng Hao<br />

Zhang Hui X<strong>in</strong>g<br />

Chen Ru Yi<br />

Positive ion YEAR OF:<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1986<br />

MANUFACTURER: TCC (II) UPGRADE:<br />

MODEL: CS-30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 26 15 30 Yes No<br />

Maximum beam available (µA) 200 200 100<br />

Typical beam employed (µA) 110<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

67<br />

61


62<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α , d) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

68<br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq


COUNTRY: CHINA CPR-6<br />

[1] INSTITUTE: Pek<strong>in</strong>g Union Medical College Hospital<br />

Nuclear Medic<strong>in</strong>e Department PET Centre<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Beij<strong>in</strong>g 100730<br />

+86 10 652 33129<br />

+86 10 652 33129<br />

Dr. Chien Chou<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 35-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

4 – 8 2 - 3 1 - 2 1 - 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence EXACT HR +<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

3 He<br />

4 He<br />

1998<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

69<br />

63


64<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 14.8 - 29.6 > 94 1.1 Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α , d) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 7.4 – 11.1 2-3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

18 F-F–Ethyl–tyros<strong>in</strong>e: not <strong>in</strong> cl<strong>in</strong>ical trial yet.<br />

70<br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq


2005 COUNTRY: CHINA CPR-7<br />

[1] INSTITUTE: Shanghai Institute <strong>of</strong> Nuclear Research<br />

P.O. Box 800-204<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

201800 Shanghai<br />

+86 21 5955 3634<br />

wyxydz@ihw.com.cn<br />

+86 21 5955 2509<br />

Pr<strong>of</strong>essor Wang Yongxian<br />

Director<br />

Cao Benhong<br />

Gao Wenzhao<br />

Yuyi<br />

Negative ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) Yes No<br />

Maximum beam available (µA) 400<br />

Typical beam employed (µA) 150<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1996<br />

h/week <strong>for</strong><br />

applications<br />

50 50<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

71<br />

65


66<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α ,d) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5500 - 7400 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 12950 - 14800 1/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 14800- 16650 2/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

72<br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq


2005 COUNTRY: CHINA CPR-8<br />

[1] INSTITUTE: The PLA General Hospital<br />

28 Fux<strong>in</strong>g Road<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Beij<strong>in</strong>g 100853<br />

+86 10 6693 9424<br />

tianih@public.east.cn.net or zhangim@s<strong>in</strong>a.com<br />

+86 10 681 31142<br />

Pr<strong>of</strong>essor Jia-he Tian<br />

J<strong>in</strong>m<strong>in</strong>g Zhang<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

8 4 1 2<br />

3 He<br />

4 He<br />

1999<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

73<br />

67


68<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 37 1.1 150 Ye<br />

No<br />

Ne (d,α) 18 F<br />

16 O (α ,d) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 18.5 2-4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq) production<br />

sales<br />

Acetate 3.7 1-2/week Yes No Yes No<br />

Methio<strong>in</strong>e 2 0-1/week Yes No Yes No<br />

RACLOPRIDE 2 0-1/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

AMMONIA 1.5 2/week<br />

16 13<br />

O(p, α ) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

WATER 74 0-1/week<br />

15 15<br />

N(p, n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

74<br />

18 OH2<br />

?<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq


2005 COUNTRY: CHINA CPR-9<br />

[1] INSTITUTE: Zibo Wanjie Hospital<br />

Boshan, Zibo<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Shandong<br />

+86 533 4650 000 8730<br />

+86 533 4650 830<br />

Dr. Sun Qiy<strong>in</strong><br />

Wang M<strong>in</strong>g Fang<br />

Zhao Jun<br />

Wang Changq<strong>in</strong>g<br />

Li Jiam<strong>in</strong><br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1995<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

16.5 Yes No<br />

Typical beam employed (µA) 20-30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

6 5 7<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 15 82<br />

C, O, Rb<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

75<br />

69


70<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

76<br />

18 OH2<br />

?<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


8. CZECH REPUBLIC<br />

2005 COUNTRY: CZECH REPUBLIC CZR-1<br />

[1] INSTITUTE: Nuclear Physics Institute<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Rez near Prague, 25068 Rez<br />

+420 2 6617 3613<br />

stursa@ujf.cas.cz<br />

+420 2 20941130<br />

Ing. Jan Stursa, MSc.<br />

Head <strong>of</strong> the Cyclotron Division<br />

J. Kucera, Deputy Head<br />

J. Lacman, Control System<br />

M. Cihak, Beam Dynamics<br />

Isochronous YEAR OF: (I)<br />

INSTALLATION<br />

1977 First beam<br />

MANUFACTURER: JINR Dubna, Russia (II) UPGRADE: 1992 Axial <strong>in</strong>jection<br />

MODEL: U-120M 1997 H - , D - Beams<br />

2000 New beam l<strong>in</strong>e<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 10-38 10-20 17-53 20-40 Yes No<br />

Maximum beam available (µA) 40 25 3 3<br />

Typical beam employed (µA) 20 10 3 3<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

78 62 13 1 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) - Stent<br />

activation<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) = 15 MeV Yes No 7<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

86 123<br />

Y, I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

- Cl<strong>in</strong>ical<br />

- Small animal<br />

- Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

77<br />

71


72<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 18<br />

O (p, n) F<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

80 95 2.0 1000 Ye<br />

No<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 45 12/week Yes No Yes No 335<br />

USD<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 4 1/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

cl<strong>in</strong>ical studies Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 4 1/week Yes No Yes No<br />

211<br />

At 1 1/month Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

81 Rb/ 81m Kr – radionuclide generator, 3/week, not <strong>used</strong> on site, distribution – yes.<br />

78<br />

18 OH2<br />

?<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: CZECH REPUBLIC CZR-2<br />

[1] INSTITUTE: Nuclear Research Institute Rez plc<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

250 68 Rez<br />

+42 02 572 16 982 or +42 02 570 90 616<br />

mailto:koy@ujv.cz or ami@ ujv.cz<br />

+4202 572 15 949<br />

Ing. Michal Antos<br />

Head, Department <strong>of</strong> PET Radiopharmaceuticals<br />

Ing. Karel Mudra, Cyclone Operator<br />

Ing. Petr Kopecky, Vice Director – Division <strong>of</strong><br />

Radiopharmaceuticals<br />

IBA cyclone YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA Belgium (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 80 40 Possible, but<br />

not <strong>used</strong><br />

Typical beam employed (µA) Up to 37 not <strong>used</strong><br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research ma<strong>in</strong>tenance applications<br />

36 36 0 6 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

3 He<br />

4 He<br />

1999<br />

18 F -5 GBq/year<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

18 11<br />

F- FDG, C- labelled pharmaceuticals<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yellow Hill Hospital Brno,FDG twice per day<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

0<br />

S<strong>in</strong>gle photon tomography (SPET) 2<br />

Positron emission tomography (PET) 2 1xPET,<br />

1xPET/CT<br />

- Cl<strong>in</strong>ical<br />

- Small animal<br />

- Plant biochemistry<br />

x<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

Yes No<br />

agricultural applications such as plant biochemistry/research?<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

79<br />

73


74<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production yield<br />

(GBq)<br />

18 O (p, n) 18 F 140/2hrs-large<br />

65/1,5hrs-medium<br />

20 Ne (d, α) 18 F Not <strong>used</strong><br />

16 O (α, d) 18 F Not <strong>used</strong><br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

>95 2,0 (2x)-large<br />

1,0 (1x)medium<br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

32g/week<br />

totally<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 50 –large volume 2x/ day Yes No Yes No<br />

18 FDG 20-medium<br />

volume<br />

1x/ day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Rout<strong>in</strong>e production <strong>of</strong> FDG only – Monday to Thursday 3 batches per day, Friday to Sunday 2 batches per day.<br />

80<br />

Ye<br />

No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


9. DENMARK<br />

2005 COUNTRY: DENMARK DEN-1<br />

[1] INSTITUTE: University Hospital <strong>of</strong> Copenhagen<br />

Cyclotron and PET Unit, KF 3982<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Blegdamsvej 9, DK – 2100 Copenhagen<br />

+45 3545 3915<br />

mikaelj@rh.dk<br />

+45 3545 3898<br />

Dr. Mikael Jensen<br />

Physicist-<strong>in</strong>-Chief<br />

Holger Jensen, Physicist<br />

Nic Gill<strong>in</strong>gs, Chemist<br />

Jacob Madsen, Chemist<br />

Negative ion, YEAR OF: (I)<br />

1992<br />

CYCLOTRON: sector-foc<strong>used</strong> INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE: 1994 – Addition <strong>of</strong> positive<br />

ions and 4 He<br />

MODEL: MC 32-NI<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 32 16 - 32 Yes No<br />

Maximum beam available (µA) 100 80 30<br />

Typical beam employed (µA) 20 10 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30-40 25 5 2 0-8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: 1 Neutron therapy:<br />

Activation analysis: Other (specify) Space component tests<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11<br />

C – FLB 457<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 6<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

81<br />

75


76<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

40 >95 1.2 200 Ye<br />

No<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/GBq<br />

(list)<br />

(GBq) production<br />

sales<br />

if available<br />

18<br />

FDG 25 2-3/week Yes No Yes No ~600 Euro<br />

18<br />

F -ALTANSERIN 4 1/week Yes No Yes No ~400 USD<br />

per. patient<br />

dose<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

Ammonia 2 2-8/week<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O (p, α) N Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water on l<strong>in</strong>e 8 hours/week<br />

14 15<br />

N (d, n ) O<br />

CO on l<strong>in</strong>e<br />

14 15<br />

N (d, n ) O<br />

OO on l<strong>in</strong>e<br />

14 15<br />

N (d, n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.1 5/year Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At 1 1/week Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

The home <strong>of</strong> : gas phase Methyl iod<strong>in</strong>e - 11 C, 10 C - carbon dioxide<br />

<strong>Production</strong> <strong>of</strong> 81 Rb/ 81m Kr generators 16/week – 12 GBq/week.<br />

82<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY DENMARK DEN-2<br />

[1] INSTITUTE: The Hevesy Laboratory<br />

Risø National Lab<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Compact, negative<br />

ion<br />

General Electric<br />

Pettrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

P.O.Box 49, DK 4000 Roskilde, Denmark<br />

+45 4677 5300<br />

isotop@risoe.dk<br />

+45 4677 5347<br />

Mikael Jensen<br />

Pr<strong>of</strong>essor<br />

Head <strong>of</strong> Programme Lars Mart<strong>in</strong>y<br />

Radiochemist Palle Rasmussen<br />

Physicist Dennis R<strong>in</strong>gkjøb<strong>in</strong>g<br />

Radiochemist Sor<strong>in</strong> Aburel<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 16,5 8 Yes X No<br />

Maximum beam available (µA) 100 60<br />

Typical beam employed (µA) 60 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

3 He<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

2004<br />

Hours/week <strong>for</strong><br />

applications<br />

40 36 4<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

Number <strong>of</strong><br />

–Cl<strong>in</strong>ical 3<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes x No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

83<br />

77


78<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 150 95-97 2,1 Yes X<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 100 2/week Yes No X Yes X No<br />

18<br />

FDOPA 0.4 1/month Yes No Yes No<br />

18<br />

Fluoride 0.5 1/month Yes No Yes No<br />

18<br />

FMISO 2 1/month Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 0.5 1/week Yes No Yes No<br />

PK11195 0.5 1/month Yes No Yes No<br />

Acetate 5 1/month Yes No Yes No<br />

Methon<strong>in</strong>e 3 1/month Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4 2/week<br />

16<br />

O(p,α) Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 3 daily<br />

14<br />

N(d,n)<br />

Oxygen 6 1/week<br />

14<br />

N(d,n)<br />

CO 3 1/week<br />

14<br />

N(d,n)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu 3 1/mo Yes x No Yes x No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

84


10. EGYPT<br />

2005 COUNTRY EGYPT EGY-1<br />

[1] INSTITUTE: Cyclotron Project, Nuclear Research Center<br />

Atomic Energy Authority, 13759,<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

AVF<br />

NIIEFA<br />

MGC-20<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Egypt<br />

+(202)4620786<br />

+(202)4620786<br />

Pp<strong>of</strong>.Dr. Sh.M. Saad<br />

Supervisor<br />

Pr<strong>of</strong>.Dr. M.N.H. Comsan<br />

Pr<strong>of</strong>.Dr. Z.A. Saleh<br />

Dr. S. Abdel-Samad<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 5-18 3-10 8-24 6-20 Yes No X<br />

Maximum beam available (µA) 50 50 25 25<br />

Typical beam employed (µA) 30 -- 10 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

40 Not yet 30 10 --<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

I-123, Ga-67, In-111, Cu-64<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No X<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No X<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number <strong>of</strong><br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes X No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

3 He<br />

4 He<br />

2000<br />

85<br />

79


80<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F In plan In plan In plan Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Trial Yes No Yes No<br />

67<br />

Ga Trial Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Trial Yes No Yes No<br />

123<br />

I<br />

Trial Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

86


11. FINLAND<br />

2005 COUNTRY: FINLAND FIN-1<br />

[1] INSTITUTE: Laboratory <strong>of</strong> Radiochemistry<br />

University <strong>of</strong> Hels<strong>in</strong>ki, Department <strong>of</strong> Chemistry<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

P.O. Box 55, 00014 University <strong>of</strong> Hels<strong>in</strong>ki<br />

+358 9191 50133<br />

kerttuli.helariutta@hels<strong>in</strong>ki.fi<br />

+358 9191 50121<br />

Dr. Kerttuli Helariutta ,<br />

Senior Laboratory Manager<br />

Martti Hakanen, Laboratory Manager<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 10/5<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 10 5 Yes No<br />

Maximum beam available (µA) 80 40<br />

Typical beam employed (µA) 10-20 Not yet <strong>used</strong><br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

~ 4.5 ~ 4 ~ 0.5 ~ 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: A couple <strong>of</strong> times Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

57<br />

Co<br />

X ray sources? (specify which & quantity) Yes No<br />

109<br />

Ag<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

124 64 86<br />

I, Cu , Y<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Hospitals (Hels<strong>in</strong>li, Tampere,<br />

Lahti, Kuojno) 1-3 times/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

- Cl<strong>in</strong>ical<br />

- Small animal<br />

- Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1997<br />

87<br />

81


82<br />

8 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 1-5 0.4, 2.0 Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 1-3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

We are still <strong>in</strong> the beg<strong>in</strong>n<strong>in</strong>g <strong>of</strong> us<strong>in</strong>g Cyclotron. Probably this year, the production <strong>of</strong> radionuclides will <strong>in</strong>crease<br />

significantly.<br />

88


2005 COUNTRY: FINLAND FIN-2<br />

[1] INSTITUTE: Turku PET Centre<br />

Turku University Central Hospital<br />

Ki<strong>in</strong>amyllynkatu 4-8<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

FIN-20520 Turku<br />

+358 2 313 1860<br />

hannu.sipila@tyks.fi<br />

+358 2 313 2882<br />

Mr. Hannu Sipilä<br />

Chemist<br />

Mika Teräs, Hospital Physicist<br />

Kari L<strong>in</strong>dberg, Technician<br />

Jukka Kaikkonen, Technician<br />

Positive ion 2H YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. Belgium (II) UPGRADE:<br />

MODEL: Cyclone 3<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 3-7 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 5-35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1992<br />

h/week <strong>for</strong><br />

applications<br />

14 14<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography: 14<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 4<br />

� Positron emission tomography (PET) 4<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

89<br />

83


84<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2 O 0.2 – 1.4 4 days/week<br />

14 15<br />

N (d, n) O<br />

CO 2.6 0-1 days/week<br />

O2 1.2 0-1 day/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

90<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: FINLAND FIN-3<br />

[1] INSTITUTE: Turku PET Centre<br />

Accelerator Laboratory<br />

Äbo Akademi, Porthansgatan 3<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

FIN-20500 Turku<br />

+358 2 2654 608<br />

esheselius@abo.fi<br />

+358 2 2654 912<br />

Dr. Sven-Johan Heselius<br />

Director<br />

Ol<strong>of</strong> Sol<strong>in</strong>; Jörgen Bergman; Jan-Ol<strong>of</strong> Lill;<br />

Ulf Hällsten; Stefen Johansson; Erkki Stenvall;<br />

Per Ol<strong>of</strong> Eriksson<br />

AVF YEAR OF:<br />

INSTALLATION<br />

(I)<br />

(II) UPGRADE:<br />

MANUFACTURER: D.V. Efremov<br />

Institute<br />

MODEL: MGC-20<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 3-20 6-10.5 9-28 12-21 Yes No<br />

Maximum beam available (µA) 30 30 20 20<br />

Typical beam employed (µA) 300 300 80 80<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

42 32 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? …….<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 2<br />

� Gamma camera 4<br />

� S<strong>in</strong>gle photon tomography (SPET) 4<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1974<br />

91<br />

85


86<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced<br />

92<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: FINLAND FIN-4<br />

[1] INSTITUTE: University <strong>of</strong> Jyväskylä<br />

Department <strong>of</strong> Physics, P.O. Box 35<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

40351 Jyväskylä<br />

+358 14 260 2350<br />

esko.liukkonen@phys.jyu.fi<br />

+358 14 260 2351<br />

Pr<strong>of</strong>essor Esko Liukkonen<br />

Pr<strong>of</strong>essor<br />

Pauli Heikk<strong>in</strong>en, <strong>in</strong> charge <strong>of</strong> Accelerator Physics<br />

Hannu Koivisto, <strong>in</strong> charge <strong>of</strong> Ion Sources<br />

Teuvo Poikola<strong>in</strong>en, Radiation Safety Officer<br />

Isochronous YEAR OF: (I)<br />

1990-92<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: JYFL, Scand<strong>in</strong>otrix (II) UPGRADE: 2000 <strong>for</strong> H - MODEL:<br />

acceleration<br />

[4] CYCLOTRON CHARACTERISTICS: E = q2 m 130 MeV<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 5-70 5-65 15 - 168 Yes No<br />

Maximum beam available (µA) 100 50 20<br />

Typical beam employed (µA) 30-50 0.1 - 10 0.1 - 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 120 18 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 20 Proton therapy:<br />

Physics: 120 Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? …….<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

93<br />

87


88<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

150 1/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced<br />

94<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


12. FRANCE<br />

2005 COUNTRY: FRANCE FRA-1<br />

[1] INSTITUTE: Centre Anto<strong>in</strong>e Lacassagne<br />

Laboratoire du Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

[3]<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

TYPE OF<br />

Compact isochronous<br />

CYCLOTRON: - negative ion<br />

MANUFACTURER: Centre Anto<strong>in</strong>e<br />

Lacassagne<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

227, Avenue de la Lanterne, 06200 Nice<br />

+33 4 920 31070<br />

Pierre.Mandrillon@FNCLCC.fr<br />

+33 4 920 31095<br />

Dr. Pierre Mandrillon<br />

Head <strong>of</strong> Cyclotron Laboratory<br />

Donadey<br />

Trimud<br />

Giusto<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 65 65 65 65 Yes No<br />

Maximum beam available (µA) 40 40 40 40<br />

Typical beam employed (µA) 0.1 - 25 0.1 - 25 0.1 - 25 0.1 - 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 10 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy: 20<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11<br />

C<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1991<br />

95<br />

89


90<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 150 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

96<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY FRANCE FRA-2<br />

[1] INSTITUTE: CNRS/CERI<br />

3a rue de la Férollerie<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

K50 isochronous<br />

CGR MeV<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

45071 Orléans cedex 2 France<br />

+33238255410<br />

blondiaux@cnrs-orleans.fr<br />

+33238630271<br />

Gilbert Blondiaux<br />

Director<br />

J.Briaud : Technical director<br />

L.Le Polotec : assistant <strong>of</strong> the technical director<br />

M.F.Barthe : leader <strong>of</strong> the research staff<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

3 He<br />

4 He<br />

1974<br />

upgraded cont<strong>in</strong>uous by the<br />

technical staff from 1998-<br />

2005<br />

Dual Beams<br />

Beam energies (MeV) 36 25 65 50 Yes No X<br />

Maximum beam available (µA) 50 40 10 5<br />

Typical beam employed (µA) 50 40 5 5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/week <strong>for</strong><br />

applications<br />

64 6 30 8 20<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: 30 Proton therapy:<br />

Physics: Neutron therapy: 20<br />

Activation analysis: 5 Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes X No 25<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 11 81m 64 123<br />

F <strong>for</strong> FDG and fluoride, C, Kr, Cu, I,<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No X<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No X<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal 1 <strong>in</strong> end 2006<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

97<br />

91


92<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At 0.1 3/month Yes No X Yes No X<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

We are <strong>in</strong>stall<strong>in</strong>g on the site a production <strong>of</strong> classical 511 keV positrons emitter <strong>for</strong>m PET imag<strong>in</strong>g <strong>of</strong> small animals.<br />

We are also start<strong>in</strong>g this month a production <strong>of</strong> 211 At <strong>for</strong> research A large part <strong>of</strong> the beam time <strong>of</strong> this mach<strong>in</strong>e is utilized<br />

<strong>for</strong> nuclear waste management studies (alpha radiolysis simulation with external beam). A project <strong>of</strong> boron capture<br />

enhance fast neutron therapy is also under progress.<br />

98


2005 COUNTRY: FRANCE FRA-3<br />

[1] INSTITUTE: Centro d'Exploration et de Recherche Medicales<br />

par Emission de Positrons (CERMEP)<br />

Cyclotron Biomedical de Lyon<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

G. Galy<br />

P. Lanai<br />

D. Comar<br />

Positive ion YEAR OF:<br />

59 Boulevard P<strong>in</strong>el, F-69003 Lyon<br />

+33 4 726 88600<br />

Pierre.Mandrillon@aima.fr<br />

+33 4 726 88610<br />

Dr. D. Le Bars<br />

Head <strong>of</strong> Radiochemistry<br />

(I) INSTALLATION<br />

MANUFACTURER: CGR-MeV (II) UPGRADE:<br />

MODEL: Cypris 325<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 16 8 Yes No<br />

Maximum beam available (µA) >50 >50<br />

Typical beam employed (µA) 30 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

>15 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG one per/month to one<br />

per week.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Number<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1987<br />

99<br />

93


94<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

100<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: FRANCE FRA-4<br />

[1] INSTITUTE: CERMEP – Imagerie du Vivant<br />

Hopital Neurocardiologique<br />

59 Bd P<strong>in</strong>el<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

F - 69003 Lyon<br />

+33 4 72 688600<br />

secretariat@cermep.fr<br />

POSITION:<br />

Dr. Gimenez<br />

Director<br />

OTHER SENIOR STAFF:<br />

Dr. D. Le Bars, Head <strong>of</strong> Radiochemistry Radiopharmacy<br />

NAME/POSITION<br />

Dr. L. Zimmer, Radiopharmacology Radiopharmacy<br />

NAME/POSITION<br />

Dr. S. Guillouet, Radiochemist<br />

[3] TYPE OF<br />

CYCLONE 18/9 YEAR OF: (I)<br />

1999<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

IBA, s.a. (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 80 40<br />

Typical beam employed (µA) 15-35 5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

20-30<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

101<br />

95


96<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 25-75 >95 0.5 50-100 Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10 3/week Yes No Yes No<br />

DOPA 6 1/week Yes No Yes No<br />

MPPF 3 3/week Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 2 1/week Yes No Yes No<br />

Flumazenil 2 1/week Yes No Yes No<br />

Raclopride 2 1/week Yes No Yes No<br />

Diprenorph<strong>in</strong>e 2 2/month Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 0.33 2/week<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

[ 11 C]acetate, [ 11 C]MQNB, [ 11 C]PE2I; [ 18 F]FLT, [ 18 F]FCH, [ 18 F]NaF<br />

102<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq<br />

Price/G<br />

Bq


2005 COUNTRY FRANCE FRA-5<br />

[1] INSTITUTE: CNRS CERI<br />

45071 Orleans Cedex 02<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

[3] TYPE OF CYCLOTRON<br />

MANUFACTURER:<br />

MODEL:<br />

Compact<br />

CGR-MeV<br />

680<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

France<br />

33 2 38 25 54 05<br />

briaud@cnrs-orleans.fr<br />

Joseph Briaud<br />

Eng<strong>in</strong>eer<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 38 25 65 50 Yes No x<br />

Maximum beam available (µA) 40 40 10 10<br />

Typical beam employed (µA) 40 20 1 1<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

65 2 30 8 25<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: 20 Proton therapy:<br />

Physics: Neutron therapy: 15<br />

Activation analysis: 10 Other (specify) 10<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes x No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 18 18<br />

F by O (p, n) F<br />

11<br />

C<br />

64<br />

Cu<br />

123<br />

I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

For the moment we deal with <strong>in</strong>dustrial partnerships the conditions <strong>of</strong> production and<br />

delivery radionuclides(frequency, activityies,…).<br />

Yes X No<br />

Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No X<br />

[10] out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

2<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No x<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1971<br />

103<br />

97


98<br />

18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

104


2005 COUNTRY FRANCE FRA-6<br />

[1] INSTITUTE: Advanced Accelerator Applications<br />

20 rue Diesel<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Negative ions, fixed<br />

energy<br />

General Electric<br />

PETrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

01630 Sa<strong>in</strong>t-Genis-Pouilly France<br />

+33-4-50993070<br />

<strong>in</strong>fo@adacap.com<br />

+33-4-50993071<br />

Stefano Buono<br />

President & CEO<br />

Luca Maciocco/cyclotron eng<strong>in</strong>eer & researcher<br />

V<strong>in</strong>cent Tad<strong>in</strong>o/research radiochemist<br />

Philippe Dasse/responsible radiopharmacist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 16.5 Yes No<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 42<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radionuclide production<br />

ma<strong>in</strong>tenance applications<br />

…… 30 10 8<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

F-MISO (2005)<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

2003<br />

105<br />

99


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

100 106<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 160 98 1.6 2500 Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 90 3/day Yes No Yes No<br />

18<br />

F-Chol<strong>in</strong>e 20 2/week Yes No Yes No<br />

18<br />

FLT 20 2/week Yes No Yes No<br />

18<br />

MPPF 10 1/week Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name (list) Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

124<br />

I<br />

Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Yes No Yes No<br />

201 Tl Yes No Yes No<br />

211 At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


13. GERMANY<br />

2005 COUNTRY: GERMANY GER-1<br />

[1] INSTITUTE: Cyclotron Laboratory<br />

Forschungszentrum Karlsruhe Technik und Umwelt<br />

Hauptabteilung Zyklotron<br />

P.O. Box 3640, 76021 Karlsruhe<br />

TELEPHONE NO.:<br />

+49 7247 82 2433<br />

E-MAIL ADDRESS:<br />

Hermann.Schweickert@hzy.fzk.de<br />

FAX NO.:<br />

+49 7247 82 3156<br />

[2] PERSON IN CHARGE:<br />

Dr. H. Schweickert<br />

POSITION:<br />

Director, Cyclotron Laboratory<br />

OTHER SENIOR STAFF:<br />

Dr. V. Bechtold, <strong>in</strong> charge <strong>of</strong> Radioisotope <strong>Production</strong><br />

NAME/POSITION<br />

Dr. P. Fehsenfeld, RTM, <strong>Radionuclide</strong> Technique<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1984<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Cyclotron<br />

Corporation<br />

(II) UPGRADE: Cont<strong>in</strong>uous<br />

MODEL: CP 42 H -<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15-40 Yes No<br />

Maximum beam available (µA) 200<br />

Typical beam employed (µA) 100<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

140 50 70 when needed 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) TLA<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? To hospitals and <strong>in</strong>dustry<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

107<br />

101


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

102 108<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 75-150 >95 Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 37 - 75 1/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Planned Yes No Yes No<br />

94m<br />

Tc Planned Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

175 1/day Yes No Yes No<br />

124<br />

I<br />

3.7 1/week Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-2<br />

[1] INSTITUTE: Cyclotron Laboratory<br />

Forschungszentrum Karlsruhe Technik und Umwelt<br />

Hauptabteilung Zyklotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

P.O. Box 3640, 76021 Karlsruhe<br />

+49 7247 82 2433<br />

Hermann.Schweickert@hzy.fzk.de<br />

+49 7247 82 3156<br />

Dr. H. Schweickert<br />

Director, Cyclotron Laboratory<br />

Dr. V. Bechtold, <strong>in</strong> charge <strong>of</strong> Radioisotope <strong>Production</strong><br />

Dr. P. Fehsenfeld, RTM, <strong>Radionuclide</strong> Technique <strong>in</strong> Mechanical<br />

Eng<strong>in</strong>eer<strong>in</strong>g<br />

Positive ion YEAR OF: (I)<br />

INSTALLATION<br />

1964<br />

MANUFACTURER: AEG (II) UPGRADE: Cont<strong>in</strong>uous<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 52 104 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 20 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15 5 5 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

109<br />

103


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

104 110<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F >95 Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At 1/week Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-3<br />

[1] INSTITUTE: Eberhard-Karls-University Tüb<strong>in</strong>gen<br />

Interdiscipl<strong>in</strong>ary PET Centre, Radiopharmacy<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Röntgenweg 15, D-72076 Tüb<strong>in</strong>gen<br />

+49 7071 29 87443<br />

machulla@uni-tueb<strong>in</strong>gen.de<br />

+49 7071 29 5264<br />

[2] PERSON IN CHARGE: Pr<strong>of</strong>essor Dr. H.-Juergen Machulla<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Dr. rer. nat. C. Solbach<br />

Dr. rer. nat. G. Reischl<br />

Dipl.-Ing. A. Stahlschmidt<br />

Negative ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: PETtrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 16.5 8 Yes No<br />

Maximum beam available (µA) 75<br />

Typical beam employed (µA) 35-55 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15-20 15-20 15-20 1 15-20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 15-20 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Kathar<strong>in</strong>enhospital (Stuttgart) 4/week, Kernchemie (Ma<strong>in</strong>z) 1/week, Dr. Hörr (Ploch<strong>in</strong>gen)<br />

1/week, Universitätskl<strong>in</strong>ikum RDI (München) 1/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera 2<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

2<br />

–Cl<strong>in</strong>ical 2 PET and<br />

PET/CT<br />

–Small animal 1<br />

–Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1995<br />

111<br />

105


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

106 112<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

75 95 0.6 1000 Yes<br />

No<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/GBq<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

if available<br />

FDG 30 5/week Yes No Yes No<br />

FLT 10 1/week Yes No Yes No<br />

FAZA 10 1/week Yes No Yes No<br />

FMISO 10 1/week Yes No Yes No<br />

FEC 13 2/week Yes No Yes No Depends<br />

on number<br />

<strong>of</strong> patients:<br />

~100<br />

€/GBq<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/GBq<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

if available<br />

Raclopride 4 3/week Yes No Yes No<br />

Methylphenidat 5 3/week Yes No Yes No<br />

DASB 6 1/week Yes No Yes No<br />

BTA-1 8 1/3 months Yes No Yes No<br />

6-OH-BTA-1 6 1/3 months Yes No Yes No<br />

Chol<strong>in</strong> 30 4/week Yes No Yes No Depends<br />

on number<br />

<strong>of</strong> patients:<br />

~750<br />

€/batch<br />

Methion<strong>in</strong> 8 1/month Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/ Price/GBq<br />

(list)<br />

batch (GBq) production<br />

sales<br />

if available<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 12 1/3month<br />

14 15<br />

N(d, n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 1 2/month Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.4 1/month Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/GBq<br />

if available<br />

Price/GBq<br />

if available


2005 COUNTRY: GERMANY GER-4<br />

[1] INSTITUTE: Euro-PET GmbH<br />

Hugstetlerstrasse 55<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITIO<br />

D-79106 Freiburg<br />

+49 761 270 9204<br />

Euro.PET@compuserve.com<br />

+49 761 270 9200<br />

Pr<strong>of</strong>essor Dr. Peter Reuland<br />

Dr. Ursula Sahm, Chief Chemist<br />

Kenneth Stalmo, Technician<br />

Bernd Morasch, Chemist<br />

Dagmar Hentschel, Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

Negative Ion YEAR OF: (I)<br />

1996<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE. (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS: …….<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) Yes No<br />

Maximum beam available (µA) 75 75<br />

Typical beam employed (µA) 40 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

3 0.25<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 15<br />

C-carbon monoxide and carbon dioxide, O–water, carbon monoxide and oxygen.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions? To different <strong>in</strong>stitutions<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET) 2<br />

- Cl<strong>in</strong>ical<br />

- Small animal<br />

- Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

113<br />

107


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

108 114<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 110 >95 1.2 1000 Ye<br />

No<br />

20 Ne (d, α) 18 F 25<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 35-45 8-10/week Yes No Yes No<br />

Fluoride Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

(see comments) Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Yes No Yes No<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

NH3 10-13 10/year Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

N2 13 O 8-10 50/year<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY GERMANY GER – 5<br />

[1] INSTITUTE: Forschungszentrum Rossendorf<br />

Institut fuer Bioanorganische und Radiopharmazeutische Chemie<br />

P.O Box 51 01 19<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Negative ion<br />

IBA, Belgium<br />

CYCLONE 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

01314 Dresden, Germany<br />

+49 (0) 351 260 3170<br />

s.ste<strong>in</strong>bach@fz-rossendorf.de<br />

+49 (0) 351 260 3232<br />

Pr<strong>of</strong>. Dr. habil. Joerg Ste<strong>in</strong>bach<br />

Director <strong>of</strong> the Institute<br />

Dr. Frank Wuest, Head <strong>of</strong> PET Tracer Dept.<br />

Dipl.-Ing. Stephan Preusche, Head <strong>of</strong> PET Cyclotron Unit<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 9 ----- ----- Yes X No<br />

Maximum beam available (µA) 35 20 Possible <strong>for</strong><br />

1 H, 2 H; not<br />

<strong>used</strong><br />

Typical beam employed (µA) 30 15-18<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

3 He<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

1996<br />

Hours/week <strong>for</strong><br />

applications<br />

13-25<br />

production<br />

13-25 <strong>for</strong> PET<br />

rout<strong>in</strong>e and R&D<br />

3<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: --------- Radiography: ---------<br />

Materials science: --------- Proton therapy: ---------<br />

Physics: --------- Neutron therapy: ---------<br />

Activation analysis: --------- Other (specify): RN<br />

production<br />

13-25<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes X No<br />

56<br />

Co (1-2)/year<br />

some kBq<br />

Mössbauer sources? (specify which & quantity) Yes No X<br />

X ray sources? (specify which & quantity) Yes No X<br />

Intense neutron beam? (specify average En = ?) Yes No X<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes X No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes X No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Number <strong>of</strong><br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

1<br />

– Cl<strong>in</strong>ical, Small animal , Plant biochemistry 1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

115<br />

109


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

110 116<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O(p, n) 18 F 60-90 97 1.4 ml 300 Yes X<br />

No<br />

20 Ne(d, α) 18 F 8-11 600 ml Ne/F2<br />

16 18<br />

O(α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

[ 18 F]FDG 33-45 1/day Yes X No Yes X No<br />

[ 18 F]FDOPA 1.2 2/week Yes X No Yes X No<br />

[ 18 F]3-O- 1.2 2/week Yes X No Yes No X<br />

Methyl-FDOPA<br />

[ 18 F]NAF 1/week Yes X No Yes No X<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

[ 11 C]Acetate 12-15 2/week Yes X No Yes No X<br />

Various<br />

research<br />

products<br />

on request Yes X No Yes No X<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Currently not<br />

<strong>used</strong><br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

[ 15 O]H2O 5-6 2/month<br />

14 15<br />

N(d,n) O<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 1.1 2/month Yes X No Yes X No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Our <strong>in</strong>ternet home pages: Forschungszentrum Rossendorf: http://www.fz-rossendorf.de<br />

Institut für Bioanorganische und Radiopharmazeutische Chemie: http://www.fz-rossendorf.de/pls/rois/Cms?pNid=130<br />

CYCLONE 18/9 and 10/5 USER COMMUNITY: http://www.fz-rossendorf.de/pls/rois/Cms?pNid=531


2005 COUNTRY: GERMANY GER-6<br />

[1] INSTITUTE: Forschungszentrum Rossendorf<br />

Institut für Bioanorganische und<br />

Radiopharmazische Chemie<br />

P.O. Box 510119, 01314 Dresden<br />

TELEPHONE NO.:<br />

+49 351 260 3170<br />

E-MAIL ADDRESS:<br />

b.johannsen@fz-rossendorf.de<br />

FAX NO.:<br />

+49 351 260 3232<br />

[2] PERSON IN CHARGE:<br />

Pr<strong>of</strong>essor habil. Bernd Johannsen<br />

POSITION:<br />

Director <strong>of</strong> the Institute<br />

OTHER SENIOR STAFF:<br />

F. Wuest, Head <strong>of</strong> PET Tracer Department<br />

NAME/POSITION<br />

St. Preusche, Head <strong>of</strong> Cyclotron Unit<br />

[3] TYPE OF<br />

U-120 YEAR OF: (I)<br />

1958<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

NIIEFA St.<br />

Petersburg<br />

(II) UPGRADE: 1989<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 7 14 28 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA) 50 50 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

50 10 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? External application <strong>of</strong><br />

radionuclides generally<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

117<br />

111


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

112 118<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-7<br />

[1] INSTITUTE: German Cancer Research Centre (DKFZ)<br />

Im Neuenheimer Feld 280<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Isochronous,<br />

D-69120 Heidelberg<br />

+49 6221 550 3<br />

g.wolber@dkfz.de<br />

+49 6221 422 572<br />

Dr. Gerd Wolber, Head, Cyclotron Operation Group<br />

Pr<strong>of</strong>essor Dr. Wolfhard Semmler, Head – Biophysics<br />

Pr<strong>of</strong>essor Dr. Michael Eisenhut, Head – Radiochemistry<br />

YEAR OF: (I)<br />

1991<br />

CYCLOTRON: negative ion<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 32 NI<br />

[4] CYCLOTRON CHARACTERISTICS: Average magnetic field: 1.59 T; pole face diam.: 135 cm; accel. freq: 24.3 MHz;<br />

2 Dees 90º; dual cold cathode ion source; total weight: 53 tons; total power dissipation: 185 kva.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16-32 8-16 Yes No<br />

Maximum beam available (µA) 100 100<br />

Typical beam employed (µA) 30 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

50 (aver), 1997-2000 25 15 2-5 45<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 1 Radiography:<br />

Materials science: 2-3 Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Neutron dosimetry - 2<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No 140 Pr<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No εn= 14MeV<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

see comments<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Dept. <strong>of</strong> Nuclear Medic<strong>in</strong>e,<br />

Radiological Cl<strong>in</strong>ic <strong>of</strong> the University <strong>of</strong> Heidelberg; daily<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Both<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal planned<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

119<br />

113


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

114 120<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

18 18<br />

O (p, n) F 50-70 >95 1 16 at 30<br />

bar<br />

20 18<br />

Ne (d, α) F 20-30<br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

300 1 Ye<br />

No<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15-20 1-2/day Yes No Yes No<br />

FLT 1.7 on demand Yes No Yes No<br />

Others, see<br />

Yes No Yes No<br />

comments Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Others, see<br />

Yes No Yes No<br />

comments Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 5-6 2-3/week<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu rare Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

<strong>in</strong> preparation Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

18<br />

F – DOPA, FU, FET, 2F-Thros<strong>in</strong>e,Chol<strong>in</strong>e<br />

11<br />

C – AIB, ethanole, doxorubic<strong>in</strong>e, dacarbac<strong>in</strong>e, acetate, chol<strong>in</strong>e<br />

In preparation : Iod<strong>in</strong>ated compounds ( 124 I, 121 I)<br />

140 Pr ( 20%β +,via 141 Pr (p, 2n) 140 Nd is <strong>used</strong> <strong>for</strong> calibration <strong>of</strong> PET systems.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-8<br />

[1] INSTITUTE: Herz- und Diabeteszentrum NRW<br />

Universitaetskl<strong>in</strong>ik der Ruhr-Universitaet Bochum<br />

Institut für Molekulare Biophysik, Radiopharmazie u.<br />

Nuklearmediz<strong>in</strong><br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Georgstrasse 11. D-32535 Bad Oeynhausen<br />

+49 5731 97 1308<br />

wburchert@hdz-nrw.de/phadjilazaros@hdznrw.de/hhenneken@hdz-nrw.de<br />

+49 5731 97 1819<br />

Pr<strong>of</strong>essor W. Burchert<br />

Director <strong>of</strong> Institute<br />

Ms. Petra Hadjilazaros (responsible <strong>for</strong> cyclotron operation)<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Mr. Harald Henneken<br />

[3] TYPE OF<br />

Negative Ion YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

d P<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 9 18 Yes No<br />

Maximum beam available (µA) 40 80<br />

Typical beam employed (µA) 5 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 20 2 days quarterly<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

4-[18F]-FBA (<strong>in</strong> vivo identification and quantification <strong>of</strong> apoptotic cells with PET)<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 4<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

121<br />

115


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

116 122<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

18 18<br />

O (p, n) F 25<br />

95 1<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

50<br />

1.6<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

400 Ye<br />

No<br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F-FDG 20 5-7 syntheses/week Yes No Yes No<br />

18<br />

F-Fluor<strong>in</strong>e 5 10/year Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 3.7 4/week Yes No Yes No<br />

MHED 2.6 2/month Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4.5 4/day<br />

16 13<br />

O(p, α ) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 3 6/week<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-9<br />

[1] INSTITUTE: Institut für Nuklearchemie<br />

Forschungszentrum Jülich GmbH<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

D-52425 Juelich<br />

+49 2461 614141<br />

s.m.qaim@fz-juelich.de<br />

+49 2461 612535<br />

Pr<strong>of</strong>essor H.H. Coenen<br />

Pr<strong>of</strong>essor S.M. Qaim<br />

Dr. M. Holschbach<br />

[3] TYPE OF<br />

Fixed energy, two YEAR OF: (I)<br />

1997<br />

CYCLOTRON: particle<br />

INSTALLATION<br />

MANUFACTURER: General Electric (II) UPGRADE: 1999<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA) 40 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 30 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.?<br />

(radiochemistry)<br />

Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

123<br />

117


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

118 124<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Ye<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Flumazenil 3 2/week Yes No Yes No<br />

Raclopride 3 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 15 daily<br />

14 15<br />

N(d, n) O<br />

Butanol 5 daily<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-10<br />

[1] INSTITUTE: Institut für Nuklearchemie<br />

Forschungszentrum Jülich GmbH<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

D-52425 Juelich<br />

+49 2461 614141<br />

s.m.qaim@fz-juelich.de<br />

+49 2461 612535<br />

Pr<strong>of</strong>essor H.H. Coenen<br />

Pr<strong>of</strong>essor S.M. Qaim<br />

Dr. J. Ermert<br />

[3] TYPE OF<br />

Baby Cyclotron<br />

Dr. K. Hamacher<br />

YEAR OF: (I)<br />

1987<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC 1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

17 10 Yes No<br />

Typical beam employed (µA) 30 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

35 20 15 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry 1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.?<br />

(radiochemistry)<br />

Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

125<br />

119


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

120 126<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 60 96 1.5 200 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 30 4/week Yes No Yes No<br />

CPFPX 15 1/week Yes No Yes No<br />

FET 15 occasionally Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 1-3 occasionally Yes No Yes No<br />

Flumazenil 1-3 occasionally Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 1 occasionally<br />

16 13<br />

O(p, α ) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/GBq<br />

if available<br />

Price/GBq<br />

if available<br />

Price/GBq<br />

if available<br />

Price/GBq<br />

if available<br />

Price/GBq<br />

if available


2005 COUNTRY: GERMANY GER-11<br />

[1] INSTITUTE: Institut für Nuklearchemie<br />

Forschungszentrum Jülich GmbH<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Variable energy<br />

CYCLOTRON: compact<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

MODEL: CV 28<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

D-52425 Juelich<br />

+49 2461 614141<br />

s.m.qaim@fz-juelich.de<br />

+49 2461 612535<br />

Pr<strong>of</strong>essor H.H. Coenen<br />

Pr<strong>of</strong>essor S. Qaim<br />

Dr. B. Scholten<br />

YEAR OF:<br />

(I) INSTALLATION<br />

1976<br />

(II) UPGRADE: 1986, 1991, 1997<br />

Dual Beams<br />

Beam energies (MeV) 6-22 4-14 18-36 10-28 Yes No<br />

Maximum beam available (µA) 30 20 10 20<br />

Typical beam employed (µA) 30 20 10 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

56 12 16 7<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 28 Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 86 Y, 94m Tc and 12y I to several<br />

cl<strong>in</strong>ics under co-operative research<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

127<br />

121


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

122 128<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 35 95 50 5 Yes<br />

No<br />

20 Ne (d, α) 18 F 15<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 2 on demand Yes No Yes No<br />

94m<br />

Tc 2 on demand Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.5 ½ weeks Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-12<br />

[1] INSTITUTE: Institute <strong>for</strong> Medical Radiation Physics<br />

Hufelandstrasse 55<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Positive Ion, sector-<br />

CYCLOTRON: foc<strong>used</strong><br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

MODEL: CV 28<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

D-45122 Essen<br />

+49 201 723 4182<br />

+49 201 723 5907<br />

Pr<strong>of</strong>essor Dr. A. Bochisch<br />

Director<br />

G. Hudepohl, Technician/Eng<strong>in</strong>eer<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 24 14 36 28 Yes No<br />

Maximum beam available (µA) 100 100 50 50<br />

Typical beam employed (µA) 100 100 50 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 20 10 5 Neutrons 5 patient<br />

treatment<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: research 5 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: research 5 Neutron therapy: 5<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1975<br />

129<br />

123


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

124 130<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F<br />

16 3 18<br />

O ( He,p) F<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

37<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 18.5 3/week Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

CO2 37 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

O 2 15/m<strong>in</strong> 3/week<br />

14 15<br />

N(d<strong>in</strong>) O<br />

CO2 15/m<strong>in</strong> 3/week<br />

14 15<br />

N(d<strong>in</strong>) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y temporary Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

7.4 temporary Yes No Yes No<br />

124<br />

I<br />

3.7 temporary Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At temporary Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Yes<br />

No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-13<br />

[1] INSTITUTE: Institute <strong>of</strong> Radiology and Nuclear Medic<strong>in</strong>e<br />

Adickes-Allee 51-53<br />

60322 Frankfurt am Ma<strong>in</strong><br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+49 69 95961 626<br />

FAX NO.:<br />

+49 69 95961 630<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pr<strong>of</strong>essor G. Hoer<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Dr. W.T. Kranert<br />

[3] TYPE OF<br />

Negative ion H YEAR OF: (I)<br />

1998<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 20 15 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Nuclide production <strong>for</strong><br />

Nuclear Medic<strong>in</strong>e<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

94m Tc, 124 I<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten? We can give addresses, after<br />

the cyclotron is established.<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

131<br />

125


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

126 132<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 80 0.8 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 40 1/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

CO 5 1/week Yes No Yes No<br />

CO2 5 1/week Yes No Yes No<br />

Am<strong>in</strong>o acids 5 1/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 5 2/week Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 1/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

The cyclotron is not established so far.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-14<br />

[1] INSTITUTE: Max-Planck-Institut fuer Neurologische Forschung<br />

Gleueler Strasse 50<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

D-50931 Koeln (L<strong>in</strong>denthal)<br />

+49 221 4726 220<br />

wdh@pet.mp<strong>in</strong>-koeln.mpg.de<br />

+49 221 4726 298<br />

Pr<strong>of</strong>essor Wolf-Dieter Heiss<br />

Director<br />

Pr<strong>of</strong>essor Dr. Klaus Wienhard<br />

[3] TYPE OF<br />

Baby cyclotron YEAR OF: (I)<br />

1987<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE: 2005<br />

MODEL: MC 16<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 8.5 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 25 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 20 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

133<br />

127


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

128 134<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15 95 1.2 100 Yes<br />

No<br />

20 Ne (d, α) 18 F 10<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10 4/week Yes No Yes No<br />

Dopa 1 2/week Yes No Yes No<br />

FLT 1 1/week Yes X No Yes No X<br />

FHBG 1 1/week Yes X No Yes No X<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 12 3/week Yes No Yes No<br />

Raclopride 5 2/week Yes No Yes No<br />

Flumazenil 10 1/week Yes No Yes No<br />

MPHA 8 1/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 6 25/week<br />

14 15<br />

N(d,n) O<br />

CO 5 1/month<br />

14 15<br />

N(d<strong>in</strong>) O<br />

O2 5 3/month<br />

14 15<br />

N(d<strong>in</strong>) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

124 I – FIAU with 124 I from outside.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY GERMANY GER-15<br />

[1] INSTITUTE: Mediz<strong>in</strong>ische Hochschule Hannover<br />

Kl<strong>in</strong>ik für Nuklearmediz<strong>in</strong><br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Isochronous,<br />

Scanditronix<br />

MC 35<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Carl-Neuberg-Str. 1, D-30625 Hannover<br />

+49 (0) 511 532 3085<br />

Helmeke.Hans-J@MH-Hannover.de<br />

Dr. Helmeke<br />

Head <strong>of</strong> the Cyclotron Group<br />

Pr<strong>of</strong>. Dr. W.H. Knapp / Director <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Pr<strong>of</strong>. Dr. G.J. Meyer / Head <strong>of</strong> the Radiopharmazie Group<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

1976/77<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 7,5-35 3,8-18 5,6-47 7,5-35 Yes No X<br />

Maximum beam available (µA) 50 50 20 20<br />

Typical beam employed (µA) 30-40 30 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

3 He<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/week <strong>for</strong><br />

applications<br />

18,5 (<strong>in</strong>cl. stand by) 17 1,5 6<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No X<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes X No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 5<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No X<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No X<br />

135<br />

129


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

130 136<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 20 - 40 85-97 1,5 ml 200 Yes X<br />

No<br />

Ne (d, α) 18 F 1,8<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F-FDG 9-20 5 / week Yes X No Yes X No<br />

18<br />

F-dopa 0,6 1 / week Yes X No Yes No X<br />

18<br />

F-NaF 4 2 / week Yes X No Yes No X<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-acetic acid 6-10 2 / week Yes X No Yes No X<br />

11<br />

C-methion<strong>in</strong>e 2-5 1 / week Yes X No Yes No X<br />

11<br />

C-m-Hed 0,5-1,5 1 / week Yes X No Yes No X<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O[H2O] 0,15 2 / week<br />

14 15<br />

N(d,n) O<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At up to 0,16 1-2/week Yes X No Yes X No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/ radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY GERMANY GER-16<br />

[1] INSTITUTE: Kl<strong>in</strong>ik für Nuklearmediz<strong>in</strong><br />

Universitätskl<strong>in</strong>ikum Aachen<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

Pauwelsstraße 30 . 52057 Aachen . Germany<br />

+49 241 80 88740<br />

ubuell@ukaachen.de<br />

+49 241 80 82520<br />

Univ.Pr<strong>of</strong>. Dr.med. Dr.med.habil. Udalrich Büll<br />

OTHER SENIOR STAFF: Dr.rer.physiol. Berthold Müller<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Negative Ion<br />

CTI, Inc.<br />

RDS 111<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No ⎩<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

1997<br />

Hours/week <strong>for</strong><br />

applications<br />

22 20 2 -<br />

[6] CYCLOTRON APPLICATIONS: Hours/week --- none --- Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No ⎩<br />

Mössbauer sources? (specify which & quantity) Yes No ⎩<br />

X ray sources? (specify which & quantity) Yes No ⎩<br />

Intense neutron beam? (specify average En = ?) Yes No ⎩<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11<br />

C<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No ⎩<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes ⎩ No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera (planar) 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No ⎩<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No ⎩<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No ⎩<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No ⎩<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No ⎩<br />

137<br />

131


18 F RADIONUCLIDE PRODUCTION --- none ---<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

132 138<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED --- none ---<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

Frequency <strong>of</strong><br />

production<br />

11 C RADIOPHARMACEUTICALS PRODUCED --- none ---<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

[ 13 N]NH4 + 4 50 (per month) 16 13<br />

O (p,α) N Yes No ⎩<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

[ 15 O]H2O 1 20 (per day)<br />

15 15<br />

N (p,n) O<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED --- none ---<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Aachen, 2005-09-28 B.Müller


2005 COUNTRY GERMANY GER-17<br />

[1] INSTITUTE: Kl<strong>in</strong>ikum Rechts der Isar der Technischen Universitaet<br />

Muenchen, Nuklearmediz<strong>in</strong>ische Kl<strong>in</strong>ik und Polikl<strong>in</strong>ik<br />

Isman<strong>in</strong>ger Strasse 22<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Siemens / CTI<br />

RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

D-81675 Muenchen / Germany<br />

+49 (0)89 4140-2972<br />

M.Schwaiger@lrz.tu-muenchen.de<br />

+49 (0)89 4140-4841<br />

Markus Schwaiger, MD<br />

Director<br />

Hans-Jürgen Wester, PhD / Radiopharm. Chemistry<br />

Ingo Wolf, PhD / Target<strong>in</strong>g<br />

Michael Herz / FDG <strong>Production</strong><br />

Petra Watzlowik / PET Tracer <strong>Production</strong><br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 10.5 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 30 - 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

16 16 — 2 —<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence —<br />

Gamma camera 1<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

4<br />

–Cl<strong>in</strong>ical 2<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1992<br />

—<br />

139<br />

133


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

134 140<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 45 97 0.7 700 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 20.0 3 / day Yes No Yes No<br />

FLT 0.75 1 / week Yes No Yes No<br />

FET 3.0 2 / week Yes No Yes No<br />

RGD 0.75 2 / month Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

methion<strong>in</strong>e 2.6 2 / week Yes No Yes No<br />

chol<strong>in</strong>e 6.0 3 / week Yes No Yes No<br />

flumazenil 1.5 1 / month Yes No Yes No<br />

BTA 1.2 1 / week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

NH3 1.2 4 / week<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2 15 O 1.2 2 / month<br />

Price/<br />

GBqe<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

11<br />

C-hydroxyephedr<strong>in</strong>e 2.2 GBq 1 / month<br />

11 C-diprenorph<strong>in</strong>e 0.9 GBq<br />

18 F-octreotide 0.5 GBq 1 / week<br />

18 F-fluoride 1.2 GBq 1 / month


2005 COUNTRY: GERMANY GER-18<br />

[1] INSTITUTE: Universitätskl<strong>in</strong>ikum Hamburg-Eppendorf<br />

Kl<strong>in</strong>ik u. Polikl<strong>in</strong>ik für Radiologie, Abteilung für<br />

Nuklaermediz<strong>in</strong>, Bereich Zyklotron u. Radiopharmazie<br />

Luruper Chaussee 149<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

D-22761 Hamburg<br />

+49 40 8998 2968<br />

bruno@ukezyk.desy.de<br />

+49 40 8998 2960<br />

Dr. Pal Mikecz<br />

Head<br />

Uve Kirchner<br />

Dr. Oliver Schulze<br />

Isochronous YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Philips (II) UPGRADE:<br />

MODEL: 140/IV<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 30 16 42 30 Yes No<br />

Maximum beam available (µA) 130(<strong>in</strong>ternal)<br />

Typical beam employed (µA) 20(external)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research ma<strong>in</strong>tenance applications<br />

40 30 2 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 5-7/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong> agricultural<br />

applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1968<br />

141<br />

135


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

136 142<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 28 75-95 0.9 500 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15 10/week Yes No Yes No<br />

18FLT 1-5 1 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

McN 5652z 1-3 4/week Yes No Yes No<br />

Chol<strong>in</strong>e 1 1 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-19<br />

[1] INSTITUTE: Universitätskl<strong>in</strong>ikum Ulm, Abteilung Nukleamediz<strong>in</strong><br />

Robert-Koch-Strasse 8<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

D-89081 Ulm<br />

+49 731 500 24981<br />

bernd.neumaier@mediz<strong>in</strong>.uni-ulm<br />

+49 731 500 24979<br />

Dr. Bernd Neumaier<br />

Head <strong>of</strong> PET Chemistry<br />

Dr. Andreas Vogg, Radiochemist<br />

Christoph Solbach, Radiochemist<br />

Dr. Michaela Schmid, Chemist<br />

Negative ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 40 20<br />

Typical beam employed (µA) 30 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 16 3 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) 20<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Research, still not specified.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Munich, Nuklearneclizimsche<br />

und Polikl<strong>in</strong>e, KRI & <strong>in</strong> cases <strong>of</strong> cyclotron ma<strong>in</strong>tenance<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

e.g. with FLP, FDOpa<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 5<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience?<br />

The candidate can only visit our cyclotron site, self-operation is impossible.<br />

Yes No<br />

3 He<br />

4 He<br />

1994<br />

143<br />

137


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

138 144<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 50 95 2 600 Yes<br />

No<br />

20 Ne (d, α) 18 F 6 21<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 22 4/week Yes No Yes No<br />

Dopa 0.8 2/week Yes No Yes No<br />

FLT 3 1/week Yes No Yes No<br />

Fluoride 6 1/week Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 7 2/week Yes No Yes No<br />

Acetate 2.5 2/week Yes No Yes No<br />

Raclopride 4 2/week Yes No Yes No<br />

PK11195 1 0-1/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonic 16 0/week 16<br />

O(p,α) Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 8 0/week<br />

14<br />

N(d<strong>in</strong>)<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

18F micliosides by electrophilic fluor<strong>in</strong>ation. 0.4GBq, occasionaly <strong>for</strong> research<br />

11<br />

C chlor<strong>in</strong>e, 6GBq/batch, 0.1/week<br />

11<br />

C alpha-methyl-tryptophane, 1.5 GBq/batch, 0.1/week<br />

11 C carfentanil, 4GBq/batch, 0-1/week<br />

11 C flumazenile, 4GBq/batch, 0.1/week.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-20<br />

[1] INSTITUTE: Universitätskl<strong>in</strong>ikum Ulm<br />

Abteilung Nukleamediz<strong>in</strong><br />

Robert-Koch-Strasse 8<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

1994 TYPE OF<br />

CYCLOTRON:<br />

D-89081 Ulm<br />

+49 731 500 24981<br />

bernd.neumaier@mediz<strong>in</strong>.uni-ulm<br />

+49 731 500 24979<br />

Dr. Bernd Neumaier<br />

Head <strong>of</strong> Cyclotron / Radiopharmacy<br />

Dr. Andreas Vogg, Radiochemist<br />

Wolfgang Scheel, Cyclotron Eng<strong>in</strong>eer<br />

Dr. Michaela Schmid, Chemist<br />

Negative ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: GE Medical Systems. (II) UPGRADE:<br />

MODEL: PETtrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

3 He<br />

4 He<br />

07 / 2002<br />

Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes No<br />

Maximum beam available (µA) 75 30<br />

Typical beam employed (µA) 35 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

25 h 20 h 5 h 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Radpharm 25<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Research, still not specified.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

e.g. with FLP, FDOpa<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 5<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience?<br />

The candidate can only visit our cyclotron site, self-operation is impossible.<br />

Yes No<br />

145<br />

139


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

140 146<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 60 95 2 600 Yes<br />

No<br />

20 Ne (d, α) 18 F 10 21<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 26 4/week Yes No Yes No<br />

DOPA 0.8 2/week Yes No Yes No<br />

Fluoride 6 1/week Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 7 2/week Yes No Yes No<br />

Chol<strong>in</strong>e 9 9/week Yes No Yes No<br />

Raclopride 2 1/week Yes No Yes No<br />

BTA-1 2 2/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonic 16 0/week 16<br />

O(p,α) Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 8 0/week<br />

14<br />

N(d,n)<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

11 C alpha-methyl-tryptophane, 1.5 GBq/batch, 1/week<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


COUNTRY: GERMANY GER-21<br />

[1] INSTITUTE: University <strong>of</strong> Frankfurt<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Kl<strong>in</strong>ikum der Johann Wolfgang Goethe-Universität<br />

Theodor-Stern-Kai 7, Jaus 21 D<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

D-60590 Frankfurt am Ma<strong>in</strong><br />

+49 69 6301 4330<br />

christian.menzel@em.uni-frankfurt.de<br />

+49 69 6301 6805<br />

Pr<strong>of</strong>essor Dr. Frank Grünwald<br />

Chairman and Director<br />

Pr<strong>of</strong>essor Dr. Christian Menzel, Deputy Director<br />

YEAR OF:<br />

2002<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: (II) UPGRADE:<br />

MODEL: PetTrace?<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] RADIONUCLIDES AND RADIOPHARMACEUTICALS PLANNED TO BE PRODUCED IN THE NEXT 1-3 YEARS (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? …….<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

147<br />

141


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

142 148<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-22<br />

[1] INSTITUTE: Westfaelische Wilhelms Universitaet<br />

Kl<strong>in</strong>ik und Polikl<strong>in</strong>ik fuer Nuklearmediz<strong>in</strong><br />

Domagkestrasse 5<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

48189 Münster<br />

+49 251 83 473 76 or 473 62<br />

eckardt@uni-muenster.de<br />

+49 251 83 473 63<br />

Pr<strong>of</strong>essor Dr. O. Schober<br />

Director<br />

Jörg Eckardt, Physicist<br />

Dr. Markus Knickmeier, Chemist<br />

Negative ion YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

11 10 1<br />

3 He<br />

4 He<br />

1999<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 10 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

149<br />

143


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

144 150<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 97 1.1 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 20 Daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 2 weekly 15 N(p,n) 15 O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: GERMANY GER-23<br />

[1] INSTITUTE: Zentralkl<strong>in</strong>ik Bad Berka GmbH<br />

Bad Berka PETCT Centre<br />

Robert-Koch-Allee 9<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

99437 Bad Berka, Germany<br />

+49 364 585 2200<br />

<strong>in</strong>fo@rpbaum.de<br />

+49 364 585 3515<br />

Pr<strong>of</strong>essor Dr. Richard P. Baum<br />

Chairman, Department <strong>of</strong> Nuclear Medic<strong>in</strong>e/Centre <strong>for</strong> PETCT<br />

Negative ion<br />

Dipl.-.Ing. R. Wortmann, Head <strong>of</strong> Radiopharmacy<br />

YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1997<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE: 1998/99 (Dual Beam)<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

16<br />

Installation underway<br />

14 - 15<br />

none<br />

1-2<br />

none<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: none Radiography: none<br />

Materials science: none Proton therapy: none<br />

Physics: none Neutron therapy: none<br />

Activation analysis: none Other (specify) none<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 13 15 18<br />

C, N, O, F<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Hospitals <strong>in</strong> Germany, daily<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals caried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera 1<br />

S<strong>in</strong>gle photon tomography (SPET) 1<br />

Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

151<br />

145


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

146 152<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F > 3.4 GBq/µA > 95 0.8 500 Yes<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

34 - 120 GBq<br />

No<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 20 - 70 daily Yes No Yes No<br />

18<br />

Fluoride 20 2/week Yes No Yes No<br />

18<br />

FET (Tyros<strong>in</strong>) 4 1/week Yes No Yes No<br />

18<br />

FECh (Chol<strong>in</strong>) 4 1/week Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

None Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

None Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

None<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

None<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Ga-68 DOTA-NOC, Y-90 DOTA-TATE, Lu177-DOTA-TATE<br />

N-13 ammonia<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


14. HUNGARY<br />

2005 COUNTRY: HUNGARY HUN-1<br />

[1] INSTITUTE: Institute <strong>of</strong> Nuclear Research<br />

<strong>of</strong> the Hungarian Academy <strong>of</strong> Sciences<br />

Bem ter 18/c, P.O. Box 51<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+36 52 417 266<br />

FAX NO.:<br />

+36 52 416 181<br />

[2] PERSON IN CHARGE:<br />

F. Tarkanyi<br />

POSITION:<br />

Head, Cyclotron Department<br />

OTHER SENIOR STAFF:<br />

Dr. L. Trón, Head <strong>of</strong> PET Centre<br />

NAME/POSITION<br />

Z. Kormany<br />

NAME/POSITION<br />

P. Kovacs<br />

[3] TYPE OF<br />

Compact isochronous YEAR OF: (I)<br />

1985<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: NIIEFA Russia (II) UPGRADE: 1997<br />

MODEL: MGC 20E<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 20 10 26 20 Yes No<br />

Maximum beam available (µA) 200 300 50 50<br />

Typical beam employed (µA) 50 50 25 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

94 28 (56 every 2nd week) 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

13 15 11 111 123 123<br />

N-Ammonia, O-Water, C-Flumez<strong>in</strong>il, In-DTPA, I-mIBG, I-Imoaz<strong>in</strong>e<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Na 123 I-every 2 weeks; 67 Ga-citric<br />

acid – every 2 weeks.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera 2<br />

S<strong>in</strong>gle photon tomography (SPET) 1<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

153<br />

147


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

148 154<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Neutron source (radiobiology, radiation hardness test, neutron activation, Th<strong>in</strong> Layer Activation (TLA), wear<br />

measurements, activation analysis (charged particle) Basic nuclear physics (<strong>in</strong> beam nuclear spectroscopy, astrophysical<br />

nuclear reactions)


15. INDIA<br />

2005 COUNTRY: INDIA IND-1<br />

[1] INSTITUTE: Radiation Medic<strong>in</strong>e Centre<br />

Bhabha Atomic Research Centre (BARC)<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Trombay, Mumbai 400 085<br />

+91 22 550 5326<br />

samuel@apsara.barc.ernet.<strong>in</strong><br />

+91 22 550 5326<br />

Dr. A.M. Samuel<br />

Director, Bio-Medical Group, BARC, Mumbai<br />

Dr. N. Ramamoorthy<br />

Chief Executive, BRIT, Mumbai<br />

Dr. B.N. Karkers, Head, MD & PDS<br />

Dr. M.R.A. Pillai, Head, Radiopharmaceuticals Division<br />

Dr. N. Nair, Head, Radiation Medic<strong>in</strong>e Centre<br />

[3] TYPE OF<br />

Medical YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Wipro GE, Mumbai (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS: Dual particle (16.5 MeV Proton and e MeV Deuteron)<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8.5 Yes No<br />

Maximum beam available (µA) 80 80<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10-12 10-12 Not yet decided<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions? If yes and available, name <strong>of</strong><br />

<strong>in</strong>stitution/s & how <strong>of</strong>ten? Planned to supply 18 F to Nuclear Medic<strong>in</strong>e Departments<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 4<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

155<br />

149


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

150 156<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

This is the first facility to be set up <strong>in</strong> the country with expertise <strong>in</strong> accelerations, radiopharmaceuticals, radiation biology<br />

and nuclear medic<strong>in</strong>e. It is anticipated that apart from the rout<strong>in</strong>e PET radiopharmaceuticals, research <strong>in</strong> the<br />

development <strong>of</strong> new PET labeled compounds will be <strong>in</strong>itiated.


2005 COUNTRY: INDIA IND-2<br />

[1] INSTITUTE: Variable Energy Cyclotron Centre (VECC)<br />

1/AF, Bidhan Nagar<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Sector-foc<strong>used</strong> (pole<br />

CYCLOTRON:<br />

diameter 224 cm)<br />

Calcutta - 700 064<br />

+91 33 3371 230<br />

+91 33 3346 871<br />

Dr. B.C. S<strong>in</strong>ha<br />

Director<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: VEC Centre (II) UPGRADE:<br />

MODEL: (Individual design)<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 6.30 12.30 25.80 Yes No<br />

Maximum beam available (µA) 200 200 200<br />

Typical beam employed (µA) 20 20 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

160 24 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

201<br />

Tl<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Regional Radiation Medic<strong>in</strong>e<br />

Centre, Thakurpukur, Calcutta – weekly, Radiation Medic<strong>in</strong>e Centre Mumbai - monthly<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1997<br />

157<br />

151


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

152 158<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


16. INDONESIA<br />

2005 COUNTRY: INDONESIA INS-1<br />

[1] INSTITUTE: National Atomic Energy Agency, BATAN<br />

PPR-Batan Kawasan<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Positive ion<br />

Puspiptek Serpong 15310<br />

+21 756 3141<br />

mutalib_a@yahoo.com<br />

Mr. Silakhudd<strong>in</strong><br />

Head, Cyclotron Division<br />

Mr. Tonny Heryanto<br />

Budi Tarigan<br />

YEAR OF: (I) INSTALLATION 1990<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE: 1995 (modified to negative<br />

ion by IBA)<br />

MODEL: CS 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 24-27 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

6 4 2 2 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

We would like to produce 123 I. Un<strong>for</strong>tunately we have no experts and facility.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Hospitals, 1-2/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

159<br />

153


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

154 160<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 1/2week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

We are plann<strong>in</strong>g to produce 18 FDG <strong>in</strong> 2002.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


17. IRAN, ISLAMIC REPUBLIC OF<br />

COUNTRY: IRAN IRA-1<br />

[1] INSTITUTE: Nuclear Research Centre <strong>for</strong> Agriculture<br />

and Medic<strong>in</strong>e (NRCAM)<br />

P.O. Box 31585-4395, Karaj<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+98 261 313 0676<br />

FAX NO.:<br />

+98 261 411 105<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pr<strong>of</strong>essor Hosse<strong>in</strong> Afarideh<br />

OTHER SENIOR STAFF:<br />

Satari; Partovi<br />

NAME/POSITION<br />

Rafii; Akbari; Shafiei<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1995<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, Belgium (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

15-30 7-15 Yes No<br />

Typical beam employed (µA) 500 150 175<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20-25 12-17 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

81m Kr – Rb generator, 18 F – FDG , 123 In<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? To all nuclear medic<strong>in</strong>e centres –<br />

Once a week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

161<br />

155


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

156 162<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 0.1 0.5/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 0.5 0.5/week Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 0.037 1/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


18. ISRAEL<br />

2005 COUNTRY: ISRAEL ISR-1<br />

[1] INSTITUTE: Hadassah Medical Organization<br />

E<strong>in</strong> Karem<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Il-91 120 Jerusalem<br />

+972 2 6777 197<br />

mishani@md2.huji.ac.il<br />

+972 2 6438 506<br />

Dr. Eyal Mishani<br />

Head <strong>of</strong> Cyclotron Unit<br />

Mr. Desideriu Laky, Cyclotron Operator<br />

Dr. Revital ben-Daniel, Research<br />

Mr. Daniel Wajnblum, Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1997<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 40 25<br />

Typical beam employed (µA) 30 18<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

18 12 6 12<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 4 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F – FDG, DOPA, 18 F – FES; 18 F –FLT; 11 C – Chol<strong>in</strong>e ; 15 O - Water<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 2<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

163<br />

157


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

158 164<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 110 97 2.3 900 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 50 2-3/day Yes No Yes No<br />

Dopa Yes No Yes No<br />

ML 01 Yes No Yes No<br />

ML 03 Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e 10 Yes No Yes No<br />

Deprenyl 3 Yes No Yes No<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 8<br />

16 13<br />

O(p,α ) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 4 -8 1/week<br />

14 15<br />

N (d, n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ISRAEL ISR-2<br />

[1] INSTITUTE: Soreq NRC<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

81800 Yavne<br />

+97 2 8943 4615<br />

shohet@mailbox.soreq.gov.il<br />

+97 2 8943 4133<br />

Eng<strong>in</strong>eer Yosef Shohet<br />

Head <strong>of</strong> Facility<br />

Dr. M.B. Goldberg, Head, Steer<strong>in</strong>g Committee<br />

Dr. D. Berkovits, Chief Physicist<br />

Bs. Phrm. B. Hoch, Chief Radiochemist<br />

Mr. T. Arbel, Head <strong>of</strong> Operation Staff<br />

[3] TYPE OF<br />

Cyclone series YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, Belgium (II) UPGRADE:<br />

MODEL: 10/5<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 10 5 Yes No<br />

Maximum beam available (µA) 80 80<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20-25 15-20 1-2 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 15-20 Radiography:<br />

Materials science: 1-2 Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 66-68 15<br />

C Ga F-DOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

165<br />

159


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

160 166<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15000 94 2 600 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 50 1-2 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


19. ITALY<br />

2005 COUNTRY: ITALY ITA-1<br />

[1] INSTITUTE: Azienda Ospedaliero Universitaria<br />

Policl<strong>in</strong>ico S. Orsola - Malpighi<br />

Via Massarenti, 9<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

40138 Bologna<br />

+39 051 636 3952<br />

marengo@med.unibo.it<br />

+39 051 636 3954<br />

Pr<strong>of</strong>essor Roberto Franchi<br />

Pr<strong>of</strong>essor <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Dr. Mario Marengo, Medical Physicist, Head Nuc. Med. Physics<br />

Dr. Stefano Boschi, Chemist, Head Radiopharmacy<br />

PETtrace YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

GE (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8 Yes No<br />

Maximum beam available (µA) 75 60<br />

Typical beam employed (µA) 38 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

25 18 6 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify): 64Cu<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten? Hospitals <strong>of</strong> Cesena and Forlì,<br />

daily<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera 5<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

5<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

167<br />

161


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

162 168<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 100 >95 1.5 1000 Yes<br />

No<br />

20 Ne (d,α) 18 F 5.5 Ne+0.3 %F2 60<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F - FDG 50 2/day Yes No Yes No<br />

18 F - FDOPA 1 1 / week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C - Chol<strong>in</strong>e 26 1 / day Yes No Yes No<br />

11 C - Methionie 26 1 / week Yes No Yes No<br />

11 C - acetate 26 1 / week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ITALY ITA-2<br />

[1] INSTITUTE: Azienda Ospedaliera 5. Maria Nuova<br />

Servizio di Medic<strong>in</strong>a Nucleare<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

V. le Risorgimento 80, Reggio Emilia<br />

+39 0522 296 284<br />

salvo.diana@asmn.re.it<br />

+39 0522 296 392<br />

Dr. Diana Salvo<br />

Department Chief<br />

OTHER SENIOR STAFF:<br />

Dr. Annibale Versari<br />

NAME/POSITION<br />

chair <strong>of</strong> PET-Center activities<br />

[3] TYPE OF<br />

10 Mev YEAR OF: (I)<br />

October 2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: General Electric (II) UPGRADE:<br />

MODEL: M<strong>in</strong>itrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 9.6 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong><br />

production<br />

research<br />

15 13 2<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Maybe 11 C<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? In 2002<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

169<br />

163


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

164 170<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 37 95 0.8 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 37 1or 2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ITALY ITA-3<br />

[1] INSTITUTE: CNR Institute <strong>of</strong> Cl<strong>in</strong>ical Physiology<br />

Via Moruzzi, 1<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

I-56100 Pisa<br />

+39 050 315 3384<br />

salvador@ifc.cnr.it<br />

+39 050 315 2166<br />

Piero A. Salvadori<br />

Head – PET/Cyclotron Facility<br />

Luca Menichetti, Radiopharmacist<br />

Debora Petroni, Radiopharmacist<br />

Michela Poli, Pharmacist<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1996<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE Medical Syst. (II) UPGRADE: 2001<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS: 5 beam ports <strong>used</strong> (6 available); targets resident on beam ports, no beam<br />

transport l<strong>in</strong>es.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.7 8.4 Yes No<br />

Maximum beam available (µA) 75 50<br />

Typical beam employed (µA) 25 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

27 15 10 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera 3<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical 1<br />

–Small animal planned<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

171<br />

165


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

166 172<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 55 97 1 150 Yes<br />

No<br />

20 Ne (d, α) 18 F 11<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 11 1/day Yes No Yes No<br />

Fluoride 3.7 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methyl iodide 37 Development Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2 1/day Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

O Development<br />

Water Development<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Development Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Development Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Development Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Additional activities planned <strong>for</strong> near future:<br />

- use <strong>of</strong> cyclotron <strong>for</strong> research <strong>in</strong> Boron neutro capture therapy<br />

- FDG manufactur<strong>in</strong>g site<br />

- research <strong>in</strong> molecular imag<strong>in</strong>g applied to genomic and proteonomic.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ITALY ITA-4<br />

[1] INSTITUTE: Consiglio Nazionale delle Ricerche<br />

Institute Pascale (CNR)<br />

Via M. Semmola<br />

I-80131 Napoli<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+39 81 5903 528/527<br />

FAX NO.:<br />

+39 81 5465 797<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pr<strong>of</strong>essor Marco Salvatore<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Antonello Green<br />

[3] TYPE OF<br />

Positive ion YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 17<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 8.5 Yes No<br />

Maximum beam available (µA) 75 50<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 15 25<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

15 O - Water , 11 C – CH3 I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

173<br />

167


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

168 174<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Fluoride Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ITALY ITA-5<br />

[1] INSTITUTE: Istituto Naziónale per lo Studío e la Çura dei Tumori<br />

Via G. Venezian 1<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

I-20133 Milano<br />

+39 2 2390 2220<br />

bombardieri@istitutotumori.mi.it<br />

+39 2 2367 874<br />

Dr. Emilio Bombardieri<br />

Director, Nuclear Medic<strong>in</strong>e Department<br />

Dr. Flavio Crippa, Co-ord<strong>in</strong>ator, Cl<strong>in</strong>ical PET<br />

Dr. Claudio Pascali, Co-ord<strong>in</strong>ator, Radiopharmacy<br />

Eng. V<strong>in</strong>icio De Sanctis, Responsible <strong>for</strong> the Cyclotron<br />

[3] TYPE OF<br />

Positive ion YEAR OF: (I)<br />

1995<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scanditronix (II) UPGRADE:<br />

MODEL: MC 17F<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 85 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 25 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

12 6 6<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) PET 35<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

Number<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

9-10 patients/day<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

175<br />

169


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

170 176<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 4500 94-97 ~ 1 250 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10-15 1/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 2 - 10 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ITALY ITA-6<br />

[1] INSTITUTE: Istituto Scientifico H. San Raffaele<br />

Servizio di Medic<strong>in</strong>a Nucleare<br />

Via Olgett<strong>in</strong>a, 60<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

I-20132 Milano<br />

+39 02 2153 056<br />

fazio@mednuc.hsr.it<br />

Pr<strong>of</strong>essor Ferruccio Fazio<br />

Mario Matarrese<br />

Francesco Perug<strong>in</strong>i<br />

[3] TYPE OF<br />

Negative ion<br />

Sergio Todde<br />

YEAR OF: (I)<br />

1988<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS: Negative hydrogen ions<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

27 20 5 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

5<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

3<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

177<br />

171


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

172 178<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 26 > 94 0.65 500 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 13 2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methyl chol<strong>in</strong>e 3 2/week Yes No Yes No<br />

FE – CIT 1 2/week Yes No Yes No<br />

Raclopride 1.5 1/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Water 370 MBq 3/week<br />

15 N (p, n ) 15 O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: ITALY ITA-7<br />

[1] INSTITUTE: Ospedale San Raffaele, Universita Degli Studi<br />

Cattedra di Medic<strong>in</strong>a Nucleare<br />

Via Olgett<strong>in</strong>a 60<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

I-20132 Milano<br />

+39 2 2153056/2643/ 2716<br />

fazio@mednuc.hsr.it<br />

+39 2 2640390<br />

Pr<strong>of</strong>essor Ferruccio Fazio<br />

Mario Matarrese, <strong>in</strong> charge <strong>of</strong> the Cyclotron<br />

Francesco Perug<strong>in</strong>i, <strong>in</strong> charge <strong>of</strong> Operations<br />

Sergio Todde, <strong>in</strong> charge <strong>of</strong> Radiochemistry<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS: Protons and deuterons beam.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 50 40<br />

Typical beam employed (µA) 25 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

32 5 25 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera 5<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical 3<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

179<br />

173


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

174 180<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 74 >94 2 700 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 37 1 run/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY ITALY ITA-8<br />

[1] INSTITUTE: European Commission – Jo<strong>in</strong>t Research Centre<br />

Institute <strong>for</strong> Health and Consumer Protection<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Compact<br />

Scanditronix<br />

MC40<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Via E. Fermi 1, I-21020 Ispra (VA), Italy<br />

+39-0332-785194<br />

uwe.holzwarth@jrc.it<br />

+39-0332-789385<br />

Uwe Holzwarth<br />

Technical Director<br />

Kamel Abbas<br />

Neil Gibson<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

3 He<br />

4 He<br />

1982<br />

none to accelerator;<br />

laboratory cont<strong>in</strong>uous<br />

Dual Beams<br />

Beam energies (MeV) 8-39 4-19.5 11-53 8-39 Yes No X<br />

Maximum beam available (µA) 60 50 20 30<br />

Typical beam employed (µA) 30 15 3 5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/week <strong>for</strong><br />

applications<br />

70 35 20 5 10<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 10 Proton therapy: 5<br />

Physics: 5 Neutron therapy: 0<br />

Activation analysis: 5 Other (Target developm.) 10<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No X<br />

Mössbauer sources? (specify which & quantity) Yes No X<br />

X ray sources? (specify which & quantity) Yes No X<br />

Intense neutron beam? (specify average En = ?) Yes No X<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes X No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Istituto Nazionale di Fiscica Nucleare accord<strong>in</strong>g to common project necessities<br />

Istituto Europeo di Oncologia (start envisaged <strong>for</strong> 2006)<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence 0<br />

Gamma camera 0<br />

S<strong>in</strong>gle photon tomography (SPET) 0<br />

Positron emission tomography (PET), (PET-CT) 0<br />

–Cl<strong>in</strong>ical 0<br />

–Small animal 0<br />

–Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes X No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Please, specify. Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

181<br />

175


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

176 182<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 100 95 1.5 ml Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 50 Yes No X Yes X No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu < 1 2/month Yes X No Yes X No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At < 1 1/month Yes X No Yes X No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

18<br />

F-FDG production <strong>in</strong> collaboration with commercial partner that is <strong>in</strong> charge with distribution<br />

(commercial data confidential) proton therapy: test and development <strong>of</strong> beam diagnostic equipment <strong>in</strong> collaborations<br />

64 211<br />

Cu and At: target development, alternative production routes, production capacity will <strong>in</strong>crease<br />

Distribution <strong>of</strong> 64 Cu and 211 At to collaboration partners <strong>in</strong> the nuclear and medical field <strong>for</strong> <strong>in</strong> vitro (later <strong>in</strong> vivo) studies;<br />

studies with 211At have to start <strong>in</strong> our labs due to miss<strong>in</strong>g licenses <strong>for</strong> handl<strong>in</strong>g alpha-emitters <strong>in</strong> hospitals<br />

CPAA <strong>for</strong> biok<strong>in</strong>etics studies on radioactive fallout components<br />

TLA <strong>for</strong> release studies on biomedical materials and implants, as well as eng<strong>in</strong>e components


2005 COUNTRY ITALY ITA- 9<br />

[1] INSTITUTE: U.O.Medic<strong>in</strong>a Nucleare centro PET<br />

Ospedale S.Giacomo via Ospedale n° 18 31033 Castelfranco<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

11 MeV<br />

CTI<br />

RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

MEDICAL CYCLOTRON<br />

NEGATIVE IONS ACC.<br />

1 H<br />

2 H<br />

Veneto Treviso, ITALY<br />

+390423732435<br />

franchierhome@t<strong>in</strong>.it<br />

+390423732426<br />

F.Chierichetti MD director <strong>of</strong> Nuclear Medic<strong>in</strong>e Department<br />

Head <strong>of</strong> PET center<br />

Dr A.F<strong>in</strong>i, radiochmist<br />

Dr M.Marcol<strong>in</strong>, radiopharmacist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 10.5 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 28<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

18 16 0 4 2<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Cl<strong>in</strong>ical<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No X<br />

Mössbauer sources? (specify which & quantity) Yes No X<br />

X ray sources? (specify which & quantity) Yes No X<br />

Intense neutron beam? (specify average En = ?) Yes No X<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18RFbFLT 18F MISO 18F DOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

2 other regional <strong>in</strong>stitutios<br />

Yes X No<br />

[10] Are cl<strong>in</strong>ical medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried out on-site? Yes X No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence 0<br />

Gamma camera 0<br />

S<strong>in</strong>gle photon tomography (SPET) 2<br />

Positron emission tomography (PET), (PET-CT) 1 PET<br />

– Cl<strong>in</strong>ical, Small animal, Plant biochemistry 1 PET-TC<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Please, specify. Yes No X<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

3 He<br />

4 He<br />

1994<br />

2002<br />

183<br />

177


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

178 184<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 37 >95 0.85 ml 800 gr Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 21 daily Yes X No Yes No X<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-Acetate 5 Twice a week Yes X No Yes No X<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N-Ammonia 1.1 Twice a week<br />

16 13<br />

O ( p alfa ) N Yes No X<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 5.5 rare<br />

15 15<br />

N (p n ) O<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY: ITALY ITA-10<br />

[1] INSTITUTE: Ospedale Maggiore di Milano<br />

Servizio di Medic<strong>in</strong>a Nucleare<br />

Via Francesco S<strong>for</strong>za 35<br />

Pad. Granelli, I-20133 Milano<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+39 02 5503 3340<br />

FAX NO.:<br />

+39 02 5503 5510<br />

[2] PERSON IN CHARGE:<br />

Dr. Paolo Gerund<strong>in</strong>i Gherardi<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

Primario<br />

NAME/POSITION<br />

Fabio Riccardo Colombo<br />

NAME/POSITION<br />

Rosangela Casati<br />

[3] TYPE OF<br />

PET Trace YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: (II) UPGRADE:<br />

MODEL: PT GEMS<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes No<br />

Maximum beam available (µA) 75 60<br />

Typical beam employed (µA) 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 8 2 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) PET<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

15 13 11<br />

O - Water, N - Ammonia, C - Radiopharmaceuticals to be decided.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

185<br />

179


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

180 186<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 44.4 95 1.2 400 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 22.2 Daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY ITALY ITA-11<br />

[1] INSTITUTE: Istituto Cl<strong>in</strong>ico Humanitas<br />

Via Manzoni 56<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Cyclone<br />

IBA<br />

Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

PROTON BEAM 18 MEV<br />

DEUTERON BEAM 9 MEV<br />

1 H<br />

2 H<br />

20089 Rozzano (MI), Italy<br />

+390282246622<br />

medic<strong>in</strong>a.nucleare@humanitas.it<br />

+390282246691<br />

Arturo Chiti<br />

Director, Nuclear Medic<strong>in</strong>e<br />

Giovanni Tosi / Physicist<br />

Katia Marzo/ Senior Radiochemist<br />

Mauro Almangano / Junior Radiochemist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 80 35<br />

Typical beam employed (µA) 30 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

radioproduction<br />

3 He<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

2003<br />

Hours/week <strong>for</strong><br />

applications<br />

12 12<br />

[6] Cyclotron applications: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11C-chol<strong>in</strong>e; 11C-metion<strong>in</strong>e; 13N-ammonia<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET), (PET-CT) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Please, specify. Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

187<br />

181


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

182 188<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 18<br />

O (p, n) F<br />

Ne (d, α)<br />

37 95 2000 µl<br />

600 µl<br />

18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 14.8 2 / DAY Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

18 O2 (l)<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Yes<br />

No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY ITALY ITA-12<br />

[1] INSTITUTE: AZIENDA OSPEDALIERA S. CROCE E CARLE - CUNEO<br />

Via M Copp<strong>in</strong>o 26<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Self-shielded<br />

GE Healthcare<br />

MINItrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

12100 Cuneo , Italy<br />

+39.0171.64.1690<br />

fisici.mn@ospedale.cuneo.it<br />

+39.0171.64.1554<br />

Dr. Alberto Biggi<br />

Head <strong>of</strong> Nuclear Medic<strong>in</strong>e Dept<br />

Dr. Gianni Perno, Physicist<br />

Dr. Michelangelo Longo, Chemist<br />

Ing. Roberto Giuliano. Chemist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 9.6 Yes No X<br />

Maximum beam available (µA) 35<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

3 He<br />

2002<br />

-<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/week <strong>for</strong><br />

applications<br />

9 8 0 1 0<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Medical<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No X<br />

Mössbauer sources? (specify which & quantity) Yes No X<br />

X ray sources? (specify which & quantity) Yes No X<br />

Intense neutron beam? (specify average En = ?) Yes No X<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11<br />

C-Chol<strong>in</strong>e<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No X<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes X No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 5<br />

� Positron emission tomography (PET), (PET-CT)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal 0<br />

– Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Please, specify. Yes No X<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

189<br />

183


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

184 190<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 45 97 1 cc 300 Yes<br />

No X<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 25 1/die Yes X No Yes No X<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

NH3 1 1/week 16 13<br />

O (p, α) N Yes No X<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY ITALY ITA-13<br />

[1] INSTITUTE: A.O. CANNIZZARO<br />

VIA MESSINA 829<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:MO<br />

DEL:<br />

IBA<br />

Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

95126 CATANIA (ITALY)<br />

++ 30 095 7263588<br />

sab<strong>in</strong>i@lns.<strong>in</strong>fn.it<br />

Dr. M. Ippolito<br />

MD/ head <strong>of</strong> Pet-Cyclotron Division<br />

MG SABINI MEDICAL PHYSICIST<br />

F. SCOPELLITI RADIOCHEMISTRY<br />

P. DIRAIMONDO RADIOCHEMISTRY<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

2004<br />

2 H<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes x No<br />

Maximum beam available (µA) 80 35<br />

Typical beam employed (µA) 40 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

12 7 N/A N/A N/A<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11C- Methyo<strong>in</strong><strong>in</strong>e and Col<strong>in</strong>e<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

<strong>in</strong> next future<br />

Yes x No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No x<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET), (PET-CT) 2 (1+1)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No x<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No x<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Please, specify. Yes No x<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No x<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

3 He<br />

4 He<br />

191<br />

185


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

186 192<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 1500mCi 95% x 100% Yes x<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 900 mCi daily Yes x No Yes No x<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


20. JAPAN<br />

2005 COUNTRY: JAPAN JAP-1<br />

[1] INSTITUTE: Biomedical Imag<strong>in</strong>g Research Centre<br />

Fukui Medical University<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

OSCAR 5,<br />

superconduct<strong>in</strong>g,<br />

negative-ion<br />

RDS eclipse,<br />

23-3 Shimoaizuki, Matsuoka, Yoshida, Fukui, 910-1193<br />

+81 776 61 8430<br />

yfuji@fmsrsa.fukui-med.ac.jp<br />

+81 776 61 8170<br />

Yoshiharu Yonekura<br />

Director, Pr<strong>of</strong>essor <strong>of</strong> Medical Imag<strong>in</strong>g<br />

Yasuhisa Fujibayashi, Pr<strong>of</strong>essor <strong>of</strong> Molecular Imag<strong>in</strong>g<br />

Tatsuo Ido, Pr<strong>of</strong>essor <strong>of</strong> PET Eng<strong>in</strong>eer<strong>in</strong>g<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER:<br />

negative-ion<br />

NKK<br />

CMI/CTI<br />

(II) UPGRADE: 2004<br />

MODEL: Ox<strong>for</strong>d<br />

RD/HP<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 12<br />

Yes No<br />

11<br />

Yes No<br />

Maximum beam available (µA) 50 - 40<br />

Typical beam employed (µA) 30 - 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

26 16 2 8 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

18<br />

F — 0.5/week<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions? If yes, name <strong>of</strong> <strong>in</strong>stitutions. Yes No<br />

[10] Are cl<strong>in</strong>ical& medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried out on-site? Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

3<br />

–Cl<strong>in</strong>ical, Small animal, Plant biochemistry 2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1994<br />

193<br />

187


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

188 194<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

37 96 4.2<br />

1.5<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10 4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 20 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4 1/month<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

O2<br />

OTHER ISOTOPES PRODUCED<br />

800 Yes<br />

No<br />

Name Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 0.37 2/week<br />

15 15<br />

N(p,n) O<br />

CO 0.37<br />

1/week<br />

15 15<br />

N(p,n) O<br />

CO2 0.37<br />

0.37<br />

1/week<br />

1/week<br />

15 15<br />

N(p,n) O<br />

15 15<br />

N(p,n) O<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu 0.37 1- 2/week Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

64 62 67 18<br />

Cu - ATSM (Hypoxia), Cu - ATSM (Hypoxia), Cu - PTSM (Perfusion) and F - FES (Estrogen receptor)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JAP-2<br />

[1] INSTITUTE: Daiichi Radioisotope Laboratories, Ltd.<br />

453-1 Shimo-okura Matsuo-machi<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Sanbu-gun Chiba 289-1592<br />

+81 479 86 4721<br />

stakashi@drl.co.jp<br />

+81 479 86 5112<br />

Mr. Takashi Syogenji<br />

Manager, RI <strong>Production</strong> Group<br />

Yasuharu Sato<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 350<br />

Typical beam employed (µA) 300<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

120 120 12<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

195<br />

189


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

190 196<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 2/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

5/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 1/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-3<br />

[1] INSTITUTE: Daiichi Radioisotope Laboratories, Ltd.<br />

453-1 Shimo-okura Matsuo-machi<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Sanbu-gun Chiba 289-1592<br />

+81 479 86 4721<br />

stakashi@drl.co.jp<br />

+81 479 86 5112<br />

Mr. Takashi Syogenji<br />

Manager, RI <strong>Production</strong> Group<br />

Yasuharu Sato<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1984<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-40<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 200<br />

Typical beam employed (µA) 180<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

120 120 12<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

197<br />

191


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

192 198<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 4/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-4<br />

[1] INSTITUTE: Department <strong>of</strong> Radiology<br />

University <strong>of</strong> Tokyo<br />

7-3-1 Hongo Bunkyo-ku<br />

Tokyo 113<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+81 3 381 55411 ext. 5129<br />

FAX NO.:<br />

+81 3 5800 8935<br />

[2] PERSON IN CHARGE:<br />

Toshimitsu Momose, MD<br />

POSITION:<br />

Assistant Pr<strong>of</strong>essor<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Sh<strong>in</strong>ya Oku<br />

[3] TYPE OF<br />

Positive ion YEAR OF: (I)<br />

1988<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitmo Heavy<br />

Industries, Ltd.<br />

(II) UPGRADE:<br />

MODEL: Cypris 370<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) PET cl<strong>in</strong>ical<br />

applications<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

199<br />

193


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

194 200<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

DOPA Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

NHSP Yes No Yes No<br />

NHPB Yes No Yes No<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammpnia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

O2<br />

CO2<br />

Water<br />

CO<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-5<br />

[1] INSTITUTE: Gunma University School <strong>of</strong> Medic<strong>in</strong>e<br />

39-15 Showa-machi 3-chome<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Maebashi-shi, Gunma-ken 371<br />

+81 27 220 8661<br />

nuclear@med.gunma-u.ac.jp<br />

OTHER SENIOR STAFF:<br />

Pr<strong>of</strong>essor Keigo Endo<br />

Chairman<br />

Tomio Inoue, M.D.<br />

NAME/POSITION<br />

Kunio Matsubara, PhD.<br />

NAME/POSITION<br />

Katsumi Tomiyoshi, PhD.<br />

[3] TYPE OF<br />

Baby cyclotron YEAR OF: (I)<br />

1983<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC 1700<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 30 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

16 10 5 0.5 0.5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 0.5 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F - α- Methyl - Tryptophan, 11 C – Annex<strong>in</strong>e<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

201<br />

195


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

196 202<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 4 -5 60 2.0 50 Yes<br />

No<br />

20 Ne (d, α) 18 F 4<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 4 -5 5/week Yes No Yes No<br />

FAMT 4 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e 10 - 15 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 10 1/month<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

O2<br />

Water<br />

21<br />

10<br />

1/week<br />

1/month<br />

15 15<br />

N(p, n) O<br />

15 15<br />

N(p, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-6<br />

[1] INSTITUTE: HIMEDIC Imag<strong>in</strong>g Center at Lake Yamanaka<br />

562-12 Yanagihara, Hirano<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Yamanakako-mura, M<strong>in</strong>amitsuru-gun<br />

+81 555 65 9135<br />

himedic@mfi.or.jp<br />

+81 555 20 3007<br />

Dr. Michiru Ide<br />

President<br />

AVF YEAR OF:<br />

INSTALLATION<br />

(I)<br />

(II) UPGRADE:<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

MODEL: HM 18<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes N<br />

Maximum beam available (µA) 70 50<br />

Typical beam employed (µA) 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

7 6 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1993<br />

203<br />

197


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

198 204<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 29 94 1.3 450 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10 5/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

Ammonia 3 20/week<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-7<br />

[1] INSTITUTE: Hokkaido University, Graduate School <strong>of</strong> Medic<strong>in</strong>e<br />

Department <strong>of</strong> Tracer K<strong>in</strong>etics<br />

Kita 15 Nishi 7<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

Kita-ku, Sapporo 060-8638<br />

+81 11 706 5150<br />

kuge@med.hokudai.ac.jp<br />

+81 11 706 7155<br />

Nagara Tamaki<br />

Pr<strong>of</strong>essor and Chairman<br />

Yuji Kuge, Associate Pr<strong>of</strong>essor<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

MODEL: CYPRIS-HM 18<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes N<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 20 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 15 2 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 C - NHSP, 18 F DOPA, 11 C Palmitic Acid , 11 C CGFI 2177<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 2<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 5<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1998<br />

205<br />

199


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

200 206<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 50 95 1.8 240 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 8 2/week Yes No Yes No<br />

Methyon<strong>in</strong>e 7 1/week Yes No Yes No<br />

Flumazenil 5 1/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2 Occasionally<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 1.5 2/week<br />

14 15<br />

N(d,n) O<br />

O2<br />

CO<br />

0.5 2/week<br />

2.0<br />

3/week<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

CO2<br />

1.0<br />

2/week<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-8<br />

[1] INSTITUTE: Hyogo Institute <strong>for</strong> Ag<strong>in</strong>g Bra<strong>in</strong> and Cognitive Disorders<br />

520 Saisho-ko, Himeji<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Superconduct<strong>in</strong>g<br />

negative ion<br />

cyclotron<br />

Hyogo 670<br />

+81 792 95 5511<br />

sasakii@hiabcd.go.jp<br />

+81 792 95 8199<br />

Dr. Masahiro Sasaki<br />

Chief, Nuclear Pharmacology Laboratory<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Ox<strong>for</strong>d (II) UPGRADE:<br />

MODEL: OSCAR-2<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 12 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

6 5 1<br />

3 He<br />

4 He<br />

1992<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11<br />

C MPHA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

207<br />

201


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

202 208<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15 50 5 25/ 95% Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 4 2 - 3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 2 - 3/year Yes No Yes No<br />

NMSP 2 - 3/year Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 5 6 - 10/week<br />

13 15<br />

N(p, n ) O<br />

O2<br />

CO<br />

5<br />

5<br />

2 - 5/month<br />

2 - 5/month<br />

13 15<br />

N(p, n ) O<br />

13 15<br />

N(p, n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-9<br />

[1] INSTITUTE: Institute <strong>for</strong> Bi<strong>of</strong>unctional Research<br />

5-7-1 Fujishiro-dai, Suita-shi<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Osaka 565<br />

+81 6 834 7000<br />

n-ejima@po.iijnet.or.jp<br />

+81 6 872 8761<br />

Dr. Naoto Hashimoto<br />

Director<br />

Norimasa Ejima<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1992<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

(II) UPGRADE:<br />

MODEL: HM 18<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 25 20<br />

Typical beam employed (µA) 15-20 10-15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

~24 810 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site? Specific to animal PET studies.<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

209<br />

203


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

204 210<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C - N2 40-50 1 per month Yes<br />

Yes<br />

No<br />

No<br />

Yes<br />

Yes<br />

No<br />

No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N –<br />

H2 16 O+5mM<br />

EtOH<br />

1.7 1 per 3 months Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

15<br />

O – N2+O2<br />

(0.4%)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

7.5 (2-3) × (5-7)<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-10<br />

[1] INSTITUTE: International Medical Centre <strong>of</strong> Japan<br />

Radiology Department<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

1-21-1 Toyama, Sh<strong>in</strong>jaku-ku<br />

+81 3 3202 7181<br />

ahara@kt.rim.or.jp<br />

+81 3 3202 7181<br />

Toshihiko Hara, MD<br />

Chief - Nuclear Medic<strong>in</strong>e<br />

Noboru Kosaka, MD<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC 2010N<br />

[4] CYCLOTRON CHARACTERISTICS: p.d.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 20 1 Yes No<br />

Maximum beam available (µA) 50 30<br />

Typical beam employed (µA) 30 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 10 5 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No 1<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

211<br />

205


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

206 212<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 18.5 70 2 260 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 7.4 Yes No Yes No<br />

Chol<strong>in</strong>e 3.7 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e 14.8 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 3.7<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-11<br />

[1] INSTITUTE: Japan Atomic Energy Research Institute (JAERI)<br />

1233 Watanuki, Takasaki<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

AVF Cyclotron, K-<br />

CYCLOTRON: 110<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries<br />

MODEL: 930<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Gunma 370-1292<br />

+81 27 346 9420<br />

sek<strong>in</strong>e@taka.jaeri.go.jp<br />

+81 27 346 9688<br />

Dr. Toshiaki Sek<strong>in</strong>e<br />

Deputy Director<br />

Department <strong>of</strong> Radiation Research <strong>for</strong> Environment and<br />

Resources<br />

Ms. Noriko Shigeta Ishikoka<br />

Mr. Sutoshi Watanabe<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 90 50 100 Yes No<br />

Maximum beam available (µA) 5 7 7<br />

Typical beam employed (µA) 5 5 3<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1990<br />

h/week <strong>for</strong><br />

applications<br />

101 15<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 32 Radiography:<br />

Materials science: 28 Proton therapy:<br />

Physics: 12 Neutron therapy:<br />

Activation analysis: Other (specify) 29,cyclotron<br />

technology<br />

development<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

76 Br, 77 Br<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry 2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

213<br />

207


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

208 214<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α, d) 18 F 0.1<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 0.03 1/month Yes No Yes No<br />

18 F - WATER 0.1 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Mehion<strong>in</strong>e 0.4 3/week Yes No Yes No<br />

CO2 3 8/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

NO - 3 0.3 15/week<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Products with our cyclotron are <strong>used</strong> <strong>in</strong> plant physiology only. Once, we have produced 186 Re <strong>for</strong> medical research.<br />

<strong>Production</strong> <strong>of</strong> this radionuclide, <strong>for</strong> medical purposes may be done aga<strong>in</strong>.<br />

Metallic positron emitters 48 V, 52 Mn, 52 Fe and 62 Zn are also produced.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-12<br />

[1] INSTITUTE: Kanazawa Cardiovascular Hospital<br />

Ha 16 Tanaka, Kanazawa<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

[3]<br />

OTHER SENIOR STAFF:<br />

TYPE OF<br />

Baby cyclotron <strong>for</strong><br />

CYCLOTRON: medical use<br />

MANUFACTURER: The Japana Steel<br />

Works Ltd.<br />

MODEL: BC 1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Ishikawa<br />

+81 76 253 8000<br />

Toshi@nshnet.or.jp<br />

+81 76 253 0008<br />

Mr. Toshihiko Morikawa<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 17 10 Yes No<br />

Maximum beam available (µA) 60 60<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

~ 20 ~ 4 ~ 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1991<br />

215<br />

209


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

210 216<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

………<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-13<br />

[1] INSTITUTE: Kyoto University Hospital<br />

54 Shogo<strong>in</strong> Kawahara-cho, Sakyo-ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

Kyoto 606-8507<br />

+81-75-751-3306<br />

kawap@kuhp.kyoto-u.ac.jp<br />

+81-75-751-3217<br />

Hidekazu Kawashima, PhD.<br />

Mr. Haruhiro Kitano<br />

[3]<br />

NAME/POSITION<br />

TYPE OF<br />

AVF YEAR OF: (I)<br />

1982<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

(II) UPGRADE: 1997 (change <strong>of</strong> electronic<br />

Industries<br />

circuit)<br />

MODEL: Cypris 325<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16 8 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 25 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

8 7 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other:<br />

Radiopharmaceuticals <strong>for</strong><br />

cl<strong>in</strong>ical and animal studies<br />

7<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[ 11 C]SCH23390, [ 11 C]CFT, [ 18 F]FDOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

217<br />

211


18 F <strong>Radionuclide</strong> production<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

212 218<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 97 4 200 Yes<br />

No<br />

20 Ne (d, α) 18 F 17<br />

16 18<br />

O (α, d) F<br />

18<br />

F radiopharmaceuticals produced<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

FDG 16 140/year Yes No Yes No<br />

FLT 2.0 10/year Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C radiopharmaceuticals produced<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 2.0 12/year Yes No Yes No<br />

Flumazenil 2.5 4/year Yes No Yes No<br />

PK11195 1.0 6/year Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N radiopharmaceuticals produced<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O radiopharmaceuticals produced<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

CO 1.5/m<strong>in</strong> 48/year<br />

14 15<br />

N(d, n ) O<br />

O2<br />

CO2<br />

0.8/m<strong>in</strong><br />

0.5/m<strong>in</strong><br />

24/year<br />

24/year<br />

14 15<br />

N(d, n ) O<br />

14 15<br />

N(d, n ) O<br />

Other isotopes produced<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Comments: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-14<br />

[1] INSTITUTE: Kyushu University<br />

Department <strong>of</strong> Radiology, Faculty <strong>of</strong> Medic<strong>in</strong>e<br />

Maidashi 3-1-1, Higashi-ku<br />

Fukuoka 812-8582<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+81 92 6425 788<br />

FAX NO.:<br />

+81 92 642 5833<br />

[2] PERSON IN CHARGE:<br />

Dr. Yasuo Kuwabara<br />

POSITION:<br />

Chief, Nuclear Medic<strong>in</strong>e Section<br />

OTHER SENIOR STAFF:<br />

Masayuki Sasaki<br />

NAME/POSITION<br />

Isuyoshi Yoshida<br />

NAME/POSITION<br />

Toshimitsu Fukumura<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1983<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE: 1998<br />

MODEL: BC 1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 10 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 30 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

11 7 2 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

219<br />

213


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

214 220<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 10 95 2 40 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 2/week Yes No Yes No<br />

DOPA Yes No Yes No<br />

Estiradiol Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 1/week Yes No Yes No<br />

Methion<strong>in</strong>e 1/week Yes No Yes No<br />

NMPB 1/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2O<br />

CO<br />

1/week<br />

1/week<br />

14 15<br />

N(d, n ) O<br />

14 15<br />

N(d, n ) O<br />

O2<br />

CO2<br />

1/week<br />

1/week<br />

14 15<br />

N(d, n ) O<br />

14 15<br />

N(d, n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-15<br />

[1] INSTITUTE: Medical School <strong>of</strong> Nagoya University<br />

Department <strong>of</strong> Radiology<br />

65 Tsurumaicho, Showa-ku<br />

Nagoya City 466<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+81 52 741 2111 or 733 9415<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Mr. Masanori Tadokoro<br />

OTHER SENIOR STAFF:<br />

Takeo Ishigaki<br />

NAME/POSITION<br />

Masanari Nish<strong>in</strong>o<br />

[3] TYPE OF<br />

Baby cyclotron YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC 2211<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 22 11 Yes No<br />

Maximum beam available (µA) 60 60<br />

Typical beam employed (µA) 100 100<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 6 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera 2<br />

S<strong>in</strong>gle photon tomography (SPET) 1<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

221<br />

215


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

216 222<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 16 3 per week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C–Methion<strong>in</strong>e 100 1 per month Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O-Water 100 1 per week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-16<br />

[1] INSTITUTE: Nagoya City Rehabilitation and Sports Center<br />

1-2 Mikanyama, Yatomi-cho<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Mizuho-ku, Nagoya 467-8622<br />

+81 52 83 4573<br />

y_ito@mua.biglobe.ne.jp<br />

+81 52 835 3745<br />

Yoshihiro Ito<br />

OTHER SENIOR STAFF:<br />

Noriyuki Kato<br />

NAME/POSITION<br />

Katsumi Araki<br />

AVF YEAR OF: (I)<br />

CYCLOTRON:<br />

INSTALLATION<br />

[3] TYPE OF<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries<br />

(II) UPGRADE:<br />

MODEL: Cypris 370<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 40 40<br />

Typical beam employed (µA) 20 5 - 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

8 2 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 C Raclopride , Na 18 H<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1989<br />

223<br />

217


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

218 224<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F 18<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 1.8 1day/week Yes No Yes No<br />

DOPA 1 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

NMSP 2.5 5 days/year Yes No Yes No<br />

Methion<strong>in</strong>e 2.5 3days/year Yes No Yes No<br />

Palmitic Acid 2.5 6 days/year Yes No Yes No<br />

Acetic Acid 2.5<br />

6 days/year Yes No Yes No<br />

Flumazenil 2.5<br />

1 day/month<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

(GBq)<br />

<strong>used</strong><br />

Water 4 days/week<br />

14 15<br />

N(d,n ) O<br />

CO, CO2 & O2 1.5 days/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-17<br />

[1] INSTITUTE: National Cardiovascular Centre<br />

5-7-1 Fujishirodai, Suita<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER: Sumitomo Heavy<br />

Osaka 565<br />

+81 6 833 5012<br />

ymiyake@hsp.ncvc.go.jp<br />

+81 6 872 7486<br />

Dr. Yoshio Ishida<br />

Director <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Dr. Yosh<strong>in</strong>ori Miyake<br />

AVF<br />

Industries<br />

YEAR OF:<br />

(I) INSTALLATION<br />

(II) UPGRADE:<br />

1989<br />

MODEL: Cypris 370<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 70 70<br />

Typical beam employed (µA) 20 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 1 2 5 12<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography: 12<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 3<br />

Gamma camera 5<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

5<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

225<br />

219


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

220 226<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F 22 94 0.7 60 Yes<br />

In future<br />

No<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

18.5<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 1.5 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Acetate 3.3 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/ Price/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

GBq<br />

Ammonia 1.4 5/week Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction Price/<br />

(list)<br />

<strong>used</strong><br />

GBq<br />

Water 3.3 3- 9/week<br />

14 15<br />

N(d, n ) O<br />

CO,CO2,O2 0.01 9/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-18<br />

[1] INSTITUTE: National Centre <strong>of</strong> Neurology and Psychiatry<br />

4-1-1 Ogawahigashi-cho<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Superconduct<strong>in</strong>g<br />

4-chome, Kodaira, Tokyo 187<br />

+81 423 412 711<br />

matsuda@ncnpmusashi.gr.jp<br />

+81 423 446 745<br />

Dr. Hiroshi Matsuda<br />

Director, Radiological Division<br />

Yutaka Takayama; Satoru Horikoshi<br />

Kenichi Ogawa; Masato Kobayashi<br />

YEAR OF: (I)<br />

1997<br />

CYCLOTRON: compact<br />

INSTALLATION<br />

MANUFACTURER: Ox<strong>for</strong>d (II) UPGRADE:<br />

MODEL: OSCAR, SCC12P<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 12 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

11.4<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

7 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera 1<br />

S<strong>in</strong>gle photon tomography (SPET) 1<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

227<br />

221


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

222 228<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 20 1-2 per week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O-Water 18<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


COUNTRY: JAPAN JPN-19<br />

[1] INSTITUTE: National Institute <strong>for</strong> Longevity Sciences<br />

Gengo, Morioka<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Negative ion<br />

CYCLOTRON: acceleration AVF<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries<br />

MODEL: HM-18<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Obu 474-8522<br />

+81 562 46 2311<br />

hatanok@nils.go.jp<br />

+81 562 44 6 596<br />

Dr. Kengo Ito<br />

Dr. Kentaro Hatano<br />

Dr. Takashi Kato<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 50 40<br />

Typical beam employed (µA) 20 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

8 4 3 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

18<br />

F, 370MBq<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

1<br />

–Cl<strong>in</strong>ical 1<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1995<br />

229<br />

223


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

224 230<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 17 >93 2 80 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 2.4 1/week Yes No Yes No<br />

DOPA 0.875 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 0.37 24/year Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 17.4 30/year<br />

14 15<br />

N(d, n ) O<br />

CO 3.7 5/year<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

11 C - SCH 23390 and B-CFT are <strong>used</strong> <strong>for</strong> animal experiments (<strong>in</strong>clud<strong>in</strong>g PET). Some novel radiopharmaceuticals are<br />

produced <strong>for</strong> drug development research.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-20<br />

[1] INSTITUTE: National Institute <strong>of</strong> Radiological Sciences<br />

Advanced Technology Division <strong>for</strong> Medical Imag<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Anagawa 4-9-1, Inage-ku<br />

+81 43 206 3262<br />

kazutosi@nirs.go.jp<br />

+81 43 206 3261<br />

Dr. Kazutoshi Suzuki<br />

Head<br />

Mr. Toshiaki Irie, Head<br />

Mr. Kiyoshi Fukushi, Senior Researcher<br />

Mr. Terushi Haradahira, Senior Researcher<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC - 2010 BC-2010<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 20 10 Yes No<br />

Maximum beam available (µA) 70 50<br />

Typical beam employed (µA) 20 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 36 10 4 26<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No <strong>for</strong> PET<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET) 2<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

3<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

231<br />

225


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

226 232<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 1 – 10 50 1.5 30 Yes<br />

No<br />

20 Ne (d, α) 18 F 3<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 3 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 4 8/week Yes No Yes No<br />

McN5652X 1-2 3/week Yes No Yes No<br />

Raclopride 1-2 1/week Yes No Yes No<br />

MP4A 2 1/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2-3 1/week<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 2 6/week 14 N(d, n ) 15 O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

11 C - Ro 15-1788, Ro 15- 4513, NMSP and SCH 23390<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-21<br />

[1] INSTITUTE: National Institute <strong>of</strong> Radiological Sciences<br />

Advanced Technology Division <strong>for</strong> Medical Imag<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Anagawa 4-9-1, Inage-ku<br />

+81 43 206 3262<br />

kazutosi@nirs.go.jp<br />

+81 43 206 3261<br />

Dr. Kazutoshi Suzuki<br />

Head<br />

Mr. Toshiaki Irie, Head<br />

Mr. Kiyoshi Fukushi, Senior Researcher<br />

Mr. Terushi Haradahira, Senior Researcher<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries<br />

(II) UPGRADE:<br />

MODEL: HM-18<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 50 40<br />

Typical beam employed (µA) 20 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 34 18 6 16<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No PET<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET) 2<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

3<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

233<br />

227


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

228 234<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 1- 10 20 - 50 1.5 30 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 1 – 10 1 - 2/week Yes No Yes No<br />

Labeled Compd. 1 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Ro15 - 4513 3 1 - 2/week Yes No Yes No<br />

Methion<strong>in</strong>e 4 6/week Yes No Yes No<br />

WAY 100635 1 -2 2 - 3/week Yes No Yes No<br />

MP4A 1 - 2 1/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2-3 1/week<br />

16 13<br />

O(p,α) N Yes No<br />

NPC 1 1/month Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 2 12/week<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

11 C - NMSP, McN 5652X(+),McN 5652, Ro15 - 1788, SCH 23390, Raclopride, FLB 457, NMPB and Cyanoimipram<strong>in</strong>e


2005 COUNTRY: JAPAN JPN-22<br />

[1] INSTITUTE: National Institute <strong>of</strong> Radiological Sciences<br />

Advanced Technology Division <strong>for</strong> Medical Imag<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Anagawa 4-9-1, Inage-ku<br />

+81 43 206 3262<br />

kazutosi@nirs.go.jp<br />

+81 43 206 3261<br />

Dr. Kazutoshi Suzuki<br />

Head<br />

Mr. Toshiaki Irie, Head<br />

Mr. Kiyoshi Fukushi, Senior Researcher<br />

Mr. Terushi Haradahira, Senior Researcher<br />

[3] TYPE OF<br />

AVF multi-particle YEAR OF: (I)<br />

1973<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Thomson CSF (II) UPGRADE:<br />

MODEL: AVF-930<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 90 55 145 110 Yes No<br />

Maximum beam available (µA) 20 20 10 10<br />

Typical beam employed (µA) 20 15 10 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 9 6 6 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 4 Radiography:<br />

Materials science: Proton therapy: 3<br />

Physics: 16 Neutron therapy:<br />

Activation analysis: Other (specify) 2<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Number<br />

S<strong>in</strong>gle photon tomography (SPET) 2<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

3<br />

–Small animal<br />

–Plant biochemistry<br />

2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

235<br />

229


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

230 236<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 1-10 20-50 1.5 30 Yes<br />

No<br />

20 Ne (d, α) 18 F 3<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 1-10 1-2/week Yes No Yes No<br />

Labeled Compd 1 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

WAY 100635 1-2 1-2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2-3 1/week Yes No<br />

NPC 1 1/month Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 2 6/week<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

3 1/month Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

11 C - NMSP, MCN 5652X(+), MCN 5652, RO15-1788, SCH 23390, RACLOPRIDE, FLB457, NMPB,<br />

CYANOIMIPRAMINE, 38K<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-23<br />

[1] INSTITUTE: National Research Institute <strong>for</strong> Metals<br />

1-2-1 Sengen, Tsukuba<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Ibaraki 305<br />

+81 298 592 014<br />

NAKAGAWA.Johsei@nims.go.jp<br />

+81 298 592 014<br />

Mr. Johsei Nagakawa<br />

Group Leader<br />

Mr. Norikazu Yamamoto, Subgroup Leader<br />

Mr. Yoshiharu Murase, Researcher<br />

Mr. Toshimitsu Fukuzawa, Researcher<br />

[3] TYPE OF<br />

AVF (fixed energy) YEAR OF: (I)<br />

1986<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC 1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 10 26 20 Yes No<br />

Maximum beam available (µA) 50 50 20 20<br />

Typical beam employed (µA) 30 30 10 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

50 40 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 40 Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

237<br />

231


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

232 238<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

We use our cyclotron only <strong>for</strong> study<strong>in</strong>g radiation damage <strong>in</strong> nuclear reactor materials and not <strong>for</strong> RADIONUCLIDE<br />

PRODUCTION<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-24<br />

[1] INSTITUTE: Nihon Medi-Physics Co. Ltd. Chiba Facility<br />

3-1 Kitasode, Sodegaura City<br />

Chiba Pref., 299-0266<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+81 438 634 771<br />

FAX NO.:<br />

+81 438 633 306<br />

[2] PERSON IN CHARGE:<br />

Dr. Masaji Takahashi<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Manager <strong>of</strong> Technical Section 1<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1986<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries<br />

(II) UPGRADE:<br />

MODEL: 750 PV<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 130/55<br />

Typical beam employed (µA) 120/50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

130 90 40<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? — everyday to hospitals.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

239<br />

233


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

234 240<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 500(@EOB) 3/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

81 Rb<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-25<br />

[1] INSTITUTE: Nihon Medi-Physics Co. Ltd. Chiba Facility<br />

3-1 Kitasode, Sodegaura City<br />

Chiba Pref., 299-0266<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+81 438 634 771<br />

FAX NO.:<br />

+81 438 633 306<br />

[2] PERSON IN CHARGE:<br />

Dr. Masaji Takahashi<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Manager <strong>of</strong> Technical Section 1<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1985<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

(II) UPGRADE: 1999 (H - acceleration)<br />

MODEL: 480P<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 28 Yes No<br />

Maximum beam available (µA) 55<br />

Typical beam employed (µA) 55<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

120 80 40<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? — everyday, to hospitals.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals<br />

carried out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

241<br />

235


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

236 242<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

300(@EOS) 5/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

81 Rb<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-26<br />

[1] INSTITUTE: Nihon Medi-Physics Co. Ltd., Hyogo Facility<br />

9-1 Techno Park, Sanda City<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Fixed field, fixed<br />

frequency,<br />

accelerat<strong>in</strong>g H-ions<br />

Hyogo Pref., 669-1339<br />

+81 795 684 771<br />

+81 795 683 071<br />

Mr. Shigeaki Kataoka<br />

Manager <strong>of</strong> Technical Section 1<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 15-30 Yes N<br />

Maximum beam available (µA) 400<br />

Typical beam employed (µA) 360<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

132 120 12<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten? Everyday, to Hospitals<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1992<br />

243<br />

237


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

238 244<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 120(EOB) 1/2week Yes No Yes No<br />

123<br />

I<br />

500(EOS) 2-3/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 400(EOS) 2-3/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-27<br />

[1] INSTITUTE: Nihon Medi-Physics Co. Ltd., Hyogo Facility<br />

9-1 Techno Park, Sanda City<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Fixed field, fixed<br />

frequency,<br />

accelerat<strong>in</strong>g H-ions<br />

Hyogo Pref., 669-1339<br />

+81 795 684 771<br />

+81 795 683 071<br />

Mr. Shigeaki Kataoka<br />

Manager <strong>of</strong> Technical Section 1<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 16-30 Yes No<br />

Maximum beam available (µA) 400<br />

Typical beam employed (µA) 360<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

132 120 12<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Everyday, to Hospitals<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1990<br />

245<br />

239


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

240 246<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 120(EOB) 1/2week Yes No Yes No<br />

123<br />

I<br />

500(EOS) 2-3/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 400(EOS) 2-3/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-28<br />

[1] INSTITUTE: Nikko Memorial Hospital<br />

Sh<strong>in</strong>tomi-cho 1-5-13<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Deep valley fixed<br />

CYCLOTRON:<br />

energy proton<br />

Muroran-shi, Hokkaido 51<br />

+81 143 24 1331<br />

+81 143 22 5296<br />

Masahiro Sh<strong>in</strong>ohara<br />

Chief <strong>of</strong> Radiology<br />

Takafumi Mochizuki, Radiology<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

3 He<br />

4 He<br />

1996/7<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

247<br />

241


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

242 248<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 11 40% 1.1 100 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 3.7 1 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-29<br />

[1] INSTITUTE: Nishidai Cl<strong>in</strong>ic Diagnostic Imag<strong>in</strong>g Center, Inc.<br />

1-83-8 Takashimadaira, Itabashi-ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Tokyo 175-0082<br />

+81 3 5922 0700<br />

tomiyoshi@ncdic.org<br />

+81 3 5922 0701<br />

Kimiichi Uno, M.D.<br />

Chairman<br />

Keiichi Nakagawa, M.D.<br />

Katsumi Tomiyoshi, PhD., M.D.<br />

[3] TYPE OF<br />

Baby cyclotron YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

(II) UPGRADE:<br />

MODEL: HM-18<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 20 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

11 10 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F - α - Methyl Tyros<strong>in</strong>e ( 18 F AMT)<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 5<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

249<br />

243


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

244 250<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 20 95 2.0 100 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10-15 1-2/day Yes No Yes No<br />

18<br />

F 10 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

MET 5 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 10 3/day<br />

16 13<br />

O(p,α) ) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 5 1/week<br />

13 15<br />

N(p, n) O<br />

CO, O2 & C O2 10 1/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced<br />

We carry out cl<strong>in</strong>ic diagnostic studies only, <strong>in</strong> collaboration with Gunma University School <strong>of</strong> Medic<strong>in</strong>e.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-30<br />

[1] INSTITUTE: Nishij<strong>in</strong> Hospital<br />

1035 Mizomae-cho, Kamigyo-ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Kyoto 602<br />

+81 75 4615514<br />

cyclo129@mbox.kyoto-<strong>in</strong>et.or.jp<br />

OTHER SENIOR STAFF:<br />

Dr. Takahiro Kanatsuna<br />

President<br />

Akira Fijii<br />

NAME/POSITION<br />

Hitoshi Horii<br />

NAME/POSITION<br />

Kazuo Wakita<br />

[3] TYPE OF<br />

Positive ion YEAR OF: (I)<br />

1985<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC 1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 10 Yes No<br />

Maximum beam available (µA) 10 ~ 50<br />

Typical beam employed (µA) 70 ~ 80 extract<strong>in</strong>g<br />

efficiency:<br />

(60 ~ 65%)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

6 ~10 6 ~10 4 ~ 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

251<br />

245


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

246 252<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-31<br />

[1] INSTITUTE: Nish<strong>in</strong>a Memorial Cyclotron Centre<br />

348-58 Tomegamori, Takizawa<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Iwate 020-0173<br />

+81 19 688 6071<br />

nmcc@jrias.or.jp<br />

+81-19 688 6072<br />

Tsuneo Takahashi<br />

Director<br />

Shoji Futatsugawa, General Manager<br />

Kouichiro Sera, Pr<strong>of</strong>essor<br />

Satoru Hatakeyama, Manager<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Shimazu (II) UPGRADE:<br />

MODEL: MCY 1750<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.9 8.3 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

30 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 6 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

253<br />

247


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

248 254<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 14.5 1 per week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Oxygen<br />

Carbon dioxide<br />

Water<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

64 Cu Yes No Yes No<br />

67 Ga Yes No Yes No<br />

86 Y Yes No Yes No<br />

94m Tc Yes No Yes No<br />

103 Pd Yes No Yes No<br />

111 In Yes No Yes No<br />

123<br />

I<br />

124<br />

I<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

201 Tl Yes No Yes No<br />

211 At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-32<br />

[1] INSTITUTE: Osaka City University Medical School<br />

Division <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

1-4-3 Asahi-machi, Abenoku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Compact<br />

superconduct<strong>in</strong>g,<br />

negative ion<br />

Osaka 545-8585<br />

+81 6 6645 3885<br />

ochi@med.osaka-cu.ac.jp<br />

Dr. Hironobu Ochi<br />

Pr<strong>of</strong>essor, Division <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Dr. Masaji Okamoto<br />

Susumu Shiomi, Associate Pr<strong>of</strong>essor<br />

YEAR OF: (I)<br />

1992<br />

INSTALLATION<br />

MANUFACTURER: Ox<strong>for</strong>d-NKK (II) UPGRADE: 1993<br />

MODEL: OSCAR SCC12P<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 12 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

8 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

255<br />

249


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

250 256<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 5 50 5 50 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5 15/month Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 5 2/month Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2 10/month Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

CO2 2 2/month<br />

O2 4<br />

CO 4<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-33<br />

[1] INSTITUTE: Research Institute <strong>for</strong> Bra<strong>in</strong> & Blood Vessels Akita<br />

6-10 Senshu-Kubota-machi<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Akita City<br />

+81 188 330 115<br />

kazu@akita.nokenigo.jp<br />

+81 188 332 104<br />

Dr. Kazuhiro Takahashi<br />

Head<br />

Masanobu Ibaraki<br />

[3] TYPE OF<br />

Baby cyclotron YEAR OF: (I)<br />

1983<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

(II) UPGRADE:<br />

MODEL: BC-168<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16 8 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 30 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

14 2 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

257<br />

251


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

252 258<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 20 60 1.5 40 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 4 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 6 2/week Yes No Yes No<br />

3NHPB 2 15/year Yes No Yes No<br />

NMSP 2 15/year Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2O 4 20/week<br />

14 15<br />

N(d, n ) O<br />

O2 20 6/week<br />

CO 10 6/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-34<br />

[1] INSTITUTE: Tohohu University<br />

Cyclotron and Radioisotope Center (CYRIC)<br />

Aramaki, Aoba-ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Sendai 980-7<br />

+81 217 7798<br />

sh<strong>in</strong>o@cyric.tahoku.ac.jp<br />

+81 263 5358<br />

Pr<strong>of</strong>essor Tsutomu Sh<strong>in</strong>ozuka<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

AVF multi particle YEAR OF: (I)<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

(II) UPGRADE:<br />

Industries<br />

MODEL: 680 AVF<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 40 25 65 50 Yes No<br />

Maximum beam available (µA) 15 12 5 5<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

87 ~ 96 16 12<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1977<br />

259<br />

253


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

254 260<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 11 3-4 per week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Doxep<strong>in</strong> Yes No Yes No<br />

Nemonapride Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water ~ 30 2 per week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-35<br />

[1] INSTITUTE: Tokyo Metropolitan Institute <strong>of</strong> Gerontology<br />

35-2 Sakaecho Itabashi<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

Tokyo 173-0015<br />

+81 3 3964 3241 ext. 3505<br />

ishiwata@pet.tmg.or.jp<br />

+81 3 3964 2188<br />

Dr. Kiichi Ishiwata<br />

Head, Positron Medical Center<br />

Dr. Yuichi Kimura, Senior Research Scientist<br />

Dr. Toru Sasaki, Research Scientist<br />

Kenji Ishii, M.D., Research Scientist<br />

Keiichi Oda, Research Scientist<br />

[3] TYPE OF<br />

AVF, positive ion YEAR OF: (I)<br />

1990<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

(II) UPGRADE:<br />

MODEL: Cypris 370<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 24 (not 18 (not Yes No<br />

rout<strong>in</strong>ely rout<strong>in</strong>ely<br />

Maximum beam available (µA)<br />

<strong>used</strong>) <strong>used</strong>)<br />

Typical beam employed (µA) 30 10 ~ 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

24 24 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

261<br />

255


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

256 262<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

18<br />

F-DOPA Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Flumazenil Yes No Yes No<br />

N-methyl<br />

spiperone<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Oxygen<br />

<strong>used</strong><br />

Carbon dioxide<br />

Carbon<br />

monoxide<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

64 Cu Yes No Yes No<br />

67 Ga Yes No Yes No<br />

86 Y Yes No Yes No<br />

94m Tc Yes No Yes No<br />

103 Pd Yes No Yes No<br />

111 In Yes No Yes No<br />

123<br />

I<br />

124<br />

I<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

201 Tl Yes No Yes No<br />

211 At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: JAPAN JPN-36<br />

[1] INSTITUTE: University <strong>of</strong> Tokyo<br />

Department <strong>of</strong> Radiology<br />

7-3-1 Hongo Bunkyo-ku<br />

Tokyo 113<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+81 3 3815 5411 ext. 5129<br />

FAX NO.:<br />

+81 3 5800 8678<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pr<strong>of</strong>essor Johru Ontoke<br />

OTHER SENIOR STAFF:<br />

Toshimitsu Momose<br />

NAME/POSITION<br />

Sh<strong>in</strong>ya Oku<br />

[3] TYPE OF<br />

Positive ion YEAR OF:<br />

1988<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: Sumitomo Heavy<br />

Industries, Ltd.<br />

(II) UPGRADE:<br />

MODEL: Cypris 370<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

18 10 Yes N<br />

Typical beam employed (µA) 50 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

32 32 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera 1<br />

S<strong>in</strong>gle photon tomography (SPET) 3<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

263<br />

257


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

258 264<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

18<br />

F-DOPA Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e Yes No Yes No<br />

N-Methylspiperone<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

Oxygen<br />

C. monoxide<br />

Carbon dioxide<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

64 Cu Yes No Yes No<br />

67 Ga Yes No Yes No<br />

86 Y Yes No Yes No<br />

94m Tc Yes No Yes No<br />

103 Pd Yes No Yes No<br />

111 In Yes No Yes No<br />

123<br />

I<br />

124<br />

I<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

201 Tl Yes No Yes No<br />

211 At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


21. KAZAKHSTAN<br />

2005 COUNTRY: KAZAKHSTAN KAZ-1<br />

[1] INSTITUTE: Institute <strong>of</strong> Nuclear Physics<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Variable energy<br />

isochronous<br />

K=50 MeV<br />

MANUFACTURER: Efremov Institute,<br />

Len<strong>in</strong>grad<br />

MODEL: U 150<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

480082 Almaty-82, Ibragimov str., 1<br />

+7 327 2 546 433<br />

artem@cyclotron.samal.kz<br />

+7 327 2 546 517<br />

Pr<strong>of</strong>essor A.A. Arzumanov<br />

Head, Accelerator Laboratory<br />

Sychikov Gennadi<br />

Popov Yuri<br />

Batischev Viktor<br />

YEAR OF: (I)<br />

INSTALLATION<br />

1965<br />

(II) UPGRADE: 1972, converted to<br />

variable energy<br />

isochronous<br />

Dual Beams<br />

Beam energies (MeV) 6-30 12-25 18.5-62 25-50 Yes No<br />

Maximum beam available (µA) 500 200 50 100<br />

Typical beam employed (µA) 300 100 20 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 16.5 15.7 4.3 3.5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 1.8 Proton therapy:<br />

Physics: 15.7 Neutron therapy:<br />

Activation analysis: Other (specify) Neutron Source, 1.7<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

57<br />

Co, (5)<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

57<br />

Co, (1)<br />

X ray sources? (specify which & quantity) Yes No<br />

57 109<br />

Co, (4) Cd,(6)<br />

[8]<br />

Intense neutron beam? (specify average En = ?) Yes No 2 MeV<br />

<strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

201 Tl Chloride, 67 Ga Citzate, 57 Co, 109 Cd, 111 In, 237 Pu, 88 Y, 85 Sr<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?If yes and available, name <strong>of</strong><br />

<strong>in</strong>stitution/s & how <strong>of</strong>ten? Hospitals, central cl<strong>in</strong>ics, on request.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical, Small animal, Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

265<br />

259


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

260 266<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

18 O2<br />

(l)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 13 Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 3.0 Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 3.3 On request. Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


22. REPUBLIC OF KOREA<br />

2005 COUNTRY: KOREA, REPUBLIC OF ROK-1<br />

[1] INSTITUTE: Korea Cancer Centre Hospital<br />

Korea Atomic Energy Research Institute<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

215-4 Gongneung-Dong, Nowon-Ku, Seoul<br />

+82 2 970 1331<br />

jschai@kcch.re.kr<br />

+82 2 970 1332<br />

CHAI, Jong-Seo<br />

Pr<strong>in</strong>cipal Researcher/Director<br />

KIM, Yu-Seok, Senior Eng<strong>in</strong>eer<br />

HONG, Seong-Seok, Eng<strong>in</strong>eer<br />

LEE, M<strong>in</strong>-Yong, Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1987<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 50<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 50 25 60 50.5 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 60 low current low current<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 20 6<br />

[6] CYCLOTRON APPLICATIONS: 60 h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 20 123 124 11 45 211 186 124<br />

F production by Ne target; High purity I production by Xe target; on plan: C, Ti, At, Re, I<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s &<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten? 67 Ga-citrate, 201 TICI, Na 123 Yes No<br />

I,<br />

123<br />

I-mIBG – 1 per week<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera 6<br />

S<strong>in</strong>gle photon tomography (SPET) 1<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

267<br />

261


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

262 268<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-2<br />

[1] INSTITUTE: Korea Cancer Centre Hospital<br />

Korea Atomic Energy Research Institute<br />

215-4 Gongneung-Dong<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Nowon-Ku, Seoul<br />

+82 2 970 1331<br />

jschai@kcch.re.kr<br />

+82 2 970 1332<br />

CHAI, Jong-Seo<br />

Pr<strong>in</strong>cipal Researcher/Director<br />

KIM, Yu-Seok, Senior Eng<strong>in</strong>eer<br />

HONG, Seong-Seok, Eng<strong>in</strong>eer<br />

LEE, M<strong>in</strong>-Yong, Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2002<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA (II) UPGRADE:<br />

MODEL: Cyclone-30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 30 Yes No<br />

Maximum beam available (µA) 350<br />

Typical beam employed (µA) 200<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

45 45<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 6<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

269<br />

263


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

264 270<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 7 2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 1 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 1.5 2/week<br />

15 15<br />

N(p, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-3<br />

[1] INSTITUTE: Korea Cancer Centre Hospital<br />

Korea Atomic Energy Research Institute<br />

215-4 Gongneung-Dong<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Nowon-Ku, Seoul<br />

+82 2 970 1331<br />

jschai@kcch.re.kr<br />

+82 2 970 1332<br />

CHAI, Jong-Seo<br />

Pr<strong>in</strong>cipal Researcher/Director<br />

KIM, Yu-Seok, Senior Eng<strong>in</strong>eer<br />

HONG, Seong-Seok, Eng<strong>in</strong>eer<br />

LEE, M<strong>in</strong>-Yong, Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: KIRAMS (II) UPGRADE:<br />

MODEL: KIRAMS -13<br />

[4] CYCLOTRON CHARACTERISTICS: H + 13 MeV, 4 sector magnet, 4 th harmonics, PIG <strong>in</strong>ternal ion source, GUI<br />

computer control.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 13 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

24 18 6 4 6<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

F-18, FDG<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? National Cancer Center; Ajou<br />

University Hospital, Yonsei University Hospital.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 2<br />

� Gamma camera 4<br />

� S<strong>in</strong>gle photon tomography (SPET) 4<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

271<br />

265


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

266 272<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-4<br />

[1] INSTITUTE: Seoul National University Hospital<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

28 Yungun-Dong, Chongro-Ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Seoul 110-744<br />

+82 2 760 3805<br />

jmj<strong>in</strong>g@plaza.snu.ac.kr<br />

+82 2 745 7690<br />

Dr. Jae M<strong>in</strong> Jeong<br />

Director, Cyclotron and Radiochemistry; Associate Pr<strong>of</strong>essor<br />

In Won Lee, Chief Technologist<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: EBCO Technology (II) UPGRADE:<br />

MODEL: TR-13<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 13 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

44 25 10 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Yunsei University Hospital —<br />

5/week; National Cancer Center — 2/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

273<br />

267


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

268 274<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 18 97 0.5 200 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 7 2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methion<strong>in</strong>e 1 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 1.5 2/week<br />

15 15<br />

N(p, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-5<br />

[1] INSTITUTE: Samsung Medical Centre<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Sungkyunkwan University School <strong>of</strong> Medic<strong>in</strong>e<br />

50 Ilwon-Dong, Kangnam-Ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Seoul 135-710<br />

+82 2 3410 2623<br />

yschoe@samsung.co.kr<br />

+82 2 3410 2639<br />

Yearn Seong Choe<br />

Assistant Pr<strong>of</strong>essor/Senior Research Scientist<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GEMS (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes No<br />

Maximum beam available (µA) 75 60<br />

Typical beam employed (µA) 20 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15 6 1 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 5<br />

� S<strong>in</strong>gle photon tomography (SPET) 5/5<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1/1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

275<br />

269


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

270 276<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 37 97 1.5 ~ 310 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 7 -11 6/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

CFT Yes No Yes No<br />

Methion<strong>in</strong>e 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia > 1.9 1/week<br />

16 13<br />

O (p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water > 3.7 1/week<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-6<br />

[1] INSTITUTE: Asan Medical Center<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Seoul<br />

+82 2 2224 4590<br />

sjoh@amc.seoul.kr<br />

+82 2 2224 4588<br />

Dr. Seung Jun Oh<br />

H - /D - YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a., Belgium (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 50 25<br />

Typical beam employed (µA) 38 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

12 9 3 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 12 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11<br />

C-neuroreceptor imag<strong>in</strong>g radiopharmaceuticals<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Two-three times <strong>in</strong> a week.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 5<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

2001<br />

277<br />

271


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

272 278<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 185 95 2.0 480 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 55 2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Methon<strong>in</strong>e 18.5 3-4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 18.5 1-2/week 160 (p,a) 13 N Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 18.5 1-2/week 14 n(D,N) 15 O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-7<br />

[1] Institute: Yonsei University Hospital<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

134 S<strong>in</strong>chon-dong, Seodaemun-gu,<br />

Seoul 120-752<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+82 2 365 8441<br />

FAX NO.:<br />

+82 2 365 8437<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Wan-won Seo<br />

[3] TYPE OF<br />

1 2<br />

H, H YEAR OF: (I)<br />

2003<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

100 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FDG<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

279<br />

273


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

274 280<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-8<br />

[1] INSTITUTE: NATIONAL CANCER CENTER<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

809 Madu1-dong, Ilsan-gu, Goyang-si,<br />

Gyeonggi-do 411-769<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+82 31 920 0176<br />

FAX NO.:<br />

+82 31 920 0179<br />

[2] PERSON IN CHARGE:<br />

Yong-keun, Kim<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Director<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI (II) UPGRADE:<br />

MODEL: RDS111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FDG, 11C-acetate, FLT<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

281<br />

275


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

276 282<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-9<br />

[1] INSTITUTE: The Catholic University <strong>of</strong> Korea, Kangnam St. Mary's Hospital<br />

Department <strong>of</strong> Radio-pharmaceutical<br />

505 Banpo-dong, Socho-gu,<br />

Seoul 137-701<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+82 2 3478 1816<br />

FAX NO.:<br />

+82 2 3478 1819<br />

[2] PERSON IN CHARGE:<br />

Hee-cheol, Kim<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Director<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2004<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI (II) UPGRADE:<br />

MODEL: RDS eclipse<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 60<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

12 12 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FDG<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

283<br />

277


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

278 284<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-10<br />

[1] INSTITUTE: Kos<strong>in</strong> University Gospel Hospital<br />

Department <strong>of</strong> Cyclotron<br />

34 Ahnnam-Dong,Seo-Ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pusan 602-702<br />

+82 51 253 1175<br />

Lsk7209@hanmail.net<br />

Sung-kwon Lee<br />

Director,<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2004<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI (II) UPGRADE:<br />

MODEL: RDS eclipse<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 60<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

5 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FDG<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

[10]<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

285<br />

279


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

280 286<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-11<br />

[1] INSTITUTE:<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Kyungbook National University Hospital<br />

50 Samduk-2ga, Jung-gu<br />

Daegu, 700-721<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

YEAR OF: (I)<br />

2005<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: KIRAMS (II) UPGRADE:<br />

MODEL: KIRAMS-13<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 13 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

287<br />

281


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

282 288<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-12<br />

[1] INSTITUTE: Yeungnam University Medical Center<br />

Department <strong>of</strong> PET-CT<br />

317-1 Daemyung-Dong, Nam-Ku<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Daegu 705-717<br />

+82 53 620 3126<br />

stkim@carecamp.com<br />

+82 53 625 3126<br />

Ssang-tae Kim<br />

Director,<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2004<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: G.E MINItrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 9.6 Yes No<br />

Maximum beam available (µA) 35<br />

Typical beam employed (µA) 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

7 7 10 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FDG<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Daegu Catholic University<br />

Hospital -5/week;<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Number<br />

Positron emission tomography (PET) 1<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

289<br />

283


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

284 290<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-13<br />

[1] INSTITUTE: Chonnam National Univeristy Hospital<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

8 Hak-dong, Dong-gu<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Gwangju 501-757<br />

+82 61 379 7262<br />

Mozorida78@hanmail.net<br />

+82 61 379 7281<br />

Jeong-young Kim<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2004<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: G.E PETtrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 Yes No<br />

Maximum beam available (µA) 70<br />

Typical beam employed (µA) 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

6 5 1 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FDG, Ammonia<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

291<br />

285


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

286 292<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-14<br />

[1] INSTITUTE: Eulji Univeristy Hospital<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

1306 Dunsan-Dong, Seo-Ku<br />

Daejeon 302-799<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+82 42 259 1425<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Mon-hyung Gu<br />

[3] TYPE OF<br />

Proton only YEAR OF: (I)<br />

2004<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo (II) UPGRADE:<br />

MODEL: Cypris HM-12S<br />

12/6MeV<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 12 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 60<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

293<br />

287


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

288 294<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: KOREA, REPUBLIC OF ROK-15<br />

[1] INSTITUTE:<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Chosun University Hospital<br />

588 Seoseok-Dong,Dong-Ku<br />

Gwangju 501-717<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

YEAR OF:<br />

2005 (Install<strong>in</strong>g)<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: KIRAMS (II) UPGRADE:<br />

MODEL: KIRAMS-13<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

295<br />

289


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

290 296<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 O (α,d ) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GB q<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


23. MEXICO<br />

2005 COUNTRY: MEXICO MEX-1<br />

[1] INSTITUTE: Unidad PET, Facultad de Medic<strong>in</strong>a<br />

Univesidad Nacional Autónoma de México<br />

Circuito Escolar S/N, Ciedad Universitaria<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

Del. Coyoacán 04510 México, D.F.<br />

+52 5623 22 88 or 5623 22 99<br />

pet_unam@hotmail.com<br />

+52 5623 21 15 or 5623 22 41<br />

Dra. Nora E. Kerik Rotenberg<br />

Chief <strong>of</strong> Department<br />

Dr. René Drucker Colín, Scientific Committee <strong>Member</strong><br />

M. en C. Adolfo Zárate Morales, Cyclotron Operator<br />

M. en C. Martha Pedraza López, Radiopharmacist<br />

Q.F.I. Irma Martínez Hernández, Radiopharmacist<br />

Fís. Miguel Angel Avila Rodríguez, Cyclotron Operators<br />

YEAR OF:<br />

2000<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

13 8 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18<br />

F - DOPA and Raclopride<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? To hospitals <strong>in</strong> the future<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical, Small animal, Plant biochemistry 1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

297<br />

291


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

292 298<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 37 95-97 0.8 7 250 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 14 1/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

HCN 33.3 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 3.7 2/week<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 28<br />

15 15<br />

N(p,n ) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


24. NETHERLANDS<br />

2005 COUNTRY: NETHERLANDS NET-1<br />

[1] INSTITUTE: Accrec B.V.<br />

E<strong>in</strong>dhoven University <strong>of</strong> Technology (TUE)<br />

Cyclotron Build<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Postbus 513, NL-5600 MB E<strong>in</strong>dhoven<br />

+31 40 247 4048<br />

<strong>of</strong>fice.cyclotron@tue.nl<br />

+31 40 243 8060<br />

Pr<strong>of</strong>essor Dr. M.J.A. de Voight/Pr<strong>of</strong>essor Dr. M.J. u.d. Wiel<br />

Directors, Accrec B.V.<br />

Negative ion YEAR OF:<br />

Planned dur<strong>in</strong>g 2002<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

18-30 Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

299<br />

293


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

294 300<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: NETHERLANDS NET-2<br />

[1] INSTITUTE: Accrec B.V.<br />

E<strong>in</strong>dhoven University <strong>of</strong> Technology (TUE)<br />

Cyclotron Build<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

2nd harmonic dees<br />

with 6th harmonic<br />

flat top dees<br />

Postbus 513, NL-5600 MB E<strong>in</strong>dhoven<br />

+31 40 247 4048<br />

<strong>of</strong>fice.cyclotron@tue.nl<br />

+31 40 243 8060<br />

Pr<strong>of</strong>essor Dr. M.J.A. de Voight/Pr<strong>of</strong>essor Dr. M.J. u.d. Wiel<br />

Directors, Accrec B.V.<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: Home-made (II) UPGRADE:<br />

MODEL: ILEC<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 3 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA) 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1989<br />

301<br />

295


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

296 302<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: NETHERLANDS NET-3<br />

[1] INSTITUTE: Accrec B.V.<br />

E<strong>in</strong>dhoven University <strong>of</strong> Technology (TUE)<br />

Cyclotron Build<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Postbus 513, NL-5600 MB E<strong>in</strong>dhoven<br />

+31 40 247 4048<br />

<strong>of</strong>fice.cyclotron@tue.nl<br />

+31 40 243 8060<br />

AVF YEAR OF: (I)<br />

INSTALLATION<br />

Pr<strong>of</strong>essor Dr. M.J.A. de Voight/Pr<strong>of</strong>essor Dr. M.J. u.d. Wiel<br />

Directors, Accrec B.V.<br />

MANUFACTURER: Philips (II) UPGRADE:<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 3- 30 2-20 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

~ 80 ~ 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Yes Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Catalysis/<br />

radiochemistry<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1 (PEP)<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

3 He<br />

4 He<br />

1963<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

303<br />

297


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

298 304<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C alkanes weekly Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

NO<br />

16 13<br />

O(p, α) N Yes No<br />

Ammonia<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

N2 15 0<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

14 15<br />

N (d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Commercial isotope production <strong>for</strong> Nycomed, Amersham and Cygne<br />

<strong>Production</strong> <strong>of</strong> short - lived positron emitters <strong>for</strong> University Research <strong>in</strong> catalysis us<strong>in</strong>g PEP<br />

Beam analysis techniques <strong>for</strong> material research (University related)<br />

This AVF Cyclotron will be shut - down <strong>in</strong> 2002 - 03 and a new Negative ion , IBA, Cyclone 30, 18-30 MeV is planned.


2005 COUNTRY: NETHERLANDS NET-4<br />

[1] INSTITUTE: Gron<strong>in</strong>gen University Hospital<br />

PET Centre<br />

P.O. Box 30.001<br />

NL-9700 RB Gron<strong>in</strong>gen<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+31 50 361 3311<br />

FAX NO.:<br />

+31 50 361 1687<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pr<strong>of</strong>essor William Vaalburg<br />

OTHER SENIOR STAFF:<br />

A.M.J. Paans<br />

NAME/POSITION<br />

P.H. Els<strong>in</strong>ga<br />

[3] TYPE OF<br />

AVF YEAR OF:<br />

1991<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 17F<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 8.5 Yes No<br />

Maximum beam available (µA) 780 750<br />

Typical beam employed (µA) 20 - 30 20 - 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 3.5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

305<br />

299


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

300 306<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 20 > 94 1 300 Yes<br />

No<br />

20 Ne (d, α) 18 F 7<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG > 8 200/year Yes No Yes No<br />

DOPA 0.5 60/year Yes No Yes No<br />

MPPF 0.5 10/year Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e > 3 60/year Yes No Yes No<br />

Tyros<strong>in</strong>e 2-3 40/year Yes No Yes No<br />

Raclopride 0.5 30/year Yes No Yes No<br />

Verapamil 2<br />

20/year<br />

Yes No<br />

Yes No<br />

Bicarbonate > 3<br />

20/year<br />

Yes No<br />

Yes No<br />

Acetate > 3<br />

10/year<br />

Yes No<br />

Yes No<br />

CSP - 12388 1<br />

20/year<br />

Yes No<br />

Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

Ammonia 0.8 - 1.0 500/year<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O (p, n) N Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 2-4 600/year<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: NETHERLANDS NET-5<br />

[1] INSTITUTE: Mall<strong>in</strong>ckrodt Medical<br />

P.O. Box 3<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

NL-1755 ZG Pette<br />

+31 224 567 890<br />

frank.de.lange@mkg.com<br />

+31 224 563 566<br />

Eng. (Ir.) H. Buurlage<br />

General Manager<br />

Eng. (Ir.) F. de Lange, Head <strong>of</strong> Cyclotron Operations<br />

Negative ion YEAR OF:<br />

1992<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15-30 Yes No<br />

Maximum beam available (µA) 400<br />

Typical beam employed (µA) 2×180<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

130 130 0 10 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify) 0<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

None<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 0<br />

� Gamma camera 0<br />

� S<strong>in</strong>gle photon tomography (SPET) 0<br />

� Positron emission tomography (PET) 0<br />

– Cl<strong>in</strong>ical 0<br />

– Small animal 0<br />

– Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

307<br />

301


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

302 308<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 2/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 1/week Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 5/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: NETHERLANDS NET-6<br />

[1] INSTITUTE: Mall<strong>in</strong>ckrodt Medical<br />

P.O. Box 3<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

NL-1755 ZG Petten<br />

+31 224 567 890<br />

frank.de.lange@mkg.com<br />

+31 224 563 566<br />

Eng. (Ir.) H. Buurlage<br />

General Manager<br />

Eng. (Ir.) F. de Lange, Head <strong>of</strong> Cyclotron Operations<br />

AVF – Positive ion YEAR OF:<br />

1966<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: Philips (II) UPGRADE: 1996<br />

MODEL: AVF<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 10-30 Yes N<br />

Maximum beam available (µA) 150<br />

Typical beam employed (µA) 120<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

100 100 0 10 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify) 0<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 0<br />

� Gamma camera 0<br />

� S<strong>in</strong>gle photon tomography (SPET) 0<br />

� Positron emission tomography (PET) 0<br />

– Cl<strong>in</strong>ical 0<br />

– Small animal 0<br />

– Plant biochemistry 0<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

309<br />

303


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

304 310<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2 (ml)<br />

18 O2 (ml)<br />

18 OH2 (g)<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

18 O2<br />

(l)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 2/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 1/week Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 5/week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price<br />

/GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUINRTY NETHERLANDS NET-7<br />

[1] INSTITUTE: Vrije Universiteit, BV Cyclotron VU<br />

De Boelelaan 1081<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

H -<br />

IBA S.A.<br />

Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

NL-1081 HV Amsterdam<br />

+31-20-4449123<br />

<strong>in</strong>fo@cyclotron.nl<br />

+31-20-4449128<br />

Dr. P.J. van der Jagt<br />

General Director<br />

Drs. P. Kruijer/Chemist<br />

Dr. <strong>in</strong>g. F. van Langevelde/Physicist<br />

P.J. van Leuffen/Daily Operations<br />

R. Mooij/Chief Cyclotron Operator<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes x<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 70<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week<br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

38 35 3<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FLT, O-15, Zr-89, I-124<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes x No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes x No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No x<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No x<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes x No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes x No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes x No<br />

3 He<br />

4 He<br />

1997<br />

311<br />

305


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

306 312<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 95 Yes x<br />

Ne (d, α) 18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15 Yes x No Yes x No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes x No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY NETHERLANDS NET- 8<br />

[1] INSTITUTE: Vrije Universiteit<br />

BV Cyclotron VU<br />

De Boelelaan 1081<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

H +<br />

Philips<br />

AVF<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

NL-1081 HV Amsterdam<br />

+31-20-4449123<br />

<strong>in</strong>fo@cyclotron.nl<br />

+31-20-4449128<br />

Dr. P.J. van der Jagt<br />

General Director<br />

Drs. P. Kruijer/Chemist<br />

Dr. <strong>in</strong>g. F. van Langevelde/Physicist<br />

P.J. van Leuffen/Daily Operations<br />

R. Mooij/Chief Cyclotron Operator<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 6-28 3-16 10-45 6-32 Yes No x<br />

Maximum beam available (µA) 200<br />

Typical beam employed (µA) 35 15 10 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

85 75 10<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes x No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes x No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No x<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No x<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes x No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes x No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes x No<br />

3 He<br />

4 He<br />

1965<br />

313<br />

307


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

308 314<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 18<br />

O (p, n) F<br />

Ne (d, α) 18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15 Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

18 O2 (l)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No x Yes x No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Rb-81 is produced <strong>for</strong> the production <strong>of</strong> Rb/Kr-generators


2005 COUNTRY NETHERLANDS NET- 9<br />

[1] INSTITUTE: Kernfysisch Versneller Institute<br />

Zernikelaan 25<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

NL-9747 AA Gron<strong>in</strong>gen<br />

+31 50 363 3600<br />

<strong>in</strong>fo@kvi.nl<br />

+31 50 363 4003<br />

W K van Asselt<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

Compact superconduct<strong>in</strong>g cyclotron <strong>for</strong> research <strong>in</strong> physics, also <strong>used</strong> <strong>for</strong> radiotherapy related radiobiological<br />

experiments, development <strong>of</strong> dose imag<strong>in</strong>g systems and radiation hardness test<strong>in</strong>g<br />

1996<br />

Ions <strong>of</strong> alle elements up to lead are accelerated, <strong>for</strong> more <strong>in</strong><strong>for</strong>mation see http://www.kvi.nl/<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 200 Yes No x<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ year Hours/year<br />

<strong>for</strong> radionuclide<br />

production<br />

3 He<br />

4 He<br />

Hours/year <strong>for</strong> research Hours/year <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/year <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: Hours/year Hours/year<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Detector development<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes X No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No X<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

315<br />

309


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

310 316<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY NETHERLANDS NET-10<br />

[1] INSTITUTE: Vrije Universiteit, BV Cyclotron VU<br />

De Boelelaan 1081<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

H -<br />

IBA S.A.<br />

Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

NL-1081 HV Amsterdam<br />

+31-20-4449123<br />

<strong>in</strong>fo@cyclotron.nl<br />

+31-20-4449128<br />

Dr. P.J. van der Jagt<br />

General Director<br />

Drs. P. Kruijer/Chemist<br />

Dr. <strong>in</strong>g. F. van Langevelde/Physicist<br />

P.J. van Leuffen/Daily Operations<br />

R. Mooij/Chief Cyclotron Operator<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes x No<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 70<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

28 25 3<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FLT, O-15, Zr-89, I-124<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes x No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes x No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No x<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No x<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes x No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes x No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes x No<br />

3 He<br />

4 He<br />

2004<br />

317<br />

311


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

312 318<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 95 Yes x<br />

Ne (d, α) 18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15 Yes x No Yes x No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


25. NORWAY<br />

COUNTRY: NORWAY NOR-1<br />

[1] INSTITUTE: University <strong>of</strong> Oslo<br />

Department <strong>of</strong> Physics<br />

P.O. Box 1048, Bl<strong>in</strong>dern<br />

N-0316 Oslo<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+47 22 856 460<br />

FAX NO.:<br />

+47 22 856 422<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Pr<strong>of</strong>essor Magne Guttormsen<br />

OTHER SENIOR STAFF:<br />

John Rekstad<br />

NAME/POSITION<br />

Sve<strong>in</strong> Messelt<br />

[3] TYPE OF<br />

Sector focus<strong>in</strong>g YEAR OF: (I)<br />

1979<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 35<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 35 17 47 35 Yes No<br />

Maximum beam available (µA) 100 80 10 20<br />

Typical beam employed (µA) 70 50 5 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5 2 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18<br />

F<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

319<br />

313


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

314 320<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


26. PHILIPPINES<br />

2005 COUNTRY: PHILIPPINES PHI-1<br />

[1] INSTITUTE: Positron Emission Tomography and Cyclotron Facility<br />

St. Luke’s Medical Center, E. Rodriguez Avenue<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Quezon City 1102<br />

+63 2 7268369<br />

isaac_nath@yahoo.com /nathgrace@yahoo.com<br />

+63 2 7268369<br />

Jonas Y. Santiago, MD, FACNP<br />

Chief, Section <strong>of</strong> PET<br />

Nathaniel B. de Vera, Manager, PET & Cyclotron Facility<br />

Katheryn S. Mandap, Radiochemist<br />

Negative Ion YEAR OF:<br />

2001 (November)<br />

(I) INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: M<strong>in</strong>itrace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 9.5 Yes No x<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 25<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5 4 0 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: N/A Radiography: N/A<br />

Materials science: N/A Proton therapy: N/A<br />

Physics: N/A Neutron therapy: N/A<br />

Activation analysis: N/A Other (specify) N/A<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No x<br />

Mössbauer sources? (specify which & quantity) Yes No x<br />

X ray sources? (specify which & quantity) Yes No x<br />

Intense neutron beam? (specify average En = ?) Yes No x<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

F-18 and N-13<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No x<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes x No x<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No x<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No x<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No x<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No x<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes x No<br />

3 He<br />

4 He<br />

321<br />

315


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

316 322<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F 18.9 <strong>for</strong> 60<br />

m<strong>in</strong><br />

bombardment<br />

97<br />

1.4<br />

16 <strong>for</strong> 60 m<strong>in</strong> 95<br />

1.4<br />

Ne (d, α) 18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5.5 <strong>for</strong> 30m<strong>in</strong> 1 per day Yes x No Yes No x<br />

9.4 <strong>for</strong> 60 m<strong>in</strong><br />

bombardment<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Yes x No Yes No x<br />

Yes No Yes No<br />

Yes No Yes No<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

N/A Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

N-13 1.1 <strong>for</strong> 30 m<strong>in</strong> occasional<br />

16 13<br />

O(p,a) N Yes No x<br />

ammonia bombardment<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

N/A<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Yes<br />

No x<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu N/A Yes No Yes No<br />

67<br />

Ga N/A Yes No Yes No<br />

86<br />

Y N/A Yes No Yes No<br />

94m<br />

Tc N/A Yes No Yes No<br />

103<br />

Pd N/A Yes No Yes No<br />

111<br />

In N/A Yes No Yes No<br />

123<br />

I<br />

N/A Yes No Yes No<br />

124<br />

I<br />

N/A Yes No Yes No<br />

201<br />

Tl N/A Yes No Yes No<br />

211<br />

At N/A Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

This is the first cyclotron <strong>in</strong> the country; will be dedicated to produce 18 F FDG and 13 N Ammonia <strong>for</strong> use <strong>in</strong> PET<br />

procedures <strong>of</strong> the Medical Center and supply to other users on request. Detailed <strong>in</strong><strong>for</strong>mation will be supplied when the unit<br />

becomes operational.


27. POLAND<br />

2005 COUNTRY: POLAND POL-1<br />

[1] INSTITUTE: Henryk Niewodnicanczanski Institute <strong>of</strong> Physics<br />

(HNIP), Radzikowskiego 152<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

PL-31-341 Krakow<br />

+48 12 637 0222<br />

dyrektor@ifj.edu.pl<br />

+48 12 637 5441<br />

Mr. Edmund Makewicz, MSc., EE<br />

Head <strong>of</strong> Cyclotron Unit<br />

Mr. Henryk Doruch, MSc., EE/Mr. Marek Talach, MSc., EE<br />

Dr. Ryszard Taraszkiewicz, Cyclotron Research<br />

Dr. Barbara Petelenz, head – Laboratory <strong>of</strong> Physical Chemistry<br />

[3] TYPE OF<br />

AVF isochronous YEAR OF: (I)<br />

1997<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: HNIP (II) UPGRADE: 2001<br />

MODEL: AIC-144<br />

[4] CYCLOTRON CHARACTERISTICS: K-factor = 60; extraction radius R = 0.62 M.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 10-60 15-30 30-60 Yes No<br />

Maximum beam available (µA) 100/45<br />

MeV<br />

100 30<br />

Typical beam employed (µA) 2-5 n/a 3-5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

Variable<br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: planned Radiography:<br />

Materials science: Proton therapy: planned<br />

Physics: variable Neutron therapy: planned<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No variable<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No planned<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

111 211<br />

In, At<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

323<br />

317


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

318 324<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

F-Dopa Yes No Yes No<br />

ML01 Yes No Yes No<br />

ML03 Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e Yes No Yes No<br />

Deprenyl Yes No Yes No<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In variable Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At variable Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

57 Co — occasionally, <strong>used</strong> on site <strong>in</strong> test <strong>of</strong> Si strip detectors,<br />

99 Rh — occasionally, <strong>used</strong> on site <strong>for</strong> Mössbauer research,<br />

173 Hf — occasionally, <strong>used</strong> on site <strong>in</strong> model studies <strong>of</strong> chemistry <strong>of</strong> transuranium elements,<br />

178 W, 181 W — occasionally, <strong>used</strong> on site <strong>in</strong> model studies <strong>of</strong> chemistry <strong>of</strong> transuranium elements.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: POLAND POL-2<br />

[1] INSTITUTE: Warsaw University<br />

Heavy Ion Laboratory<br />

uL Pasteura 5A<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

AVF, 4-sector,<br />

CYCLOTRON: 2-dee, 2 m diameter<br />

MANUFACTURER: Magnet - Dubna,<br />

rest all Polish parts<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

PL-02-097 Warszawa<br />

+48 22 658 2021<br />

+48 22 659 2714<br />

Pr<strong>of</strong>essor Dr. hab. Jan Kowracki<br />

Mr. Tomasz Czosnyka<br />

Mr. Jerzy Jastrzebski<br />

YEAR OF:<br />

INSTALLATION<br />

(I)<br />

1994<br />

(II) UPGRADE: ECR <strong>in</strong>stallation, 1997<br />

Dual Beams<br />

Beam energies (MeV) * Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

100 24<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

123 111<br />

I, In<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Planned after the ECR <strong>in</strong>stallation<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

325<br />

319


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

320 326<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Basic research, e.g. Coulomb excitation, Giant Dipole Resonances<br />

In-beam high-sp<strong>in</strong> spectroscopy<br />

Radioactive decays <strong>in</strong> He-jet system and isotope separation <strong>in</strong>-l<strong>in</strong>e.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


28. ROMANIA<br />

2005 COUNTRY: ROMANIA ROM-1<br />

[1] INSTITUTE: National Institute <strong>for</strong> Physics and Nuclear Eng<strong>in</strong>eer<strong>in</strong>g<br />

IFIN-HH Bucharest, Str. Atomistilor 407<br />

TELEPHONE NO./ FAX NO.:<br />

E-MAIL ADDRESS:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Classical, var.<br />

energy, 60 cm<br />

magnetic pole radius<br />

MANUFACTURER: URSS -<br />

Petrograd/Len<strong>in</strong>grad<br />

MODEL: U-120/1956<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

POB MG-6, 76900 Bucharest-Magurele<br />

+40 1 404 23 00/4406/+401 4023 1701<br />

ddudu@if<strong>in</strong>.nipne.ro<br />

Dipl. Eng. Dor<strong>in</strong> Dudu<br />

Head <strong>of</strong> the Cyclotron Accelerator<br />

Dip. Eng. Nicolae Tetcu, Deputy Head<br />

Dr. Eugen Ivanov<br />

Dr. Petru Mihai Racolta<br />

YEAR OF:<br />

1957/1958<br />

(I) INSTALLATION<br />

2 H<br />

(II) UPGRADE: 1970 development <strong>of</strong> 7 beam<br />

transport l<strong>in</strong>es<br />

1999 upgrad<strong>in</strong>g <strong>of</strong> RF controls<br />

Dual Beams<br />

Beam energies (MeV) 10-15 10-13 - 20-27 Yes No<br />

Maximum beam available (µA) 25 25 - 10<br />

Typical beam employed (µA) 55 10 - 3<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

45 10 10 10 15<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: - Radiography: -<br />

Materials science: 15 Proton therapy: -<br />

Physics: 5 Neutron therapy: -<br />

Activation analysis: 5 Other (specify) -<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) 22 Na/1 mCi Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) 5 MeV Ø –<br />

10 12 n/cm 2 s typically <strong>for</strong> d (13 MeV) on Be target.<br />

Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18f, 103 Pd, 22 Na, 67 Ga, 111 In, 123 I, 68 Ge<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

[12]<br />

– Cl<strong>in</strong>ical; – Small animal; – Plant biochemistry<br />

Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

327<br />

321


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

322 328<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


29. RUSSIAN FEDERATION<br />

2005 COUNTRY: RUSSIA RUS-1<br />

[1] INSTITUTE: Bakoulev Scientific Centre <strong>for</strong> Cardiovascular Surgery<br />

Roubevsekoe sh 135<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Self-shielded, proton<br />

121552 Moscow<br />

+7 095 414 7917<br />

izotop@ntt.ru<br />

+7 095 414 7782<br />

Dr. Evgeny Derevyanko, PhD.<br />

Head <strong>of</strong> PET Radiochemistry<br />

Pr<strong>of</strong>essor Leo Bokeria, Director <strong>of</strong> Bakoulev Cardiosurgery<br />

Dr. Iracly Aslanidis, Head <strong>of</strong> Nuclear Diagnostics<br />

Dr. Vladimir Leonov, Cyclotron Eng<strong>in</strong>eer<br />

YEAR OF: (I)<br />

1998 - mounter<br />

CYCLOTRON: cyclotron<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE: 2001 - accepted<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Nil nil Nil Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

6 2 - 4 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 15 11 11 15<br />

C, O, C - acetate, C - meth<strong>in</strong>ione, O – water<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence -<br />

� Gamma camera -<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal -<br />

– Plant biochemistry -<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

329<br />

323


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

324 330<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 10 70-95 1.1 - 100 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 4 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

13<br />

N - ammonia 1 1/month<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Water<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16<br />

O(p,a) Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-2<br />

[1] INSTITUTE: Central Research Institute <strong>of</strong> Roentgenology and Radiology<br />

189646 St. Petersburg<br />

Pesochny-2<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Isochronous<br />

cyclotron with<br />

variable energy<br />

Len<strong>in</strong>grad ul., 70<br />

+7 812 596 6609<br />

oshtuk@cards.lanck.net or chemcrir@cityl<strong>in</strong>e.spb.ru<br />

+7 812 596 6609<br />

Oleg A. Shtukovski, PhD.<br />

Head <strong>of</strong> the Department <strong>of</strong> Cyclotron Radiopharmaceuticals<br />

Mikhail Korsakov, Scientific Expert<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Efremov Institute, St.<br />

Petersburg, Russia<br />

(II) UPGRADE:<br />

MODEL: MGC-20P<br />

[4] CYCLOTRON CHARACTERISTICS: H - and D - energy beam 16.4 MeV.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 4-18 7-10 10-28 4-20 Yes No<br />

Maximum beam available (µA) 100 50 30 25<br />

Typical beam employed (µA) 30 - - -<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

60 40 12 8 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

67 111<br />

Ga, In<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 11 different cl<strong>in</strong>ical <strong>in</strong>stitutions <strong>in</strong><br />

St. Petersburg, 2times/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1991<br />

331<br />

325


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

326 332<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15-18 95+ 1,4 nil 150 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5-10 2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C – butyrate 4-6 2/week Yes No Yes No<br />

11<br />

C – acetate 2-3 validation <strong>for</strong><br />

patient studies<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N – ammonia 3-5 1 runday/week Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

2/week Yes No Yes No<br />

124<br />

I<br />

1/week Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

123 I - iodide, 123 I – iodo hippurate, 123 I – iodo bengal rose, 123 I – iodo iodopentadecanoic acid.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-3<br />

[1] INSTITUTE: Cyclotron Co. Ltd.<br />

Bondarenko Sq. 1, Obn<strong>in</strong>sk,<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Kaluga Region 249033<br />

+7 95 255 2385<br />

cyclotron@obn<strong>in</strong>sk.com<br />

+7 95 255 2326<br />

Pr<strong>of</strong>essor N.N. Krasnov<br />

Director General<br />

A.A. Ponomarev, Chief Eng<strong>in</strong>eer<br />

Dr. Yuri Sevastianov, Deputy Director General<br />

[3] TYPE OF<br />

lsochronic YEAR OF: (I)<br />

1999<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scientific Institute,<br />

Electrophysics<br />

(II) UPGRADE: 2003<br />

MODEL: RIC - 14<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 14 Yes No<br />

Maximum beam available (µA) 1000<br />

Typical beam employed (µA) 850<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

52 weeks 130 8 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

57 Co, 109 Cd , 68 Ge<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

68<br />

Ge<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

57<br />

Co<br />

X ray sources? (specify which & quantity) Yes No<br />

57 109<br />

Co, Cd<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

333<br />

327


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

328 334<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Upto 30 1/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Upto 200 1/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-4<br />

[1] INSTITUTE: Cyclotron Co. Ltd.<br />

Bondarenko Sq. 1, Obn<strong>in</strong>sk,<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Kaluga Region 249033<br />

+7 95 255 2385<br />

cyclotron@obn<strong>in</strong>sk.com<br />

+7 95 255 2326<br />

Pr<strong>of</strong>essor N.N. Krasnov<br />

Director General<br />

A.A. Ponomarev, Chief Eng<strong>in</strong>eer<br />

Dr. Yuri Sevastianov, Deputy Director General<br />

[3] TYPE OF<br />

Classical cyclotron YEAR OF: (I)<br />

1963<br />

CYCLOTRON:<br />

INSTALLATION -<br />

MANUFACTURER: Scientific Institute<br />

Electrophysics<br />

(II) UPGRADE: 1993<br />

MODEL: U - 150 - 1<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 22 22 Yes No<br />

Maximum beam available (µA) 1000 1000<br />

Typical beam employed (µA) 700 700<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

52 weeks <strong>in</strong> year 2000 144 hours 4 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) 57 Co,<br />

109 68<br />

Cd, Ge<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

68<br />

Ge<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

57<br />

Co<br />

X ray sources? (specify which & quantity) Yes No<br />

57 109<br />

Co, Cd<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

335<br />

329


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

330 336<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Up to 30 1/week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Up to 200 1/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-5<br />

[1] INSTITUTE: Institute <strong>of</strong> Human Bra<strong>in</strong> RAS<br />

9 Pavlov Street<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

St. Petersburg 197376<br />

+7 812 234 9347<br />

raisa@ihb.spu.ru<br />

+7 812 234 3247<br />

Demianov Alexandr<br />

Cyclotron Eng<strong>in</strong>eer<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Krasikova Raisa, Head <strong>of</strong> Radiopharmacy<br />

[3] TYPE OF<br />

Medical YEAR OF: (I)<br />

1990<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 85 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 15-40 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

16 7 4 -<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify): PET 16<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

337<br />

331


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

332 338<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 14.8 95 1.0 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 8.8 1/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

L- 11 C – methyl<br />

methion<strong>in</strong>e<br />

4.4 4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

13<br />

N[NH3] 2.6 1/month<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

15 13<br />

O(p,a) N Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O[H2O] 4.4 25/week<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-6<br />

[1] INSTITUTE: Kurchatov Institute <strong>of</strong> Atomic Energy (KIAE)<br />

Moscow 123 182<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+7 095 196 9782 or +7 095 196 9977*<br />

FAX NO.:<br />

+7 095 737 0600<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Unezhev Vitaly<br />

OTHER SENIOR STAFF:<br />

Oglob<strong>in</strong> Alexei<br />

NAME/POSITION<br />

V.E. Jarosh<br />

[3] TYPE OF<br />

KIAEC YEAR OF: (I)<br />

1976<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

(II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 32 30 70 60 Yes No<br />

Maximum beam available (µA) 30 15 15 20<br />

Typical beam employed (µA) 25 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

60 35 4 15 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 2 Proton therapy:<br />

Physics: 4 Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

[8]<br />

Intense neutron beam? (specify average En = ?) Yes No En=30MeV<br />

<strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

339<br />

333


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

334 340<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 98.6 1.5 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No On<br />

request<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

37 3 days/week Yes No Yes No On<br />

request<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl 10 2 days/month Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


COUNTRY: RUSSIA RUS-7<br />

[1] INSTITUTE: Nuclear Physics Institute at Tomsk Polytechnic University<br />

Len<strong>in</strong>a 2-1 St., P.O. Box 25<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

634050 Tomsk<br />

+7 3822 417 953 or +7 3822 424 003*<br />

golovkov@npi.tpu.ru<br />

+7 3822 423 934<br />

V.M. Golovkov<br />

Deputy Director<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

A.I. Komov*, Chief <strong>of</strong> the Cyclotron Department<br />

[3] TYPE OF<br />

Tomsk(U-120) YEAR OF: (I)<br />

1959<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: “Electrosila” St.<br />

Petersburg<br />

(II) UPGRADE: 1971<br />

MODEL: R - 7M<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15 14 30 28 Yes No<br />

Maximum beam available (µA) 35 50 20 55<br />

Typical beam employed (µA) 30 45 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

35 19 5 11<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy: 6<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No En=7.5 MeV<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

123<br />

I, Sodium Iodide, Iod - O - gippurate, MIBG, Iodophen<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Institute <strong>of</strong> Cardiology <strong>of</strong> Tomsk<br />

Research Centre (TRC) <strong>of</strong> Siberian Branch <strong>of</strong> Russian Academy Medical Sciences (SB<br />

RAMS)- 2 per week; Institute <strong>of</strong> Oncology <strong>of</strong> TRC SB RAMS- 2 per week; Siberian State<br />

Medical University- 2 per week.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

341<br />

335


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

336 342<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

S<strong>in</strong>ce 1990, TI-199 isotope is produced as analog <strong>of</strong> TI-201. The “Thallium Chloride, TI-99” radiopharmaceutical is<br />

provided to some medical <strong>in</strong>stitutes. Deliverables are realized twice per week. Quantity <strong>of</strong> the supply<strong>in</strong>g<br />

radiopharmaceutical with the TI-11 is equal to 5-6 Ku/year.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-8<br />

[1] INSTITUTE: Research Institute <strong>of</strong> Nuclear Physics<br />

St. Petersburg Technical University<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

194223 St. Petersburg, ul. Kurchatova 10<br />

+812 552 98 96<br />

zabrod<strong>in</strong>@yandex.ru<br />

+812 552 98 31<br />

V.N. Lomasov<br />

Director, Research Institute <strong>of</strong> Nuclear Physics (RINP)<br />

B.V. Zabrod<strong>in</strong>, Director <strong>of</strong> the Cyclotron Laboratory, RINP<br />

[3] TYPE OF<br />

MGC-20 YEAR OF: (I)<br />

1985<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

SRIEPhA, Russia (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 10 27 20 Yes No<br />

Maximum beam available (µA) 50 50 20 25<br />

Typical beam employed (µA) 20 20 5 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

0 – 50 0 - 50 0 – 20 2 – 5 50<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 0 - 20 Proton therapy:<br />

Physics: 0 - 20 Neutron therapy:<br />

Activation analysis: sometimes Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

67 Ga, 124 I, 85 Sr.<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? As required.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

343<br />

337


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

338 344<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 1 - 10 As required Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

1 - 10 as required Yes No Yes No<br />

124<br />

I<br />

0,5 - 4 as required Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

85 Sr<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: RUSSIA RUS-9<br />

[1] INSTITUTE: V.G. Khlop<strong>in</strong> Radium Institute<br />

2nd Mur<strong>in</strong>ski Prospect 28<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

149 021 St. Petersburg<br />

+7 812 247<br />

sol<strong>in</strong>@atom.nw.ru<br />

+7 812 237 6181<br />

L.M. Sol<strong>in</strong>, PhD.<br />

Head <strong>of</strong> Laboratory<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Efremov NIIEFA (II) UPGRADE:<br />

MODEL: MGC-20<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 5-18 3-10 8-24 8-20 Yes No<br />

Maximum beam available (µA) 50 50 20 20<br />

Typical beam employed (µA) 5-15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance<br />

60 48 12<br />

3 He<br />

4 He<br />

1988<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Sodium iodide, 123 I; Sodium-Iodohippurate, 123 I; 123 I -MIBG; 123 I -BMIPP; 67 Ga Citrate:<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

345<br />

339


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

340 346<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 3.5 1/ month Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

10 2-3 / week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


30. SAUDI ARABIA<br />

2005 COUNTRY: SAUDI ARABIA SAU-1<br />

[1] INSTITUTE: K<strong>in</strong>g Faisal Specialist Hospital and Research Centre<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Positive ion, AVF,<br />

electrostatic<br />

P.O. Box 3354, Riyadh 11211<br />

+966 1 442 7856<br />

Jamnaz@kfshrc.edu.sa<br />

+966 1 442 4743<br />

Eng. Salman Melibari<br />

Head <strong>of</strong>, Cyclotron Operations<br />

Eng. Salam Rahma, Senior Eng<strong>in</strong>eer<br />

Ahmad Algaith, Eng<strong>in</strong>eer<br />

Faisal Alromayanman, Eng<strong>in</strong>eer<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER:<br />

extraction<br />

The Cyclotron<br />

Corporation<br />

(II) UPGRADE:<br />

MODEL: CS 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 28.5 15 38 30 Yes No<br />

Maximum beam available (µA) 200 300 135 90<br />

Typical beam employed (µA) 100 100 100 80<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

45 < 10 < 10 < 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy: 25 (on hold)<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

[8]<br />

Intense neutron beam? (specify average En = ?) Yes No En =14 MeV<br />

<strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 103 123<br />

C, Pd, and I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

124 203<br />

I, Pb<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 5<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1981<br />

347<br />

341


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

342 348<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 28 > 95 0.33 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15 Every day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 3.7 1-2/week Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 44.0 Every week Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 16.7 Occasionally Yes No Yes No<br />

123<br />

I<br />

28.0 Every day Yes No Yes No<br />

124<br />

I<br />

16.0 Occasionally Yes No Yes No<br />

201<br />

Tl 34.0 Every Week Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Kr 81m generator production everyday.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


31. SLOVAKIA<br />

2005 COUNTRY: SLOVAKIA SLR-1<br />

[1] INSTITUTE: Slovak Office <strong>for</strong> Standards, Metrology and Test<strong>in</strong>g<br />

Cyclotron Centre <strong>of</strong> the Slovak Republic<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Stefanovicova 4, P.O. Box 76, SK-81005 Bratislava<br />

+421 7 524 91085<br />

podhorsky@norm<strong>of</strong>f.gov.sk<br />

+421 7 524 91050<br />

Dr. Dusan Podhorsky<br />

Chairman<br />

Dr. Peter Kovac, Senior Operators<br />

Dr. Josef Kristiak, Senior Scientist<br />

Pr<strong>of</strong>essor Fedor Macasek, Senior Scientist<br />

Pr<strong>of</strong>essor Jan Ruzicka, Scientific Secretary<br />

Pr<strong>of</strong>essor Stefan Saro, Senior Scientist<br />

[3] TYPE OF<br />

Fixed energy H<br />

CYCLOTRON:<br />

- and<br />

D - YEAR OF: (I)<br />

2001 - 2002<br />

ions<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a., Belgium (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

80 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: 5 (Planned) Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 11<br />

F – FDG, C – Raclopride<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

349<br />

343


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

344 350<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 2 x 50 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 2 x 20 Yes No Yes No<br />

18<br />

F-DOPA Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 40 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4<br />

16 13<br />

O(p,α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

CO2 (10)<br />

14 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


32. SOUTH AFRICA<br />

2005 COUNTRY: SOUTH AFRICA SAF-1<br />

[1] INSTITUTE: Themba LABS<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Separated sector w/<br />

solid pole <strong>in</strong>jector<br />

cyclotron<br />

P.O. Box 722, Somerset West 7129<br />

+27 21 843 1334<br />

director@tlabs.ac.za or clive@tlabs.ac.za*<br />

+27 21 843 3525<br />

Pr<strong>of</strong>essor J.F. Sharpey-Schafer until 30 June 2005<br />

Pr<strong>of</strong>essor K Bharuth-Ram from 1 July 05 to 31 December 06<br />

Dr ZZ Vilakazi, from 1 January 2007 Director<br />

Mr Y Manjoo, Head - Adm<strong>in</strong>istration<br />

Dr C. Naidoo*, Head - <strong>Radionuclide</strong> <strong>Production</strong><br />

Dr. L. Conradie, Head - Accelerator Group<br />

YEAR OF:<br />

INSTALLATION<br />

(I)<br />

1986<br />

MANUFACTURER: NAC (II) UPGRADE: 1994 (2nd <strong>in</strong>jector)<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 66 - 200 Yes No<br />

Maximum beam available (µA) 180<br />

Typical beam employed (µA) 90<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

144 38 24 24 ~20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy: 12<br />

Physics: 24 Neutron therapy: 10<br />

Activation analysis: Other (specify)<br />

<strong>Radionuclide</strong> production<br />

38<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 18 68 82 88<br />

F and F FDG; Ge; Sr, Yr<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Nuclear medic<strong>in</strong>e centres <strong>in</strong><br />

South Africa and Namibia — on a weekly basis. 22 Na to USA , European and Far East<br />

Markets, RbCl & Ga irradiated targets to USA (DOE)<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical, Small animal, Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

351<br />

345


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

346 352<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 2 2-4 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch<br />

(list)<br />

(GBq)<br />

18<br />

FDG To be<br />

determ<strong>in</strong>ed, not<br />

<strong>in</strong> production<br />

yet<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

production<br />

sales<br />

GBq<br />

4 times a week Yes No Yes No Not<br />

availabl<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga weekly Yes No Yes No $ 372<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

weekly Yes No Yes No $ 405<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

81 Rb/ 81M Kr generators, 123 I – MIBG, 123 I-NaI capsule, , 123 I-NaI solution, 67 Ga-res<strong>in</strong>


33. SPAIN<br />

2005 COUNTRY: SPAIN SPA-1<br />

[1] INSTITUTE: BARNATRON<br />

Anselm Clave, 100<br />

08950 Espluges de Llobregar<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Barcelona<br />

+34 93 473 5144<br />

iramirez@cetir.es<br />

+34 93 473 4839<br />

Isabel R. de Arellano<br />

Radiochemist, responsible <strong>for</strong> Installation<br />

Carlos Piera, responsible <strong>for</strong> Quality Control<br />

Pedro Larroza, Technician – <strong>Production</strong><br />

Mart<strong>in</strong> Vargas, Technician – Quality Control<br />

YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS: H - and D - energy beam 16.4 MeV.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

16.4 MeV Yes No<br />

Typical beam employed (µA) 36<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

11 7 - 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1 Advanced GE<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

353<br />

347


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

348 354<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F >95.5 1.6 mL Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 65/2 MR bomb 4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: SPAIN SPA-2<br />

[1] INSTITUTE: Centro Andaluz de Díagnóstíco PET (CADPET)<br />

Ronda de Capuch<strong>in</strong>os, 11<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

41009 Sevilla<br />

+34 954 432 537 ext. 172<br />

adm<strong>in</strong>istracíon@cadpet.es/mcantero@cadpet.es/riglesias@cadpe<br />

t.es<br />

+34 954 435 5850<br />

Mr. Miguel Perez<br />

Consejero Delegado (Manag<strong>in</strong>g Director)<br />

Mr. Miguel Cantero, Radiochemist<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Mrs. Rocío Iglesias, Radiopharmacist<br />

[3] TYPE OF<br />

YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: PET Trace 2132402<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 Yes No<br />

Maximum beam available (µA) 75<br />

Typical beam employed (µA) 36<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

26 26 n/a<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

Radiopharmaceuticals 26/week<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

CADPET Málaga: 3/week; Hospital Universitario Virgen del Rocío (Sevilla): 5/week<br />

Hospital Universitario Virgen de las Nieves (Granada): 6/week;<br />

IPO (Lisboa): 5/week ;<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

355<br />

349


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

350 356<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 95 1,5 mL Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α,d ) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 37 17/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: SPAIN SPA-3<br />

[1] INSTITUTE: Centro PET Complutense (CPC)<br />

Manuel Bartolome Cossio, 10<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Superconduct<strong>in</strong>g,<br />

E-28040 Madrid<br />

+34 91 534 4896<br />

radi<strong>of</strong>armacia@petmadrid.com<br />

+34 91 553 0845<br />

José Miguel Alfonso<br />

President<br />

Antonio Maldonado, Medical Director<br />

Magdalena Melgarejo Icaza, Laboratory Director<br />

José Manuel Nieto, Adm<strong>in</strong>istrative Director<br />

YEAR OF: (I)<br />

1994<br />

CYCLOTRON: negative ion<br />

INSTALLATION<br />

MANUFACTURER: Ox<strong>for</strong>d Intr. (II) UPGRADE:<br />

MODEL: OSCAR IV<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 12 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

FDG fabrication<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? IVO (Valencia): 3-4/week;<br />

Hospital del Rocío (Sevilla: 5-9/week; Hospital Dr. Peset (Valencia): 2-3/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

Number<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

357<br />

351


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

352 358<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 25 >95 5 ± 400 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 25 2-4/day Yes No Yes No P45,000<br />

/<strong>in</strong>jectio<br />

n to<br />

patient<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Centro PET Complutense S.A. is dedicated only <strong>in</strong> the production and utilization <strong>of</strong> 1`8 FDG <strong>for</strong> cl<strong>in</strong>ical use. Dur<strong>in</strong>g this<br />

utilization it participates <strong>in</strong> diverse projects <strong>of</strong> cl<strong>in</strong>ical <strong>in</strong>vestigation.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: SPAIN SPA-4<br />

[1] INSTITUTE: Cl<strong>in</strong>ica Universitaria de Navarra<br />

Facultad de Medic<strong>in</strong>a<br />

Apartado, 4029<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

31080 Pamplona<br />

+34 948 255 400 ext. 4941<br />

jarichter@unav.es<br />

+34 948 296 500<br />

José A. Richter<br />

MD, PhD.<br />

Chief <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

Josep M. Marti-Climent, PhD.<br />

Iván Peñuelas, PhD.<br />

Javier Arbizu, MD<br />

María J. García-Velloso, MD, PhD.<br />

[3] TYPE OF<br />

Double particle YEAR OF: (I)<br />

1996<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 80 35<br />

Typical beam employed (µA) 30 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

10<br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

359<br />

353


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

354 360<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d,a) 18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: SPAIN SPA-5<br />

[1] INSTITUTE: MOLYPHARMA<br />

Avenida Dr. Severo Ochoa, 37-41-1<br />

28100 Alcobendas<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Madrid<br />

+34 91 490 5730<br />

[www.molypharma.es]<br />

+34 91 490 5740<br />

Mr. Rafael Jimenez Shaw<br />

Director de Operaciones<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Mr. Tomas Arroyo, Radiopharmacist<br />

[3] TYPE OF<br />

GE M<strong>in</strong>it-11 YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

(II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 9.6 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 35<br />

[5] CYCLOTRON OPERATION: (ESTIMATION)<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 19 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 5 dur<strong>in</strong>g 2001 (expected)<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

361<br />

355


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

356 362<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 52 96 0.5 Yes<br />

No<br />

20 Ne (d,α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 37 Daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

Ammonia 5 Daily<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


34. SWEDEN<br />

2005 COUNTRY: SWEDEN SWE-1<br />

[1] INSTITUTE: Uppsala Universitet<br />

PET-Centrum<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

UAS, S-75185 Uppsala<br />

+46 18 471 5388<br />

Joachim.Schulz@pet.uu.se<br />

+46 18 471 53890<br />

Joachim Schultz<br />

Eng<strong>in</strong>eer<br />

Mr. Gunnar Antonio, Senior Chemist<br />

[3] TYPE OF<br />

Isochron, deflector YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 17<br />

[4] CYCLOTRON CHARACTERISTICS: 17 MeV protons, 8,5 deuterons, mx 50 µA on target<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17 17 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 45 45<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

60 57 0 2 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal 2<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

363<br />

357


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

358 364<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 37 95 0.9 1.2 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15 3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

CO2 ~20 5/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O water 1 5/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


35. SWITZERLAND<br />

2005 COUNTRY: SWITZERLAND SWI-1<br />

[1] INSTITUTE: Paul Scherrer Institute<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

CH-5232 Villigen-PSI<br />

+41 56 310 2813<br />

August.Schubiger@psi.ch<br />

+41 56 310 2849<br />

Pr<strong>of</strong>essor P.A. Schubiger<br />

Head <strong>of</strong> Centre <strong>for</strong> Radiopharmacy<br />

Simon Ametamey<br />

Peter Bläuenste<strong>in</strong><br />

[3] TYPE OF<br />

PSI construction<br />

Roger Schibli<br />

YEAR OF: (I)<br />

1974<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

Philips (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS: Total beam is 200 Micro Amp; a splitter divides <strong>in</strong>to ma<strong>in</strong> beam and a small part<br />

<strong>for</strong> the radiopharmacy; this sheet is filled out with respect to RPH applications<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 72 - - - Yes No<br />

Maximum beam available (µA) 70<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

140 150<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

365<br />

359


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

360 366<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 50 >80 2 50 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Dopa Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Flumazenil Yes No Yes No<br />

Raclopride Yes No Yes No<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Ketam<strong>in</strong>e Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Water<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

20 2/month Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

We are concentrat<strong>in</strong>g on research <strong>of</strong> new radiopharmaceuticals <strong>for</strong> bra<strong>in</strong> imag<strong>in</strong>g and tumour therapy. The products are<br />

<strong>in</strong>vestigated <strong>in</strong> vitro and <strong>in</strong> vivo (animals). If good results are obta<strong>in</strong>ed, first cl<strong>in</strong>ical tests are started, but there is no regular<br />

distribution to hospitals anywhere. In addition to 18 F, we are produc<strong>in</strong>g 11 C, 67 Cu and 76 Br.


2005 COUNTRY: SWITZERLAND SWI-2<br />

[1] INSTITUTE: Geneva University Hospitals (HUG)<br />

Department <strong>of</strong> Radiology and Medical In<strong>for</strong>matics,<br />

Nuclear Medic<strong>in</strong>e Service,<br />

Cyclotron Unit<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Negative ion, fixed<br />

energy<br />

24, rue Micheli-du-Crest, CH-1211 Geneva<br />

+41 22 37 27 580<br />

soloviev.dmitri@hcuge.ch<br />

+41 22 37 27 585<br />

Dr. Dmitri Soloviev, PhD.<br />

Radiopharmacist, Qualified Person, Head <strong>of</strong> Cyclotron Unit a.i.<br />

Claire Tamburella, PhD., Cyclotron Physicist<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

3 He<br />

4 He<br />

2001<br />

(mach<strong>in</strong>e manufactured <strong>in</strong><br />

1997)<br />

Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 40 15<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 30 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 C, 18 F, 64 Cu, 55 Co, 86 Y, 124 I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? [ 18 F]FDG to PET Centers <strong>in</strong><br />

Switzerland daily beg<strong>in</strong>n<strong>in</strong>g <strong>in</strong> December, 2005.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 2<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

367<br />

361


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

362 368<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 95 1.5; 2.5;3 600 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

[ 18 F]FDG 20 daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

[ 11 C]acetate 20 3 d/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: SWITZERLAND SWI-3<br />

[1] INSTITUTE: University Hospital Zürich, PET Center<br />

Raemistrasse 100<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

CH-8081 Zürich<br />

+41 1 255 1111<br />

gerrit.westera@dmr.usz.ch<br />

+41 1 255 4428<br />

Pr<strong>of</strong>essor A. Schubiger<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Dr. G. Westera<br />

[3] TYPE OF<br />

Fixed energy, YEAR OF:<br />

CYCLOTRON: negative ion (I) INSTALLATION<br />

1994<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

16.5 8.5 Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 Stand-by 20 Beam on target 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 11<br />

F – DOPA, FLT, C – Various<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Number<br />

Gamma camera 2<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

3<br />

–Cl<strong>in</strong>ical 2<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

369<br />

363


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

364 370<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 110 95 1.6 600 Yes<br />

No<br />

Ne (d, α) 18 F 600 MBq<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 45 1/day Yes No Yes No SFR<br />

200<br />

18<br />

FET 2.5 1/week Yes No Yes No<br />

18 -<br />

F 1.5 1/week Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Raclopride 2.5 1/2 weeks Yes No Yes No<br />

Flumarenil 2.5 1/2 weeks Yes No Yes No<br />

Acetate 2.5 1/month Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/ Price/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

GBq<br />

13<br />

NH3 10 10 / week<br />

16 13<br />

O (p, a) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2O Cont<strong>in</strong>uous 10 / week<br />

15 15<br />

N(p.n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq


36. SYRIAN ARAB REPUBLIC<br />

2005 COUNTRY: SYRIA SYR-1<br />

[1] INSTITUTE: Atomic Energy Commission <strong>of</strong> Syria (AECS)<br />

P.O. Box 6091<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Damascus<br />

+963 11 391 2896 or 391 3923<br />

+963 11 611 2289<br />

Dr. Abdul Hamid Al-Reyyes<br />

Negative ion,<br />

2001<br />

CYCLOTRON: variable energy<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15-30 Yes No<br />

Maximum beam available (µA) 350<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

YEAR OF: (I)<br />

INSTALLATION<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

123 111 103 11 15<br />

I, In, Pd, C, O<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Not yet.<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

371<br />

365


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

366 372<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F ~ 90 97 1.3 250 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 30 3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


37. TURKEY<br />

2005 COUNTRY TURKEY TUR-1<br />

[1] INSTITUTE: MONROL Nuclear Products Inc.<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

(-) Ion Beam<br />

CTI<br />

RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Tubitak MAM Teknoparki Gebze / Kocaeli<br />

+90 262 646 40 66<br />

monrol@monrol.com<br />

+90 262 646 40 66<br />

Baris Cakir<br />

Eng. / Specialist<br />

Ozgur Ustaoglu / Asst. Specialist<br />

H. Ozgur Kazanci / Asst. Specialist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong><br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

31 30 - 1 -<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FLT, FDOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Various National Institutions<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

2000<br />

373<br />

367


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

368 374<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l) Yes<br />

No<br />

18 18<br />

O (p, n) F<br />

Ne (d, α)<br />

55.5 97 1.2 600<br />

18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 25 2 Yes No Yes No -<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY TURKEY TUR-2<br />

[1] INSTITUTE: MONROL Nuclear Products Inc.<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

(-) Ion Beam<br />

IBA<br />

18/9<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Tubitak MAM Teknoparki Gebze / Kocaeli<br />

+90 262 646 40 66<br />

monrol@monrol.com<br />

+90 262 646 40 66<br />

Baris Cakir<br />

Eng. / Specialist<br />

Ozgur Ustaoglu / Asst. Specialist<br />

H. Ozgur Kazanci / Asst. Specialist<br />

Halil Kusanlı / Asst. Specialist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

3 He<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

2004<br />

-<br />

Hours/week <strong>for</strong><br />

applications<br />

31 30 - 1 -<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

FLT<br />

FDOPA<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Various National Institutions<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

375<br />

369


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

370 376<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l) Yes<br />

No<br />

18 18<br />

O (p, n) F<br />

Ne (d, α)<br />

166.5 97 2.1 2000<br />

18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 74 2 Yes No Yes No -<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


38. UNITED KINGDOM<br />

2005 COUNTRY: UNITED KINGDOM UK-1<br />

[1] INSTITUTE: Douglas Cyclotron Unit<br />

Clatterbridge <strong>for</strong> Oncology<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

AVF, s<strong>in</strong>gle particle,<br />

CYCLOTRON:<br />

fixed energy<br />

Beb<strong>in</strong>gton, Wirral L63 4JY<br />

+44 151 334 6366<br />

andrzejk@cco.trust.co.uk<br />

+44 151 334 2845<br />

Dr. Andrzej Kacperek<br />

Head, Cyclotron Unit<br />

B. Marsland<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE: 1988 (beaml<strong>in</strong>e <strong>of</strong> proton<br />

therapy)<br />

MODEL: MC-62<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 62 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 20 - 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 5 2 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy: 15<br />

Physics: 2 Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

22<br />

Na<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

64 55<br />

Cu, Co<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Paterson Institute, Christie<br />

Hospital, (4-8/month) Manchester, M20 4BX, U.K.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1984<br />

377<br />

371


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

372 378<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F<br />

Ne (d, α)<br />

40 95 1 Mostly<br />

recycled<br />

18 F<br />

16 18<br />

O (α, x) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Yes<br />

No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

1 1/month Yes No Yes No Research<br />

contract<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

We only produce isotopes, not pharmaceuticals.


2005 COUNTRY: UNITED KINGDOM UK-2<br />

[1] INSTITUTE: Hammersmith Imanet Limited<br />

Cyclotron Build<strong>in</strong>g<br />

Hammersmith Hospital<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Ducane Road, London W12 ONN<br />

+44 (0) 208 383 3162<br />

bruce.mackay@csc.mrc.ac.uk<br />

+44 (0) 208 383 2029<br />

Sue Matthews<br />

Manag<strong>in</strong>g Director<br />

Bruce Mackay, Cyclotron Operations Manager<br />

Mike Renton, Chief Cyclotron Eng<strong>in</strong>eer<br />

Shaun Creasey, Radiochemistry <strong>Production</strong> Manager<br />

[3] TYPE OF<br />

O-15 generator YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 3D<br />

[4] CYCLOTRON CHARACTERISTICS: Positive ion, fixed energy, fixed frequency, <strong>in</strong>ternal beam only.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 3.8 Yes N<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 28 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) O-15<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

379<br />

373


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

374 380<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

H2O<br />

15<br />

CO<br />

cont<strong>in</strong>uous<br />

cont<strong>in</strong>uous<br />

daily<br />

daily<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

15<br />

O cont<strong>in</strong>uous weekly<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED KINGDOM UK-3<br />

[1] INSTITUTE: Hammersmith Imanet Limited<br />

Cyclotron Build<strong>in</strong>g<br />

Hammersmith Hospital<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Positive ion, variable<br />

Ducane Road, London W12 ONN<br />

+44 (0) 208 383 3162<br />

bruce.mackay@csc.mrc.ac.uk<br />

+44 (0) 208 383 2029<br />

Sue Matthews<br />

Manag<strong>in</strong>g Director<br />

Bruce Mackay, Cyclotron Operations Manager<br />

Mike Renton, Chief Cyclotron Eng<strong>in</strong>eer<br />

Shaun Creasey, Radiochemistry <strong>Production</strong> Manager<br />

YEAR OF: (I)<br />

1986<br />

CYCLOTRON: energy<br />

INSTALLATION<br />

MANUFACTURER: Scanditronix (II) UPGRADE:<br />

MODEL: MC 40 Mark II<br />

[4] CYCLOTRON CHARACTERISTICS: Isochronous cyclotron <strong>for</strong> acceleration <strong>of</strong> light ions, delivers high quality<br />

external beams via a beam transport system with seven (7) l<strong>in</strong>es to more than 20 <strong>in</strong>stalled targets.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 10-40 5-20 12-53 10-40 Yes No<br />

Maximum beam available (µA) 65 65 50 60<br />

Typical beam employed (µA) 30 30 30 55<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

110 65 40 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Daily<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

381<br />

375


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

376 382<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 10/F2; 55/F- 95 1.2 150 400 10 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 20 daily Yes No Yes No<br />

Wide range <strong>of</strong><br />

compounds<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Extensive range<br />

<strong>of</strong> compounds<br />

daily Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

CO cont<strong>in</strong>uous daily<br />

14 15<br />

N(d,n) O<br />

15<br />

CO2<br />

15<br />

H2O<br />

cont<strong>in</strong>uous<br />

cont<strong>in</strong>uous<br />

daily<br />

daily<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.3 Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

81 Rb/Kr generators<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED KINGDOM UK-4<br />

[1] INSTITUTE: Hammersmith Imanet Limited<br />

Cyclotron Build<strong>in</strong>g<br />

Hammersmith Hospital<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Ducane Road, London W12 ONN<br />

+44 (0) 208 383 3162<br />

bruce.mackay@csc.mrc.ac.uk<br />

+44 (0) 208 383 2029<br />

Sue Matthews<br />

Manag<strong>in</strong>g Director<br />

Bruce Mackay, Cyclotron Operations Manager<br />

Mike Renton, Chief Cyclotron Eng<strong>in</strong>eer<br />

Shaun Creasey, Radiochemistry <strong>Production</strong> Manager<br />

[3] TYPE OF<br />

GE PETtrace YEAR OF: (I)<br />

2004-2005<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GEMS Uppsala. (II) UPGRADE:<br />

MODEL: PETtrace selfshielded<br />

[4] CYCLOTRON CHARACTERISTICS: Positive ion, fixed energy, fixed frequency, <strong>in</strong>ternal beam only.<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes No<br />

Maximum beam available (µA) 75 60<br />

Typical beam employed (µA) 40 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

60 60 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) O-15<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

383<br />

377


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

378 384<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F 100 95 0.8 Yes<br />

as F-<br />

No<br />

18 18<br />

Ogas (p, n) F<br />

as F2<br />

16 18<br />

O (α, x) F<br />

50<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

11C CO2 Yes No Yes No<br />

11C Methane Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/ Price/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

GBq<br />

Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction Price/<br />

(list)<br />

<strong>used</strong><br />

GBq<br />

15<br />

H2O<br />

15<br />

CO<br />

cont<strong>in</strong>uous<br />

cont<strong>in</strong>uous<br />

daily<br />

daily<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

15<br />

O cont<strong>in</strong>uous weekly<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY: UNITED KINGDOM UK-5<br />

[1] INSTITUTE: John Mallard Scottish PET Centre<br />

University <strong>of</strong> Aberdeen<br />

Department <strong>of</strong> Biomedical Physics and Bioeng<strong>in</strong>eer<strong>in</strong>g<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Foresterhill, Aberdeen, AB9 2ZD<br />

+44 1 224554767<br />

m.g.dodd@abdn.ac.uk<br />

+44 1 224552514<br />

Dr. Andrew Welch<br />

Director<br />

M.G. Dodd, Cyclotron Eng<strong>in</strong>eer<br />

Dr. Lutz Schweiger, Senior Chemist<br />

Negative ion YEAR OF: (I)<br />

1998<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 12 4 0.2 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 16 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify): Target dev. 1<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

385<br />

379


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

380 386<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 16 40 1.1 180 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 8 daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e 2 weekly Yes No Yes No<br />

Methylene blue 4 weekly Yes No Yes No<br />

methionone 4 Yes x No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 3 as required<br />

16 ��<br />

O(p, �� � Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 3 weekly<br />

15 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED KINGDOM UK-6<br />

[1] INSTITUTE: St. Thomas Hospital<br />

The Cl<strong>in</strong>ical PET Centre<br />

Guy’s, K<strong>in</strong>g’s, St. Thomas School <strong>of</strong> Medic<strong>in</strong>e<br />

Lambeth Palace Road, London SE1 7EH<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+44 207 188 4988<br />

FAX NO.:<br />

+44 207 922 0790<br />

[2] PERSON IN CHARGE:<br />

Dr Michael O’Doherty<br />

POSITION:<br />

Director, The Cl<strong>in</strong>ical PET Centre<br />

OTHER SENIOR STAFF:<br />

Ms. Margaret Dak<strong>in</strong><br />

NAME/POSITION<br />

Mr. Gav<strong>in</strong> d’Costa<br />

NAME/POSITION<br />

Mr. Phil Halstead<br />

NAME/POSITION<br />

Mr. Paul Marsden<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11.5 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

19 15 4 As required<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

64 18 18<br />

Cu – In development; F – FLT – In development; F –Peptides – In development<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Fluoride <strong>for</strong> scanner applications<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 2<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

387<br />

381


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

382 388<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F > 95 0.5 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 2 /day Yes No Yes No £ 325/<br />

patient<br />

dose<br />

FLT Yes No Yes No<br />

FMISO Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

11<br />

C Metnion<strong>in</strong>e Yes No Yes No<br />

11<br />

C Fumazenl Yes No Yes No<br />

11<br />

C Methyl<br />

acetate<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

13 NH3<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Water<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O(p,��) N Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

15 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED KINGDOM UK-7<br />

[1] INSTITUTE: University <strong>of</strong> Cambridge<br />

Wolfson Bra<strong>in</strong> Imag<strong>in</strong>g Centre<br />

Box 65, Addenbrook's Hospital<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Negative ion, fixed<br />

CYCLOTRON:<br />

energy<br />

Cambridge CB2 2QQ<br />

+44 1223 33 1820<br />

jcc24@wbic.cam.ac.uk<br />

+44 1223 33 1826<br />

John C. Clark, DSc.<br />

PET Science Director<br />

Pr<strong>of</strong>essor John D. Pickard, Cl<strong>in</strong>ical Director and Chairman<br />

Dr. Frankl<strong>in</strong> I. Aigbirhio, Radiopharmaceutical Chemist<br />

Dr. Peter J. Johnstrom, Radiopharmaceutical Chemist<br />

Mr. Paul Burke, Cyclotron Eng<strong>in</strong>eer<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 16 8.5 Yes No<br />

Maximum beam available (µA) 100 40<br />

Typical beam employed (µA) 45 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

28 6 10 4 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify): PET<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 11 64<br />

F peptides; C ligands and substrates; Cu antibody fragments/chelates<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 3/week to two centres.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 1<br />

Gamma camera 1<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1994<br />

389<br />

383


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

384 390<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Water<br />

CO<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

O2<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


39. UNITED STATES OF AMERICA<br />

2005 COUNTRY: UNITED STATES OF AMERICA USA-1<br />

[1] INSTITUTE: Bowman Gray School <strong>of</strong> Medic<strong>in</strong>e<br />

Medical Centre Boulevard<br />

W<strong>in</strong>ston-Salem, NC 27157<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+1 910 716 7461<br />

[2] PERSON IN CHARGE:<br />

Dr. Richard L. Witc<strong>of</strong>ski<br />

POSITION:<br />

Director<br />

OTHER SENIOR STAFF:<br />

Richard Ehrenkaufer<br />

NAME/POSITION<br />

Henry Chilton<br />

[3] TYPE OF<br />

Negative ion YEAR OF:<br />

1991<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS-112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15 15 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG, daily<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

391<br />

385


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

386 392<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F – FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C - methion<strong>in</strong>e Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

15<br />

O - water<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-2<br />

[1] INSTITUTE: Brookhaven National Laboratory<br />

Chemistry Department, Bldg. 901<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER: Japan Steel Works,<br />

Upton, NY 11973<br />

+631 344 4587<br />

schlyer@bnl.gov<br />

+631 344 4587<br />

David J. Schlyer<br />

Isochronous YEAR OF:<br />

Ltd.<br />

MODEL: BC 1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Manager, BNL Cyclotron Facility<br />

Joanna Fowler, Programme Director<br />

Richard Ferrieri, Chemist<br />

Michael Schueller, Assistant Chemist<br />

1981<br />

(I) INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 17 10 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 35 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 30 0 4 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

393<br />

387


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

388 394<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 13.5 95 3.1 45 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 3.5 daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Coca<strong>in</strong>e 0.5 3/week Yes No Yes No<br />

Raclopride 0.5 3/week Yes No Yes No<br />

Deprenyl 0.5 2/week Yes No Yes No<br />

Clorgyl<strong>in</strong>e 0.5 2/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 1.0 On demand<br />

16 13<br />

0(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

195m Pt<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA USA-3<br />

[1] INSTITUTE: Brookhaven National Laboratory<br />

Build<strong>in</strong>g 901<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Negative ion<br />

Ebco Technologies<br />

Inc.<br />

TR19<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Upton, NY 11973<br />

(631) 344-4587<br />

schlyer@bnl.gov<br />

(631) 344-7350<br />

David J. Schlyer<br />

Head, BNL Cyclotron Facility<br />

Michael Schueller Assistant Scientist<br />

Richard Ferrieri Chemist<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 19 10 Yes No<br />

Maximum beam available (µA) 100 100 100<br />

Typical beam employed (µA) 30 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

3 He<br />

4 He<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

2002<br />

Hours/week <strong>for</strong><br />

applications<br />

25 20 5 4<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

New tracers <strong>for</strong> receptor systems<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence 2<br />

Gamma camera 0<br />

S<strong>in</strong>gle photon tomography (SPET) 0<br />

Positron emission tomography (PET) 0<br />

–Cl<strong>in</strong>ical 2<br />

–Small animal 2<br />

–Plant biochemistry 1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

395<br />

389


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

390 396<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 13.5 95% 2.3 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 13.5 daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Coca<strong>in</strong>e 0.5 3/week Yes No Yes No<br />

Raclopride 0.5 8/week Yes No Yes No<br />

Rital<strong>in</strong> 0.5 1/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

ammonia 0.25 1/week<br />

16 13<br />

O (p, a) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

[ 11 C] Jasmonic acid <strong>for</strong> plant studies


2005 COUNTRY: UNITED STATES OF AMERICA USA-4<br />

[1] INSTITUTE: Carol<strong>in</strong>as Medical Center<br />

Department <strong>of</strong> NM & PET<br />

1000 Blyth Blvd., P.O. Box 32861<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Charlotten NC 28232<br />

+1 704 355 2276<br />

Zedd@worldnet.att.net<br />

Dr. Ron Borchert<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11.5 Yes N<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1993<br />

h/week <strong>for</strong><br />

applications<br />

80 80<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Confidential<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 6<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

397<br />

391


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

392 398<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F ~ 37 95 0.5 500 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 400-450 2-4/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

Ammonia 15 - 22 1-2/week<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-5<br />

[1] INSTITUTE: Case Western Reserve University<br />

and University Hospitals <strong>of</strong> Cleveland<br />

Division <strong>of</strong> Radiology<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

11100 Euclid Avenue, Cleveland, OH 44139<br />

+1 216 844 7350<br />

msb5@po.cwru.edu<br />

Dr. Marc Berridge<br />

Associate Pr<strong>of</strong>essor<br />

Lei Zheng<br />

Ken Voelker<br />

YEAR OF: (I)<br />

1985<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

17 8 Yes No<br />

Typical beam employed (µA) 30 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

25 25 average: 6 (some<br />

weeks, none)<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-Fluoride; 13 N-Ammonia; 18 F-<br />

FDG<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 2<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

399<br />

393


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

394 400<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-6<br />

[1] INSTITUTE: Childrens Hospital <strong>of</strong> Michigan<br />

PET Center<br />

3901 Beaubien Boulevard<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Detroi, MI 48201<br />

+1 313 993 2618<br />

tmangner@PET.wayne.edu<br />

+1 313 993 3845<br />

Dr. Thomas J. Mangner<br />

Director, PET Chemistry<br />

Dr. Harry T. Chugani, Medical Director<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1993<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 20 - 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 20-24 10 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 20 - 24 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 11<br />

C – leuc<strong>in</strong>e; C - DWAY<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

401<br />

395


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

396 402<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 22 >95 0.35 150 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 12 5-6/week Yes No Yes No<br />

18<br />

F FLT 2 1/week Yes No Yes No<br />

18<br />

F FMAU 1.5 1/monoth Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C FMZ 15 2-3/week Yes No Yes No<br />

11<br />

C AMT 6 2-3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N NH3 2 5-10/week 16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O Water 4 5-6/month<br />

15 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Other radiopharmaceuticals produced on an irregular basis: C-11 acetate, C-11 m-hydroxyephedr<strong>in</strong>e (HED), 2-C-11<br />

thymid<strong>in</strong>e, C-11 methion<strong>in</strong>e, F-18 FAU, F-18 FIAU, F-18 FBAU.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA. USA-7<br />

[1] INSTITUTE: Columbia University, Kreitchman PET Center<br />

177 Ft Wash<strong>in</strong>gton Ave, MHB B1 room 4<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

Negative Ion<br />

Medical Cyclotron<br />

CTI<br />

New York, NY 10032<br />

(212)923-1555<br />

nrs17@columbia.ed<br />

(212)543-8879<br />

Ronald Van Heertum M.D<br />

Director Kreitchman PET Center<br />

Norman Simpson, Director Radioisotope & Radioligand<br />

Product<br />

Dave Wilson, Radiopharmacy Manager<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

MODEL:<br />

RDS112<br />

(II) UPGRADE:<br />

n/a<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11MeV N/A N/A N/A Yes No<br />

Maximum beam available (µA) 120 µA<br />

(spilt<br />

beam)<br />

N/A N/A N/A N/A<br />

Typical beam employed (µA) 30-40 N/A N/A N/A N/A<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong> Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

75<br />

18<br />

F – 15<br />

0 cyclotron research 20<br />

15<br />

O – 0.5<br />

13<br />

N – 0.25<br />

11<br />

C -15<br />

2 hours chem. Res<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: 40 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify) 0<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence 3<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical, Small animal, Plant biochemistry 3<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1992<br />

403<br />

397


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

398 404<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 81.4 98% 1.2ml 624 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 40.7 2 Batches/Day Yes No Yes No<br />

FPS 3.7 1/month Yes No Yes No<br />

Fallypride 3.7 2/month Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

M100907 7.4 2 Batches/week Yes No Yes No<br />

Raclopride 7.4 4 Batches/week Yes No Yes No<br />

WAY 100635 0.37 2 Batches/week Yes No Yes No<br />

DASB .74 2 Batches/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/ Price/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

GBq<br />

Ammonia 1.85 2-3 per week 16 13<br />

0(p,α) N Yes No N/A<br />

Yes No N/A<br />

Yes No N/A<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction Price/<br />

(list)<br />

<strong>used</strong><br />

GBq<br />

Oxygen 3.7 1 Batch every 2-3 months<br />

15 15<br />

N(p,n) O N/A<br />

Water 3.7 2-3 Batches per month<br />

15 15<br />

N(p,n) O N/A<br />

Carbon<br />

Monoxide<br />

N/A<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu N/A N/A Yes No Yes No<br />

67<br />

Ga N/A N/A Yes No Yes No<br />

86<br />

Y N/A N/A Yes No Yes No<br />

94m<br />

Tc N/A N/A Yes No Yes No<br />

103<br />

Pd N/A N/A Yes No Yes No<br />

111<br />

In N/A N/A Yes No Yes No<br />

123<br />

I<br />

N/A N/A Yes No Yes No<br />

124<br />

I<br />

N/A N/A Yes No Yes No<br />

201<br />

Tl N/A N/A Yes No Yes No<br />

211<br />

At N/A N/A Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

[C-11]NNC112, [C-11]acetate, [C-11]Palmitate, [C-11]mHED, [C-11]coca<strong>in</strong>e, [C-11]Carfentil, [C-11]DTBZ,<br />

[C-11]McN5652


2005 COUNTRY: UNITED STATES OF AMERICA USA-8<br />

[1] INSTITUTE: Creighton University<br />

Center <strong>for</strong> Metabolic Imag<strong>in</strong>g<br />

901 Dorcas Street<br />

Omaha, NE 88106<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+1 402 346 4181<br />

[2] PERSON IN CHARGE:<br />

Dr. Marc Wrichelt<br />

POSITION:<br />

Manager<br />

OTHER SENIOR STAFF:<br />

Dr. Mike Harr<strong>in</strong>gton<br />

NAME/POSITION<br />

Mr. Steve Torres<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

~ 7 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s &<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten? 18 Yes No<br />

F-FDG<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

405<br />

399


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

400 406<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-9<br />

[1] INSTITUTE: Crocker Nuclear Laboratory<br />

University <strong>of</strong> Cali<strong>for</strong>nia, Davis, 1 Ba<strong>in</strong>er Drive<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER: W.M. Brobeck &<br />

Davis, CA 95616<br />

+1 916 752 1460<br />

Solar@Crocker.UCDavis.edu<br />

+1 916 752 0952<br />

Dr. Manuel C. Lagunas-Solar<br />

Senior Radiochemist<br />

Mr. Nolan X. Zeng<br />

Mr. Carlos M. Castaneda<br />

Ms. Krystyna Trzepla-Nabaglo<br />

76 <strong>in</strong>ch isochronous<br />

Associates<br />

YEAR OF:<br />

(I) INSTALLATION<br />

(II) UPGRADE:<br />

1964-1966<br />

[4]<br />

MODEL:<br />

CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

4-68 15-45 20-90 16-90 Yes No<br />

Typical beam employed (µA) 30 40 1 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

112 4-8 ~ 16<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) Food irradiation<br />

& conservation<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 205 206 67<br />

F; Bi; Bi; Cu<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Benedict Nuclear Pharmaceuticals,<br />

CO. USA – 4/w; University <strong>of</strong> Cali<strong>for</strong>nia, Irv<strong>in</strong>e, CA, USA – 1-2/w; University <strong>of</strong> Cali<strong>for</strong>nia,<br />

Berkley, CA, USA –1-2/w; VA Hospital, Palo Alto CA. USA – 1-2/w; National Institute <strong>of</strong><br />

Health, MD, USA – 2-4/y; NeoRx Corporation, WA, USA – 2-4/y<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried out<br />

on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical; – Small animal; – Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

407<br />

401


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

402 408<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

3.7 – 7.4 4/week Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

205 Bi, 206 Bi<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-10<br />

[1] INSTITUTE: Downstate Cl<strong>in</strong>ical PET Center<br />

Methodist Medical Center<br />

221 North East Glen Oak Ave.<br />

Ill<strong>in</strong>ois 61606<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 309 6724 191<br />

FAX NO.:<br />

+1 309 6712 166<br />

[2] PERSON IN CHARGE:<br />

Dr. Danny B<strong>in</strong>gham<br />

POSITION:<br />

Manager<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Brenda Shields<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1990<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

CTI, Inc. (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 20 0.5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG, 5/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

409<br />

403


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

404 410<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-11<br />

[1] INSTITUTE: Duke University Medical Centre<br />

Department <strong>of</strong> Radiology<br />

Box 3808<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Isochronous fixed<br />

CYCLOTRON: field, positive ion<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

MODEL: CS-30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Durham, NC 27710<br />

+1 919 684 7708<br />

zalut001@mc.duke.edu<br />

+1 919 684 7121<br />

Dr. Bruce Wieland<br />

Director, Cyclotron<br />

Dr. Michael Zalutsky, Pr<strong>of</strong>essor<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 27.6 14 28.3 Yes No<br />

Maximum beam available (µA) 120 120 100<br />

Typical beam employed (µA) 70 70 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

32 28 4 8<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1985<br />

411<br />

405


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

406 412<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 97 0.4 300 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 12 3/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

ammonia 1 3/week 13 C(p,n) 13 N Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2O<br />

O2<br />

CO<br />

1<br />

8<br />

8<br />

2/week<br />

2/week<br />

2/week<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.1 4/week Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At 4 1/week Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-12<br />

[1] INSTITUTE: Emory University, Division <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

1364 Clifton Road NE<br />

Atlanta, GA 30322<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+1 404 712 7930<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Mark Goodman<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Ronald Crowe<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1992<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 ~ 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

413<br />

407


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

408 414<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-13<br />

[1] INSTITUTE: Gershenson Radiation Oncology Center<br />

Harper University Hospital and Wayne State University<br />

3990 John R<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

50 MeV deuteron<br />

superconduct<strong>in</strong>g<br />

Detroit, MI 48201<br />

+1 313 745 2487<br />

maughanr@kci.wayne.edu<br />

+1 313 745 2314<br />

Dr. Richard L. Maughan<br />

Mark Yudelev, PhD., Senior Cl<strong>in</strong>ical Medical Physicist<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER:<br />

cyclotron<br />

Michigan State<br />

University<br />

(II) UPGRADE:<br />

MODEL: K100-Harper<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 48.5 Yes No<br />

Maximum beam available (µA) ~ 20<br />

Typical beam employed (µA) ~ 12<br />

[5] CYCLOTRON OPERATION:<br />

Totalhours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

71 6 15 50<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 1 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: (medical) 5 Neutron therapy: 50<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No En = 19MeV, 55<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

None<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1990<br />

415<br />

409


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

410 416<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-14<br />

[1] INSTITUTE: Good Samaritan Medical Center<br />

PET Net Pharmaceutical Services<br />

1111 E. McDowell Road, West Tower, Lower Level 1<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

+1 602 239 4100/4747<br />

+1 602 239 2810<br />

Dr. Tricia Giurlani<br />

PDC Manager<br />

Dr. Michael Lawson<br />

Mr. David Stith<br />

Mr. Jay Stivers<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1990<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40-100<br />

Typical beam employed (µA) 20-100<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15-30 5-10 5-10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG, daily; 13 N-ammonia,<br />

1/month.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

417<br />

411


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

412 418<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-15<br />

[1] INSTITUTE: Indiana University Cyclotron Facility<br />

2401 Milo B. Sampson Lane<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Bloom<strong>in</strong>gton, IN 47408<br />

+1 812 8559 365<br />

@iucf.<strong>in</strong>diana.edu<br />

+1 812 8556 645<br />

Dr. John M. Cameron<br />

Director<br />

D. Friesel<br />

J. Coll<strong>in</strong>s<br />

[3] TYPE OF<br />

Separated sector<br />

G. East<br />

YEAR OF: (I)<br />

1975<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: In-house (II) UPGRADE:<br />

MODEL: K200<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 205 Yes N<br />

Maximum beam available (µA) 5<br />

Typical beam employed (µA) 5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

125 10 20 95<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 5 Radiography:<br />

Materials science: 50 Proton therapy: 90<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

None<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

419<br />

413


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

414 420<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-16<br />

[1] INSTITUTE: Indiana University Cyclotron Facility<br />

2401 Milo B. Sampson Lane<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Bloom<strong>in</strong>gton, IN 47408<br />

+1 812 8559 365<br />

@iucf.<strong>in</strong>diana.edu<br />

+1 812 8556 645<br />

Dr. John M. Cameron<br />

Director<br />

D. Friesel<br />

J. Coll<strong>in</strong>s<br />

G. East<br />

Separated sector YEAR OF:<br />

1972<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: In-house (II) UPGRADE:<br />

MODEL: K16<br />

[4] CYCLOTRON CHARACTERISTICS: (Used as <strong>in</strong>jector to K2000).<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 16 Yes No<br />

Maximum beam available (µA) 20<br />

Typical beam employed (µA) 5<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

125 10 20 95<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 5 Radiography:<br />

Materials science: 50 Proton therapy: 90<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

421<br />

415


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

416 422<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-17<br />

[1] INSTITUTE: John Hopk<strong>in</strong>s University School <strong>of</strong> Medic<strong>in</strong>e<br />

Division <strong>of</strong> Nuclear Medic<strong>in</strong>e, PET Center<br />

600 North Wolfe Street, Nelson B1-150<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Baltimore, MD 21287<br />

+1 410 955 2916<br />

rfd @jhu.edu<br />

+1 410 955 0691<br />

Robert F. Dannais, PhD.<br />

Pr<strong>of</strong>essor, Radiology/Director, PET Center<br />

Hayden T. Ravert, PhD.<br />

John L. Musachio, PhD.<br />

William B. Mathews, PhD.<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: GE (II) UPGRADE: The <strong>in</strong>stallation <strong>of</strong> the<br />

PETtrace<br />

MODEL: PET Trace represents an upgrace from our previous Scand<strong>in</strong>otrix MC-16F<br />

which is still on-site, but no longer <strong>used</strong>.<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes No<br />

Maximum beam available (µA) 75 40<br />

Typical beam employed (µA) 60 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 39 20 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify): Radiotracer<br />

chemistry<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 2<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

423<br />

417


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

418 424<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F ~ 90 > 90 1.5 800 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG > 55 2/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Many 11 C<br />

ligands<br />

~ 3.7 4/daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water On-l<strong>in</strong>e, ~ 3 GBq daily<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-18<br />

[1] INSTITUTE: Ketter<strong>in</strong>g Memorial Hospital<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e and PET<br />

3535 Southern Boulevard<br />

Ketter<strong>in</strong>g, OH 45429<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 937 296 7211<br />

FAX NO.:<br />

+1 937 296 4265<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Dr. Joseph Mantil<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Dr. Mart<strong>in</strong> Satter<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 25-43<br />

Typical beam employed (µA) 20-35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

12 12 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

425<br />

419


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

420 426<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-19<br />

[1] INSTITUTE: LA Tech Center<br />

UCLA School <strong>of</strong> Medic<strong>in</strong>e<br />

Department <strong>of</strong> Molecular and Medical Pharmacology and<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PETNet Pharmaceuticals, Inc.<br />

+1 310 670 1010<br />

hpadgett@mednet.ucla.edu<br />

+1 310 670 2521<br />

[2] PERSON IN CHARGE:<br />

Henry C. Padgett, PhD.<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Manag<strong>in</strong>g Director<br />

[3] TYPE OF<br />

Deep Valley YEAR OF: (I)<br />

2000<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS-111 (2)<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20-30 20-30<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

124<br />

I<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

427<br />

421


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

422 428<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 95+ ~ 1 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5 days/week Yes No Yes No<br />

F-dopa (<strong>in</strong> progress) Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

[ 11 C] CO2 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-20<br />

[1] INSTITUTE: Lawrence Berkeley Laboratory<br />

Department <strong>of</strong> Functional Imag<strong>in</strong>g<br />

1 Cyclotron Road, 55-121<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Berkeley, CA 94720<br />

+1 510 486 5276<br />

JPONEIL@LBL.gov<br />

+1 510 486 6208<br />

James P. O’Neil<br />

Supervisor, Biomedical Isotope Facility<br />

Dr. Thomas F. Bud<strong>in</strong>ger<br />

Dr. Henry VanBrockl<strong>in</strong><br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS: Prototype(1 st built), H + only, dual beam, 1 fixed 112–style target, 1 8 position<br />

turret assembly<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics:


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

424 430<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

18 18<br />

O (p, n) F 9<br />

33<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

37<br />

> 95<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

0.3<br />

1<br />

10 Yes<br />

No<br />

Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Various 1/week Yes No Yes No<br />

18<br />

FMT 1.9 - 3.7 24/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Chol<strong>in</strong>e Various 1 week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 1.1 3/month<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-21<br />

[1] INSTITUTE: Mall<strong>in</strong>ckrodt Institute <strong>of</strong> Radiology<br />

Wash<strong>in</strong>gton University<br />

510 K<strong>in</strong>gshighway<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Cyclone 30; 4 beam<br />

CYCLOTRON:<br />

l<strong>in</strong>es<br />

MANUFACTURER: IBA, s.a., The<br />

Cyclotron Corp., and<br />

Japan Steel Works<br />

MODEL: CS-15 (3); JSW 168<br />

(1)<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

St. Louis, MO<br />

+1 314 362 8435<br />

Pr<strong>of</strong>essor M.J. Welch<br />

Division Head <strong>of</strong> Radiological Sciences<br />

YEAR OF:<br />

(I) INSTALLATION<br />

(II) UPGRADE:<br />

3 He<br />

4 He<br />

1977 and 1991<br />

Dual Beams<br />

Beam energies (MeV) 16 8 Yes No<br />

Maximum beam available (µA) 80 80<br />

Typical beam employed (µA) 40-50 30-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

h/week <strong>for</strong><br />

applications<br />

35 35<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify): PET 35<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 5<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

431<br />

425


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

426 432<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 18<br />

O (p, n) F<br />

20 18<br />

Ne (d, α) F<br />

16 18<br />

O (α, d) F<br />

37-111 95 1.7<br />

1.2<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 29-60 daily Yes No Yes No<br />

Captopi1 Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 10 3/week Yes No Yes No<br />

Palmitate 8 3/week Yes No Yes No<br />

Glucose 1.5 3/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 4-8 Varies<br />

14 15<br />

N(d,n) O<br />

Oxygen 4-8 Varies<br />

14 15<br />

N(d,n) O<br />

CO 4-8 Varies<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu 15 2/week Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

76 Br, 66 Ga<br />

Yes<br />

No<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-22<br />

[1] INSTITUTE: Massachusetts General Hospital<br />

Department <strong>of</strong> Radiology<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

Boston, MA 02114<br />

+1 617 726 8336<br />

correia@PET.mgh.harvard.edu<br />

+1 617 726 5123<br />

John A. Correia, PhD.<br />

Director, Cyclotron Laboratory<br />

Eli Livni, PhD., Radiochemist<br />

David Elmaleh, PhD., Radiochemist<br />

Alan Fischman, MD, PhD., Physician<br />

William Bucekwicz, Cyclotron Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

AVF YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17<br />

[4] CYCLOTRON CHARACTERISTICS: Fixed energy, 18 MeV protons, 8.5 MeV deuterons<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 8.5 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 35 35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

55 20 6 4 25<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 FDG daily, ten local<br />

<strong>in</strong>stitutions/hospitals.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 2<br />

� Gamma camera 15<br />

� S<strong>in</strong>gle photon tomography (SPET) 6<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal 3<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

433<br />

427


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

428 434<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 80 97+ 1 500 Yes<br />

No<br />

20 Ne (d, α) 18 F 1.2 250<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 40 daily Yes No Yes No<br />

DOPA 0.05 weekly Yes No Yes No<br />

Setopir<strong>in</strong>e 0.1-0.5 weekly Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-CFT,<br />

Yes No Yes No<br />

Raclopride<br />

Altopene, SCH 50 mCi 10/week Yes No Yes No<br />

11<br />

CO 100 mCi 2/week Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N2<br />

13<br />

N2H3<br />

100 mCi<br />

300 mCi<br />

10/week<br />

5/week<br />

12<br />

C(d,n)<br />

16<br />

O(p, α)<br />

Yes<br />

Yes<br />

No<br />

No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

C 15 O2<br />

15<br />

O2<br />

H21<br />

300 mCi<br />

300 mCi<br />

10/week<br />

2/week<br />

14 15<br />

N(d,n) O<br />

14 15<br />

N(d,n) O<br />

5 O 300 mCi 5/week<br />

14 15<br />

N(d,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.037 Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


COUNTRY: UNITED STATES OF AMERICA USA-23<br />

[1] INSTITUTE: Medi-Physics, Inc.<br />

Amersham Healthcare<br />

900 Durham Avenue<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Negative ion, fixed<br />

field, fixed freq., var.<br />

energy<br />

South Pla<strong>in</strong>field, NJ 07080<br />

+1 908 757 0500<br />

Gordon Glass<br />

Site Adm<strong>in</strong>istration Manager<br />

William McCla<strong>in</strong><br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) Proprietary Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1989<br />

h/week <strong>for</strong><br />

applications<br />

Proprietary <strong>in</strong>fo<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Proprietary <strong>in</strong>fo<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

435<br />

429


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

430 436<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-24<br />

[1] INSTITUTE: Medi-Physics, Inc.<br />

Amersham Healthcare<br />

3350 Ridge Avenue<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Positive ion, variable<br />

CYCLOTRON:<br />

energy<br />

Arl<strong>in</strong>gton Heights, IL 60004<br />

+1 847 3988 400<br />

Thomas Spr<strong>in</strong>ger<br />

Director <strong>of</strong> Operations<br />

Brian Carus<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Sumitomo & CGR (II) UPGRADE:<br />

MODEL: PV-750<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) Proprietary Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1986<br />

h/week <strong>for</strong><br />

applications<br />

Proprietary <strong>in</strong>fo<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Proprietary <strong>in</strong>fo<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

437<br />

431


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

432 438<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-25<br />

[1] INSTITUTE: Medi-Physics, Inc.<br />

Amersham Healthcare<br />

3350 Ridge Avenue<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Positive ion, variable<br />

CYCLOTRON:<br />

energy<br />

Arl<strong>in</strong>gton Heights, IL 60004<br />

+1 847 3988 400<br />

Thomas Spr<strong>in</strong>ger<br />

Director <strong>of</strong> Operations<br />

Brian Carus<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-40<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) Proprietary Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

production<br />

h/week <strong>for</strong><br />

research<br />

3 He<br />

h/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

4 He<br />

1979<br />

h/week <strong>for</strong><br />

applications<br />

Proprietary <strong>in</strong>fo<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Proprietary <strong>in</strong>fo<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

439<br />

433


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

434 440<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-26<br />

[1] INSTITUTE: Medi-Physics, Inc.<br />

Amersham Healthcare<br />

900 Durham Avenue<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Positive ion,<br />

Azimuthally vary<strong>in</strong>g<br />

South Pla<strong>in</strong>field, NJ 07080<br />

+1 847 3988 400<br />

Gordon Glass<br />

Site Adm<strong>in</strong>istration Manager<br />

William McCla<strong>in</strong><br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER:<br />

field, isochronous<br />

The Cyclotron<br />

Corporation<br />

(II) UPGRADE:<br />

MODEL: MC-40<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

Proprietary Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

Proprietary <strong>in</strong>fo<br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Proprietary <strong>in</strong>fo<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1973<br />

441<br />

435


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

436 442<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-27<br />

[1] INSTITUTE: Mount S<strong>in</strong>ai Medical Center<br />

4300 Alton Road<br />

Miami Beach, FL 33140<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 305 674 2465<br />

FAX NO.:<br />

+1 305 674 2428<br />

[2] PERSON IN CHARGE:<br />

Dr. Thomas E. Boothe<br />

POSITION:<br />

Director, Cyclotron/Radiochemistry<br />

OTHER SENIOR STAFF:<br />

Mike Plitnikes<br />

NAME/POSITION<br />

Patricia Smith<br />

NAME/POSITION<br />

Manny Tavana<br />

[3] TYPE OF<br />

Positive ion YEAR OF:<br />

1972<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

(II) UPGRADE:<br />

MODEL: CS-30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

Proprietary Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

Proprietary Proprietary Proprietary<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 67 Ga-chloride; 111 In-chloride;<br />

201<br />

Tl-chloride – world wide<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

443<br />

437


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

438 444<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced):<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-28<br />

[1] INSTITUTE: National Institute <strong>of</strong> Drug Abuse<br />

NIDA/IRP, NIH<br />

5500 Nathan Shock Drive, Room 405<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Baltimore, MD 21224<br />

+1 410 550 1440 (general)/ +1 410 550 2916 (cyclotron)<br />

ahorti@<strong>in</strong>tra.nida.nih.gov<br />

+1 410 550 2724<br />

Alane Kimes, PhD.<br />

Act<strong>in</strong>g Branch Chief<br />

Andrew Horti, PhD., Chief Radiochemist<br />

Carlo Contoreggi, MD, Authorized Radiation User/Nuclear<br />

Medic<strong>in</strong>e Physician<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1997<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 25-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 0 8 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify): 20: PET<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

445<br />

439


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

440 446<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 12-15 95 1.1 200 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 4-8 1-2/week Yes No Yes No<br />

18<br />

F – 2-Fa 1 0-2/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 4-8 0-6/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

n/a Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 0.7-1 0-30/week<br />

15 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Many research tracers labeled with 11 C and 18 F.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-29<br />

[1] INSTITUTE: National Institute <strong>of</strong> Health<br />

Build<strong>in</strong>g 10, Room 1C401, MSC 1180<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Bethesda, MD 20892<br />

+1 301 496 0345<br />

paul@nmdhst.cc.nih.gov<br />

+1 301 402 3521<br />

Dr. William Eckelman<br />

Chief, PET Department<br />

Paul S. Plascjak<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: (II) UPGRADE:<br />

MODEL: PET Trace<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 16.5 8.4 Yes No<br />

Maximum beam available (µA) 50 50<br />

Typical beam employed (µA) 35 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 5 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 40 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? ORNL - monthly;<br />

NIST - yearly.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1999<br />

447<br />

441


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

442 448<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 95 1.5 600 Yes<br />

No<br />

20 Ne (d, α) 18 F 10<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 20 1/day Yes No Yes No<br />

Dopam<strong>in</strong>e 0.3 1/week Yes No Yes No<br />

DOPA 0.3 1/week Yes No Yes No<br />

FPTZTP 0.2 1/week Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Raclopride 1 1/week Yes No Yes No<br />

Palmitic acid 1 2/week Yes No Yes No<br />

Aracidonic 0.5 4/week Yes No Yes No<br />

CO 2 2/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 1.5 10/week<br />

16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water Cont<strong>in</strong>uous daily<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 0.75 1/week Yes No Yes No<br />

94m<br />

Tc 1.0 1/week Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

1.5 1/month Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At 1.5 1/month Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-30<br />

[1] INSTITUTE: National Institute <strong>of</strong> Health<br />

Build<strong>in</strong>g 10, Room 1C401, MSC 1180<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Fixed energy<br />

CYCLOTRON: compact<br />

MANUFACTURER: Japan Steel Works,<br />

Ltd.<br />

Bethesda, MD 20892<br />

+1 301 496 0345<br />

+1 301 402 3521<br />

Dr. William Eckelman<br />

Chief, PET Department<br />

Paul S. Plascjak<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

MODEL: JSW-1710<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17.5 9.8 Yes No<br />

Maximum beam available (µA) 150 150<br />

Typical beam employed (µA) 50 50<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

72 (6 days/ week) ~ 35 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F FDG provided to one centre<br />

1/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 3<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1985<br />

449<br />

443


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

444 450<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Dopa Yes No Yes No<br />

Dopam<strong>in</strong>e Yes No Yes No<br />

F Pr TZPZ Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

6 - 18 F – Cyl<strong>of</strong>oxy.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-31<br />

[1] INSTITUTE: National Institute <strong>of</strong> Health<br />

Build<strong>in</strong>g 10, Room 1C401, MSC 1180<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Fixed energy<br />

CYCLOTRON: compact<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

MODEL: CS 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Bethesda, MD 20892<br />

+1 301 496 0345<br />

paul@nmdhst.cc.nih.gov<br />

+1 301 402 3521<br />

Dr. William Eckelman<br />

Chief, PET Department<br />

Paul S. Plascjak<br />

YEAR OF: (I)<br />

INSTALLATION<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 26.5 14.8 38.1 29.6 Yes No<br />

Maximum beam available (µA) 200 300 135 90<br />

Typical beam employed (µA) 60 100 60 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

72 (6 days/week) ~ 35 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 FDG provided to one centre,<br />

1/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site? Research/diagnosis on site.<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 3<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1985<br />

451<br />

445


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

446 452<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Dopa Yes No Yes No<br />

Dopam<strong>in</strong>e Yes No Yes No<br />

F Pr TZPZ Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

6 - 18 F – Cyl<strong>of</strong>oxy.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA USA- 32<br />

[1] INSTITUTE: National Superconduct<strong>in</strong>g Cyclotron Laboratory<br />

Michigan State University, 1 Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Superconduct<strong>in</strong>g<br />

magnet cyclotron<br />

In-house, K1200<br />

East Lans<strong>in</strong>g, MI 48824-1321<br />

+1-517-355-9671<br />

gelbke@nscl.msu.edu<br />

+1-517-353-5967<br />

Dr. C.-K. Gelbke<br />

Director<br />

Dr. Peter S. Miller / Head, Operations Department<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1200 q 2 /A 2 MeV/nucleon, focus<strong>in</strong>g limit 400 q/A MeV/nucleon<br />

16 136 209<br />

O 150 MeV/u, Xe 120 MeV/u, Bi 80 MeV/u <strong>for</strong> example<br />

1 2<br />

H H<br />

3 He<br />

4 He<br />

1980-1987<br />

1996-2000<br />

Dual Beams<br />

Beam energies (MeV) Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/week <strong>for</strong><br />

applications<br />

156 156 12<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

<strong>Production</strong> <strong>of</strong> rare isotope<br />

beams by nuclear<br />

fragmentation process<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

Yes No<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

We supply beams <strong>of</strong> rare isotopes to users, many from other <strong>in</strong>stitutions.<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical Small animal Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

453<br />

447


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

448 454<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

18 FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/G<br />

Bq<br />

if<br />

availabl<br />

e<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY UNITED STATES OF AMERICA USA-33<br />

[1] INSTITUTE: National Superconduct<strong>in</strong>g Cyclotron Laboratory<br />

Michigan State University, 1 Cyclotron<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

Superconduct<strong>in</strong>g<br />

magnet cyclotron<br />

In-house, K500<br />

East Lans<strong>in</strong>g, MI 48824-1321<br />

+1-517-355-9671<br />

gelbke@nscl.msu.edu<br />

+1-517-353-5967<br />

Dr. C.-K. Gelbke<br />

Director<br />

Dr. Peter S. Miller / Head, Operations Department<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

520 q 2 /A 2 MeV/nucleon, focus<strong>in</strong>g limit 160 q/A MeV/nucleon<br />

1 2<br />

H H<br />

3 He<br />

4 He<br />

1977-1981<br />

1996-2000<br />

Dual Beams<br />

Beam energies (MeV) Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week<br />

<strong>for</strong> radionuclide<br />

production<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong><br />

ma<strong>in</strong>tenance<br />

Hours/week <strong>for</strong><br />

applications<br />

156 156 12<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

Injector <strong>for</strong> K1200cyclotron<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried Yes No<br />

out on-site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

455<br />

449


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

450 456<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


2005 COUNTRY: UNITED STATES OF AMERICA USA-34<br />

[1] INSTITUTE: North Shore University Hospital<br />

Research Department - Cyclotron/ PET Facility<br />

350 Community Drive<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Manhasett, NY 11021<br />

+1 516 562 1055<br />

rdahl@nshs.edu<br />

+1 516 562 1120<br />

Dr. J. Robert Dahl<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Thomas Chaly<br />

[3] TYPE OF<br />

Positive ion YEAR OF: (I)<br />

1987<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17F<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 17.5 8.75 17.5 Yes No<br />

Maximum beam available (µA) 180 180<br />

Typical beam employed (µA) 30-40 30-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 20 4, plus 2 weeks/year<br />

<strong>for</strong> periodic<br />

ma<strong>in</strong>tenance<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Only to research collaborators<br />

with cont<strong>in</strong>u<strong>in</strong>g jo<strong>in</strong>t projects.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 1<br />

� S<strong>in</strong>gle photon tomography (SPET) 1<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

457<br />

451


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

452 458<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-35<br />

[1] INSTITUTE: Northern Cali<strong>for</strong>nia PET Imag<strong>in</strong>g Center<br />

3195 Folsom Boulevard<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Sacramento, CA 95816<br />

+1 916 737 3200<br />

Dr. Peter Valk<br />

Mason Jones<br />

Negative ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 10 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG, 1/month<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1992<br />

459<br />

453


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

454 460<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F-FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

N-ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15 O-water<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-36<br />

[1] INSTITUTE: Oak Ridge National Laboratory<br />

Bldg. 6000, MS 6368<br />

Oak Ridge, TN 37831-6368<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 423 574 4111<br />

FAX NO.:<br />

+1 423 574 1268<br />

[2] PERSON IN CHARGE:<br />

B.A. Tatum<br />

POSITION:<br />

Eng<strong>in</strong>eer<strong>in</strong>g Manager<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

S.W. Mosko<br />

[3] TYPE OF<br />

K=100 Isochronous YEAR OF: (I)<br />

1960<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER:<br />

MODEL:<br />

ORNL (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) < 60 < 40 Yes No<br />

Maximum beam available (µA) < 100 < 200<br />

Typical beam employed (µA) < 50 < 100<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 40<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

461<br />

455


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

456 462<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-37<br />

[1] INSTITUTE: PET Net - Chicago<br />

200 E. Howard Street No. 240<br />

Des Pla<strong>in</strong>es, IL 60018<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

+1 847 297 1322<br />

Mr. Russ Greenberg<br />

Manager<br />

Clyde Cole<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1995<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 10 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG, 5 × per week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

463<br />

457


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

458 464<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

F-FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-38<br />

[1] INSTITUTE: PETNet Pharmaceutical Services<br />

1350 Manufactur<strong>in</strong>g Drive, Suite 105<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

Dallas, TX 75207<br />

+1 214 741 2075<br />

steve.torres@cti-pet.com<br />

+1 214 741 9323<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Mr. Steve Torres<br />

[3] TYPE OF<br />

YEAR OF: (I)<br />

2001<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 33 18<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

465<br />

459


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

460 466<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 133 96 1.3 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 59 3 /day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-39<br />

[1] INSTITUTE: PETNet Pharmaceutical Services<br />

1350 Manufactur<strong>in</strong>g Drive, Suite 105<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Dallas, TX 75207<br />

+1 214 741 2075<br />

steve.torres@cti-pet.com<br />

+1 214 741 9323<br />

Mr. Steve Torres<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 33 18<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1999<br />

467<br />

461


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

462 468<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 133 96 1.3 Yes<br />

No<br />

20 Ne (d, α) 18 F<br />

16 18<br />

O (α, d) F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 59 3 /day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-40<br />

[1] INSTITUTE: PET Net/VAMC Palo Alto<br />

Nuclear Medic<strong>in</strong>e Service (115)<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

3801 Miranda Avenue<br />

+1 415 493 5000<br />

pa-pet@ix.netcom.com<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Dr. Henry C. Padgett<br />

Manager<br />

Dave Wilson<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1996<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 25-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5-15 5-15 ~ 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

15<br />

O<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 2-3/ week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 3<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

469<br />

463


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

464 470<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-41<br />

[1] INSTITUTE: Regional Nuclear Pharmaceutical, LLC<br />

1224 3rd Avenue South<br />

University Park<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Birm<strong>in</strong>gham, Alabama 35233<br />

+1 205 322 4252<br />

jhaynes@nti.net<br />

+1 205 322 4859<br />

Mr. John Haynes<br />

Director <strong>of</strong> Operations<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 80<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 25 0 2 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

18<br />

F production<br />

25/week<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? New Orleans, Regional PET;<br />

Memphis Regional PET; Jeff Anderson Regional Medical Centre.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

2000<br />

471<br />

465


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

466 472<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 37 >95 1 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

18<br />

FDG 55 2/day Yes No Yes No $750/<br />

dose<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yield on batch<br />

(GBq)<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Frequency <strong>of</strong><br />

production<br />

Used on site Distribution/<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-42<br />

[1] INSTITUTE: Sa<strong>in</strong>t Louis University<br />

Health Sciences Center, School <strong>of</strong> Medic<strong>in</strong>e<br />

Division <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

3635 Vista Avenue at Grand Blvd.<br />

P.O. Box 15250<br />

St. Louis, MO 63110-0250<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 314 577 8801<br />

FAX NO.:<br />

+1 314 268 5486<br />

[2] PERSON IN CHARGE:<br />

Dr. Ranajit K. Bera<br />

POSITION:<br />

Assistant Pr<strong>of</strong>essor<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Dr. James W. Fletcher, Director<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

Radiopharmaceuticals 20 h/week<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) Advanced<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

473<br />

467


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

468 474<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 95 0.38 140 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 15-20 everyday Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on<br />

(list)<br />

batch (GBq)<br />

13<br />

NH3 0.8<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

13 13<br />

C(p,n) N Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2 15 O 15<br />

15 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

18 F - Cycl<strong>of</strong>oxy<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-43<br />

[1] INSTITUTE: Sa<strong>in</strong>t Joseph's Positron Center<br />

3003 W. Dr. Mart<strong>in</strong> Luther K<strong>in</strong>g, Jr. Boulevard<br />

Tampa, FL 33607-4227<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

+1 813 876 5620<br />

John Mather<br />

Kathie Krista<br />

Mike Mosley<br />

John O'Connen<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11 Yes No<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

10 10 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG, 5 days/week<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

Yes No<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

475<br />

469


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

470 476<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-44<br />

[1] INSTITUTE: State University <strong>of</strong> New York at Buffalo<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

105 Parker Hall, 3435 Ma<strong>in</strong> Street<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Buffalo, NY 14214-3007<br />

+1 716 838 5889<br />

fred@nucmed.buffalo.edu<br />

+1 716 838 4918<br />

Pr<strong>of</strong>. R. E. Ackerhalt<br />

Director <strong>of</strong> the Cyclotron Facility<br />

Michael S. Haka<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1992<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 15-30 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

0-450<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

164 8 ~ 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

103<br />

Pd<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG VA, daily; 13 Nammonia,<br />

weekly; - 18 F-FDG, MFH 3-4 x/week/Roswell 1/week/Biomedical Research, 1-<br />

2/week<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera 15<br />

� S<strong>in</strong>gle photon tomography (SPET) 22<br />

� Positron emission tomography (PET) 3<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

477<br />

471


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

472 478<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 1/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 1/week Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

CO<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

62 Cu, 62 Zn<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA USA-45<br />

[1] INSTITUTE: Texas A&M University<br />

Cyclotron Institute<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

MANUFACTURER:<br />

K500<br />

Superconduct<strong>in</strong>g<br />

TAMU<br />

College Station, TX 77843<br />

979-845-1411<br />

<strong>of</strong>fice@comp.tamu.edu<br />

979-845-1899<br />

Robert Tribble<br />

Director<br />

Don May<br />

Fred Abegglen<br />

George Kim<br />

Henry Clark<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

MODEL:<br />

K500<br />

(II) UPGRADE:<br />

none<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He<br />

Dual Beams<br />

Beam energies (MeV) 10-70 55-70 MeV/nuc 25-40 15-70 Yes No<br />

MeV/nuc<br />

MeV/nuc MeV/nuc<br />

Maximum beam available (µA) 0.2 1 1 1<br />

Typical beam employed (µA) 0.01 0.01 0.01 0.05<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

<strong>for</strong> radionuclide<br />

production<br />

ma<strong>in</strong>tenance applications<br />

168 0 69% 1% 30%<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 30% Proton therapy: 0<br />

Physics: 69% Neutron therapy: 0<br />

Activation analysis: 0 Other (specify) 1%<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

1988<br />

479<br />

473


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

474 480<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:<br />

produced)<br />

(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g


2005 COUNTRY: UNITED STATES OF AMERICA USA-46<br />

[1] INSTITUTE: The Christ Hospital<br />

2139 Auburn Avenue<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

C<strong>in</strong>c<strong>in</strong>nati, OH 45219<br />

+1 513 585 0836<br />

kemmet@healthall.com<br />

+1 513 585 0835<br />

Mr. Thomas G. Kemme<br />

Manager<br />

Ms. Carla C. Pemberton, RPh.<br />

Mr. George H. Day, RPh.<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1991<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

12 12 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 13<br />

F- FDG, NH3<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? University <strong>of</strong> C<strong>in</strong>c<strong>in</strong>nati –<br />

2/week; Fort Hamilton Hughes Hostpital – 1/month; Proctor & Gamble – 1/month<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

481<br />

475


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

476 482<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 32 > 95 0.33 100 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 10 daily Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 30 1-2/yr Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 1.2 1/week Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-47<br />

[1] INSTITUTE: The Queen's Medical Center<br />

1301 Punchbowl Street<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Honolulu, HI 96813<br />

+1 808 537 7077<br />

pmcguigan@queens.org<br />

+1 808 585 5095<br />

Pat McGuigan<br />

Manager<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Marc Coel, MD<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1998<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) (yes) Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5 1 5 0<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[F-18] Chol<strong>in</strong>e<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Tripler Hospital and Kuak<strong>in</strong>i<br />

Hospital<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

483<br />

477


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

478 484<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F > 95 1.1 200 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 9 1/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

[F-18] Chol<strong>in</strong>e<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-48<br />

[1] INSTITUTE: Theragenics Corporation<br />

5325 Oakbrook Parkway<br />

Norcross, GA 30093<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+1 770 381 8447<br />

[2] PERSON IN CHARGE:<br />

Tony Longo<br />

POSITION:<br />

Cyclotron Facility Manager<br />

OTHER SENIOR STAFF:<br />

Tom West; Ty Tob<strong>in</strong><br />

NAME/POSITION<br />

Mr. Joe Rodgers; J. Hwung<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1996<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18+<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 Yes No<br />

Maximum beam available (µA) various<br />

Typical beam employed (µA) N/A<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

144-168 Typical 0-36<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Medical; Typical 1 to 10 / month/<br />

client<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

485<br />

479


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

480 486<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd 10 - 60 1/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Brachytherapy<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-49<br />

[1] INSTITUTE: Theragenics Corporation<br />

5325 Oakbrook Parkway<br />

Norcross, GA 30093<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+1 770 3818 447<br />

[2] PERSON IN CHARGE:<br />

Tony Longo<br />

POSITION:<br />

Cyclotron Facility Manager<br />

OTHER SENIOR STAFF:<br />

Tom West; Ty Tob<strong>in</strong><br />

NAME/POSITION<br />

Mr. Joe Rodgers; J. Hwung<br />

[3] TYPE OF<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1994<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18+<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 Yes No<br />

Maximum beam available (µA) various<br />

Typical beam employed (µA) N/A<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

144-168 Typical 0-36<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Medical; Typical 1 to 10 / month/<br />

client<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

Number<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

487<br />

481


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

482 488<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd 10 - 60 1/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Brachytherapy<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-50<br />

[1] INSTITUTE: Theragenics Corporation<br />

5325 Oakbrook Parkway<br />

Norcross, GA 30093<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

+1 770 381 8447<br />

[2] PERSON IN CHARGE:<br />

Tony Longo<br />

POSITION:<br />

Cyclotron Facility Manager<br />

OTHER SENIOR STAFF:<br />

Tom West; Ty Rob<strong>in</strong><br />

NAME/POSITION<br />

Joe Rodgers; J. Hwung<br />

[3] TYPE OF<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1992<br />

MANUFACTURER: IBA, s.a. (II) UPGRADE:<br />

MODEL: Cyclone 18+<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 Yes No<br />

Maximum beam available (µA) various<br />

Typical beam employed (µA) N/A<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

144-168 Typical 0-36<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Medical; Typical 1 to 10 / month/<br />

client<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

489<br />

483


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

484 490<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd 10 - 60 1/week Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Brachytherapy<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-51<br />

[1] INSTITUTE: University <strong>of</strong> Cali<strong>for</strong>nia at Los Angeles<br />

Biomedical Cyclotron<br />

10833 Le Conte Avenue<br />

Los Angeles, CA 90095<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 310 825 6231<br />

FAX NO.:<br />

+1 310 825 4517<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

N. Satyamurthy<br />

[3] TYPE OF<br />

Negative ion YEAR OF: (I)<br />

1994<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 100<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

40 20 10 2-3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Several 18 F and 11 C labeled radiopharmaceuticals<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 3<br />

– Small animal 3<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

491<br />

485


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

486 492<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 40 95 0.8 15 750 5 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 20 10/week Yes No Yes No<br />

Variety <strong>of</strong> 18 Flabeled<br />

prods.<br />

10/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

11<br />

C-Acetate 10 2/week Yes No Yes No<br />

Variety <strong>of</strong> 11 Clabeled<br />

prods.<br />

4/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 3 20/week 16 13<br />

O(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2O 4 10/week<br />

15 15<br />

N(p, n) O<br />

O2 4 3/week<br />

CO 4 3/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-52<br />

[1] INSTITUTE: University <strong>of</strong> Cali<strong>for</strong>nia-Irv<strong>in</strong>e<br />

Bra<strong>in</strong> Imag<strong>in</strong>g Centre<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Irv<strong>in</strong>e, CA 92697<br />

+1 714 824 2018<br />

aanajafi@uci.edu<br />

+1 714 824 2230<br />

Dr. Ahmod A. Najafi<br />

Positive ion YEAR OF<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1988<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC 17<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 8-10 Yes No<br />

Maximum beam available (µA) 20<br />

Typical beam employed (µA) 2-3<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

12 12 2 -3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) (yes)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

493<br />

487


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

488 494<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Dopa Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-53<br />

[1] INSTITUTE: University <strong>of</strong> Iowa<br />

PET Imag<strong>in</strong>g Centre<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Positive ion, sectorfoc<strong>used</strong>,<br />

resistive<br />

magnet<br />

Iowa City, IA 52242<br />

+1 319 356 4100<br />

richard-hichwa@uiowa.edu<br />

+1 319 353 6512<br />

Pr<strong>of</strong>essor Richard D. Hichwa<br />

Director<br />

G. Leonard Watk<strong>in</strong>s<br />

Laura Boles Ponto<br />

Mark T. Madsen<br />

YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17 F<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 18 7.3 (fixed energy) Yes No<br />

Maximum beam available (µA) 1-70 1-70<br />

Typical beam employed (µA) 25-50 100 10-15<br />

max 100 max<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

> 40 20-30 < 1 target<br />

ma<strong>in</strong>tenance 1/year<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site? Medical research/diagnosis<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1990<br />

495<br />

489


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

490 496<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Mehion<strong>in</strong>e Yes No Yes No<br />

Acetate Yes No Yes No<br />

CO, CO2 Yes No Yes No<br />

Receptor<br />

ligands<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

CO, CO2<br />

O2<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

48 V<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-54<br />

[1] INSTITUTE: University <strong>of</strong> Michigan<br />

3480 Kresge III<br />

Ann Arbor, MI 48109-0552<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

+1 313 763 9244<br />

FAX NO.:<br />

+1 313 764 0288<br />

[2] PERSON IN CHARGE:<br />

Pr<strong>of</strong>essor Michael R. Kilbourn<br />

POSITION:<br />

Director, PET Chemistry<br />

OTHER SENIOR STAFF:<br />

Dr. Robert Koeppe<br />

NAME/POSITION<br />

Mr. James Moskwa<br />

[3] TYPE OF<br />

Medical YEAR OF:<br />

1982<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: The Cyclotron<br />

Corporation<br />

(II) UPGRADE:<br />

MODEL: CS-30<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 26.0 15.0 38.0 30.0 Yes No<br />

Maximum beam available (µA) 200 300 100 90<br />

Typical beam employed (µA) 30 30 50 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

15 12 4<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 3<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

497<br />

491


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

492 498<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Ep<strong>in</strong>ephr<strong>in</strong>e Yes No Yes No<br />

Pseuolophedr<strong>in</strong>e Yes No Yes No<br />

Diahydiotetaben<br />

az<strong>in</strong>e<br />

Yes No Yes No<br />

Acetate Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

62 Zn<br />

Price/<br />

Bq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA USA-55<br />

[1] INSTITUTE: University <strong>of</strong> Pennsylvania<br />

Department <strong>of</strong> Radiology<br />

420 Curie Blvd<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

MANUFACTURER:<br />

MODEL:<br />

Positive Ion<br />

Japan Steel Works<br />

3015 BC<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Philadelphia, PA 19104<br />

215-662-7550<br />

freifeld@mail.med.upenn.edu<br />

215-662-7551<br />

Richard Freifelder, Ph.D.<br />

Senior Research Investigator,<br />

Cyclotron Facility Manager<br />

Joel S. Karp, Ph.D.<br />

Harry White<br />

Larry Toto<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

(II) UPGRADE:<br />

Dual Beams<br />

Beam energies (MeV) 18, 22, 30 11 Yes No<br />

Maximum beam available (µA) 30 15<br />

Typical beam employed (µA) 10-15 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week or<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

40 30 3<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)PET Tracers 30<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18-F, 11-C Chol<strong>in</strong>e, FIAU, Fallypride, 11-C Cartentenil<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site Number <strong>of</strong><br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera 3<br />

� S<strong>in</strong>gle photon tomography (SPET) 5<br />

� Positron emission tomography (PET) 5<br />

– Cl<strong>in</strong>ical 4<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1985<br />

499<br />

493


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

494 500<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 55 97 0.6 cc 250 g Yes<br />

No<br />

Ne (d, α) 18 F 3.7 50 cc Ne<br />

gas<br />

16 O (α, x) 18 F n/a<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 18 Daily Yes No Yes No<br />

18<br />

F-DOPA 0.37 Once/week Yes No Yes No<br />

18<br />

F-FHBG 0.19 Once/week Yes No Yes No<br />

18<br />

F-FLT 0.19 Once/week Yes No Yes No<br />

11 C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

11<br />

C-<br />

Raclopride<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(GBq)<br />

production<br />

sales<br />

0.19 Once/month Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

13<br />

N-ammonia 3.7 Once/month<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

12 13<br />

C(p,n) N Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

EF5 (18-F)<br />

15-O water<br />

18-F NaF


2005 COUNTRY: UNITED STATES OF AMERICA USA-56<br />

[1] INSTITUTE: University <strong>of</strong> Southern Cali<strong>for</strong>nia<br />

1510 San Pablo, #350<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Los Angeles, CA 9003<br />

+1 213 342 5884<br />

pconti@hsc.usc.edu<br />

+1 213 342 5778<br />

Dr. Peter S. Conti<br />

Director, PET Imag<strong>in</strong>g & Radiological Resources<br />

James R. Bad<strong>in</strong>g; Miar Alaudd<strong>in</strong><br />

Mr. John Fissikis; Mr. Keith Higa<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1990<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 111<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 150<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

20 15 3<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-FDG daily<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site? Both on and <strong>of</strong>f site<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

501<br />

495


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

496 502<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

O<br />

CO, CO2<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

64 Cu Yes No Yes No<br />

67 Ga Yes No Yes No<br />

86 Y Yes No Yes No<br />

94m Tc Yes No Yes No<br />

103 Pd Yes No Yes No<br />

111 In Yes No Yes No<br />

123<br />

I<br />

124<br />

I<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

201 Tl Yes No Yes No<br />

211 At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-57<br />

[1] INSTITUTE: University <strong>of</strong> Tennesse Medical Centre<br />

Biomedical Imag<strong>in</strong>g Center<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

1924 Alcoa Highway, Knoxville, TN 37920<br />

+1 865 544 9818 or 865 544 9697<br />

Long<strong>for</strong>d@scanner.hosp.utk.edu OR<br />

desmond.long<strong>for</strong>d@petnepharmaceutical.com<br />

+1 865 544 8395<br />

C.P.D. Long<strong>for</strong>d<br />

Manager<br />

K.F. Hubner<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1987<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112 2000 - two (2) high pressure target; APS power supply upgraded<br />

2001 - new ma<strong>in</strong> magnet power supply - solid state; new<br />

automated chemistry equipment<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

11.2 Yes No<br />

Typical beam employed (µA) 32/target<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30-40 30-40 1-2 4-8 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Daily deliveries <strong>of</strong> 18 FDG to<br />

hospitals with<strong>in</strong> 4-5 km radius. Currently have 20 customers, shipp<strong>in</strong>g up to 20 doses/day<br />

with planned expansion to ship 60 doses/day.<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

503<br />

497


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

498 504<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 65 > 94 0.90 5 1200 None Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 30-60 2-3/day Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

ACBC 3.0 5-10/year Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Planned: 18 F -BPA and DOPA – not yet available.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-58<br />

[1] INSTITUTE: University <strong>of</strong> Texas Houston<br />

[2]<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Variable energy<br />

CYCLOTRON:<br />

isochronous<br />

6431 Fann<strong>in</strong> Street, Houston, TX 77030<br />

+1 713 500 7755<br />

carlos.gonzalez-lepera@uta.tmc.edu<br />

+1 713 500 7771<br />

Carlos Gonzalez Lepera<br />

Associate Pr<strong>of</strong>essor and Executive Director<br />

Nancy Haberman, Chemist<br />

Kev<strong>in</strong> Grilley, Radiopharmacist<br />

Russell Hildebrandt, Radiopharmacist<br />

Isidoro Vaquila, Cyclotron Eng<strong>in</strong>eer<br />

David Andews, Cyclotron Operator<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-40<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 40 20 40 Yes N<br />

Maximum beam available (µA) 150 40 30<br />

Typical beam employed (µA) 40 15 15<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

50 25 10 4 5<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 1 Radiography:<br />

Materials science: 1 Proton therapy:<br />

Physics: 1 Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

22<br />

Na, 0.037<br />

GBq<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

124 211<br />

I , At<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Hospitals and PET Centres<br />

throughout Southeast Texas<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal 1<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1983<br />

505<br />

499


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

500 506<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 100 95 1.4 300 Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 50 2/day Yes No Yes No<br />

NaF 50 1/day Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 4 6/day 16 13<br />

0(p, α) N Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 4 1/day<br />

14 15<br />

N(d, n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga 555 Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In 370 Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-59<br />

[1] INSTITUTE: University <strong>of</strong> Texas Research Imag<strong>in</strong>g Center<br />

Health Science Center, San Antonia<br />

7703 Floyd Curl Drive<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Fixed energy,<br />

isochronous, positive<br />

ion<br />

San Antonio, TX 78284<br />

+1 210 567 8190<br />

jerabet@uthscsa.edu<br />

+1 210 567 8152<br />

Dr. Peter Fox<br />

Director<br />

Paul Jerabbk<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-17F<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 17.2 8.6 Yes N<br />

Maximum beam available (µA) < 10 < 10<br />

Typical beam employed (µA) 10-50 10-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

3-5 3-5 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Number<br />

Positron emission tomography (PET)<br />

- Cl<strong>in</strong>ical<br />

- Small animal<br />

- Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1991<br />

507<br />

501


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

502 508<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate Yes No Yes No<br />

Methion<strong>in</strong>e Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA SA-60<br />

[1] INSTITUTE: University <strong>of</strong> Wash<strong>in</strong>gton Medical Centre<br />

Department <strong>of</strong> Radiation Oncology<br />

Box 356043, Room NN-136, 1959 NE Pacific Street<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

Compact room<br />

temperature<br />

cyclotron<br />

Seattle, WA 98195-6043<br />

+1 206 548 4136<br />

risler@radonc.wash<strong>in</strong>gton.edu<br />

+1 206 548 6218<br />

Dr. Ruedi Risler<br />

Senior Cyclotron Eng<strong>in</strong>eer<br />

Pr<strong>of</strong>essor Kenneth A. Krohn<br />

Pr<strong>of</strong>essor Jeanne A. L<strong>in</strong>k<br />

YEAR OF:<br />

(I) INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 50.5 Yes No<br />

Maximum beam available (µA) 60<br />

Typical beam employed (µA) 60<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research ma<strong>in</strong>tenance applications<br />

10 3 6 30<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: 1 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy: 30<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No 35<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 F, 11 C, 15 O, 13 N, 86 Y, 99 Tc, 124 I, 19 Ne<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

511 KeV co<strong>in</strong>cidence 0<br />

Gamma camera 6<br />

S<strong>in</strong>gle photon tomography (SPET) 2<br />

Positron emission tomography (PET) 1<br />

–Cl<strong>in</strong>ical<br />

–Small animal<br />

–Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1983<br />

509<br />

503


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

504 510<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15-20 95 3 No 60 None Yes<br />

No<br />

Ne (d, α) 18 F No<br />

16 O (α, x) 18 F No<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5 2/day Yes No Yes No<br />

FES 1 3/month Yes No Yes No<br />

FM180 1 3/month Yes No Yes No<br />

FLT 1 3/month Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Glucose 1 1/month Yes No Yes No<br />

Thyamid<strong>in</strong>e 1 3/momth Yes No Yes No<br />

MHED 1 4/month Yes No Yes No<br />

CGP12177 2 8/month Yes No Yes No<br />

Flumazenile 1 1/month Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

H2O<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

O2<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 2/yr Yes No Yes No<br />

94m<br />

Tc 2/yr Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

planned Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA USA-61<br />

[1] INSTITUTE:<br />

MEDICAL PHYSICS DEPARTMENT<br />

UNIVERSITY OF WISCONSIN, 1530 MEDICAL SCIENCE CENTER<br />

1300 UNIVERSITY AVE, MADISON, WI, 53706, A<br />

TELEPHONE NO.:<br />

608-263-3910<br />

E-MAIL ADDRESS:<br />

rnickles@wisc.edu<br />

FAX NO.:<br />

FAX 608-262-2143<br />

[2] PERSON IN CHARGE:<br />

RJ Nickles<br />

TITLE/POSITION:<br />

Pr<strong>of</strong>essor <strong>of</strong> Medical Physics<br />

OTHER SENIOR STAFF:<br />

Brad Christian, Assistant Pr<strong>of</strong>essor <strong>of</strong> Medical Physics<br />

NAME/POSITION<br />

On<strong>of</strong>re DeJesus, Pr<strong>of</strong>essor <strong>of</strong> Medical Physicss<br />

[3] TYPE OFCYCLOTRON: 11 MeVproton YEAR OF:<br />

MANUFACTURER: CTI Inc<br />

(I) INSTALLATION:<br />

1985<br />

MODEL:<br />

112 (first prototype) (II) UPGRADE:<br />

2005<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

11 MEV PROTON, NEGATIVE ION, 50 MICROAMPS ONTO 4 TARGET POSITIONS, ONE A VERTICAL<br />

BEAM PORT FOR MOLTEN TARGETS<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He<br />

Dual Beams<br />

Beam energies (MeV) 11 Yes x No<br />

Maximum beam available (µA) 50<br />

Typical beam employed (µA) 20-30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week or<br />

Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radiopoduction<br />

ma<strong>in</strong>tenance applications<br />

10-20 10 5 2<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify) teach<strong>in</strong>g<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes x No Ce-139<br />

Intense neutron beam? (specify average En = ?) Yes x No Protons on Be-9<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

Br-76, Cl-34m, O-14,<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Stan<strong>for</strong>d (monthly)<br />

TRIUMF (soon to start)<br />

Yes x No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried out<br />

on-site?<br />

Yes x No<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

Number <strong>of</strong><br />

–Cl<strong>in</strong>ical, Small animal, Plant biochemistry 2<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

[F-18] atraz<strong>in</strong>e (Roundup) leachng <strong>in</strong>to ground water<br />

Yes x No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes x No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes x No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes x No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes x No<br />

511<br />

505


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

506 512<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F 20 30-50% 0.9 ml 20 ml 100 30 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Purchase<br />

commercially<br />

Yes No Yes No<br />

F-DOPA, FMT 3 30 Yes x No Yes No<br />

fallypride 2 50 Yes x No Yes No<br />

Fatty acids 2 2 Yes x No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

SCH 23,390 2 10 Yes x No Yes No<br />

Raclopride 2 15 Yes x No Yes No<br />

PK 11195 2 15 Yes x No Yes No<br />

Methyphenidate<br />

2 15 Yes x No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

NH3 4 5 Protons on O-16 water Yes No x<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu 20-40 10 Yes x No Yes x No $162/<br />

GBq<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y 2 5 Yes x No Yes No<br />

94m<br />

Tc 4 5 Yes x No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

0.2-0.4 10 Yes x No Yes x No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS:(e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Over the period <strong>of</strong> 1971 to the present, about 120 radioisotopes have been studied, mak<strong>in</strong>g about over hundred<br />

labeled compounds. (Nickles RJ, . <strong>Production</strong> <strong>of</strong> a Broader Palette <strong>of</strong> PET Tracers. J Lab Comp<br />

Radiopharmaceuticals 46, 1-27: 2003


2005 COUNTRY: UNITED STATES OF AMERICA USA-62<br />

[1] INSTITUTE: VA Medical Centre (11P)<br />

1 Veterans Drive<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

NAME/POSITION<br />

[3] TYPE OF<br />

CYCLOTRON:<br />

M<strong>in</strong>neapolis, MN 55417<br />

+1 612 725 2230<br />

sajjad@euler.pet.med.va.gov<br />

+1 612 725 2068<br />

Dr. David Rotenberg<br />

Mr. Rashid Syed<br />

Ms. Carroll Arnett<br />

E. Akguen<br />

Munawwar Sajjad<br />

Positive ion YEAR OF: (I)<br />

INSTALLATION<br />

MANUFACTURER: Scand<strong>in</strong>otrix (II) UPGRADE:<br />

MODEL: MC-40<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1 H<br />

2 H<br />

Dual Beams<br />

Beam energies (MeV) 40 20 Yes N<br />

Maximum beam available (µA) 40 50<br />

Typical beam employed (µA) 25 30<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide<br />

h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30 15 2 6<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & Yes No<br />

<strong>in</strong>stitutions?<br />

how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

3 He<br />

4 He<br />

1985<br />

513<br />

507


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

508 514<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 15 > 95 1.2 100 Yes<br />

No<br />

Ne (d, α) 18 F 11 99.999<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 6.5 3/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Acetate 1.8 on demand Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia 2.2 5/week<br />

16 13<br />

O(p,a) N Yes No<br />

Yes No<br />

Yes No<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

15<br />

O Water 6.0 36/week<br />

14 15<br />

N(d,n) O<br />

14<br />

O Water 3.5 on demand<br />

14 14<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-63<br />

[1] INSTITUTE: VAMC & University <strong>of</strong> Pittsburgh Medical Facility<br />

PET Center -9B<br />

200 Lothrop Street<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Pittsburg, PA 15213<br />

+1 412 647 0736<br />

mathis@vad.arad.upmc.edu<br />

+1 412 647 0700<br />

Pr<strong>of</strong>essor Chet Mathis<br />

Co-Director, PET Facility<br />

Pr<strong>of</strong>essor David Townsend, Co-Dir., PET Facility<br />

Negative ion YEAR OF:<br />

1991<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 80<br />

Typical beam employed (µA) 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

35 20 15


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

510 516<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 22 > 95 0.3 200 Ye<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 7 5/week Yes No Yes No<br />

18<br />

F-Altanar<strong>in</strong> 2 2/week Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Flumezenil 4 1/week Yes No Yes No<br />

McN 5652 4 2/week Yes No Yes No<br />

Way 100635 1 4/week Yes No Yes No<br />

PMD 4 4/week Yes No Yes No<br />

Raclopride 3 10/week Yes No Yes No<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

NH3 3 4/week<br />

16 13<br />

O(p,a) N Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

H2O<br />

O2<br />

4-20<br />

4-10<br />

20/week<br />

5/week<br />

15 15<br />

N(p,n) O<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-64<br />

[1] INSTITUTE: Vanderbilt University Medical Center<br />

Radiology Department<br />

100 Medical Center South<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

NAME/POSITION<br />

Nashville, TN 3723206315<br />

+1 615 3220508<br />

jim.patton@mcmail.vanderbilt.edu<br />

Dr. Ronald G. Mann<strong>in</strong>g<br />

Jeff Clanton<br />

Jeff Clauton, om<strong>in</strong>ique Delbeke<br />

[3] TYPE OF<br />

Negative ion<br />

Robert Kessler<br />

YEAR OF: (I)<br />

1989<br />

CYCLOTRON:<br />

INSTALLATION<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

80<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

25 25 20<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? PETNet Site; Several Customers<br />

>15<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site? Both on & <strong>of</strong>f sites.<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence 1<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET) 4<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

517<br />

511


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

512 518<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBqe<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITES STATES OF AMERICA USA-65<br />

[1] INSTITUTE: Weill Medical College at Cornell University and<br />

Memorial Sloan Ketter<strong>in</strong>g Cancer Center Consortium<br />

1300 York Avenue<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

New York, NY 10021<br />

+1 212 639 2458<br />

f<strong>in</strong>nr@msbcc.org<br />

+1 212 717 3821<br />

Dr. Ron F<strong>in</strong>n<br />

Head, Cyclotron Division<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

Yiauchung Sheh, MS, Senior Cyclotron Eng<strong>in</strong>eer<br />

[3] TYPE OF<br />

Negative Ion YEAR OF:<br />

Ongo<strong>in</strong>g and <strong>in</strong> progress<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

(2001)<br />

MANUFACTURER: EBCO Industries (II) UPGRADE: Incorporation <strong>of</strong> external<br />

beam<br />

MODEL: TR 19/9 l<strong>in</strong>e with target changer<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

Typical beam employed (µA)<br />

Yes No<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: 10% anticipated Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

<strong>Radionuclide</strong> preparation<br />

90% anticipated<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? On scientific collaborative basis<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

Number<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

1<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

519<br />

513


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

514 520<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F >95 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

69<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Imag<strong>in</strong>g Center build<strong>in</strong>g completion scheduled <strong>for</strong> October 2001. Cyclotron already <strong>in</strong> vault, await<strong>in</strong>g build<strong>in</strong>g service<br />

availability <strong>for</strong> start <strong>of</strong> the assembly.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-66<br />

[1] INSTITUTE: West Virg<strong>in</strong>ia University Hospital PET Centre<br />

P.O. Box 9236<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

Morgantown, WV 26506-9236<br />

+1 304 293 7798<br />

smazza@wvuhscl.hsc.wvu.edu<br />

+1 304 293 7142<br />

Dr. Naresh C. Gupta<br />

Director<br />

Mr. Samuel M. Mazza<br />

Mr. Raymond R. Raylman<br />

YEAR OF:<br />

CYCLOTRON:<br />

Negative ion, dual<br />

beam<br />

(I) INSTALLATION<br />

1995<br />

MANUFACTURER:<br />

MODEL:<br />

General Electric (II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV)<br />

Maximum beam available (µA)<br />

16.5 8.5 Yes No<br />

Typical beam employed (µA) 20 10<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

5 5 1<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? 18 F-Fluoride – irregularly; 18 F-<br />

FDG - planned<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

521<br />

515


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

516 522<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

Ammonia Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

Water<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-67<br />

[1] INSTITUTE: William Beaumont Hospital<br />

Department <strong>of</strong> Nuclear Medic<strong>in</strong>e<br />

3601 West Thirteen Mile Road<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

Royal Oak, MI 48083-6769<br />

+1 313 551 831<br />

Dr. Ram B. Sharma<br />

Radiochemist<br />

[3]<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

TYPE OF<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1991<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 20-35<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

13 13 2<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Nucl. Med. 40 Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

11 15<br />

C and O<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET) 1<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

523<br />

517


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

518 524<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F 30 95-98 0.3 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 16/batch 5/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

13<br />

NH3 1.9 2/month Yes No<br />

Yes No<br />

Yes No<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBqle<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY: UNITED STATES OF AMERICA USA-68<br />

[1] INSTITUTE: Yale University/VAMC West Haven<br />

PET Imag<strong>in</strong>g Center (115A)<br />

950 Campbell Avenue<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OF<br />

West Haven, CT 06516<br />

+1 203 937 4884<br />

garg@biomed.med-yale.edu<br />

Dr. Pradeep Garg<br />

Director, Radiopharmaceutical Chemistry<br />

Negative ion YEAR OF:<br />

CYCLOTRON:<br />

(I) INSTALLATION<br />

1991<br />

MANUFACTURER: CTI, Inc. (II) UPGRADE:<br />

MODEL: RDS 112<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 11 Yes No<br />

Maximum beam available (µA) 40<br />

Typical beam employed (µA) 20-40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours (h)/ week h/week <strong>for</strong> radionuclide h/week <strong>for</strong> h/week <strong>for</strong><br />

h/week <strong>for</strong><br />

production<br />

research<br />

ma<strong>in</strong>tenance applications<br />

30-40 ~ 10<br />

[6] CYCLOTRON APPLICATIONS: h/week h/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify):<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No<br />

Mössbauer sources? (specify which & quantity) Yes No<br />

X ray sources? (specify which & quantity) Yes No<br />

Intense neutron beam? (specify average En = ?) Yes No<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

18 18<br />

F- labeled androgens, F- labeled prostate probes<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten? Yale University and<br />

VA Nuclear Medic<strong>in</strong>e: 0-2 times/month<br />

Yes No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No<br />

[11] TYPE OF IMAGING EQUIPMENT AVAILABLE ON-SITE Number<br />

� 511 KeV co<strong>in</strong>cidence<br />

� Gamma camera<br />

� S<strong>in</strong>gle photon tomography (SPET)<br />

� Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical 1<br />

– Small animal<br />

– Plant biochemistry<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes No<br />

525<br />

519


18F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

520 526<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18<br />

OH2 (ml)<br />

18<br />

O2 (ml)<br />

18<br />

OH2 (g)<br />

18<br />

O2 (l)<br />

18<br />

OH2?<br />

18 O (p, n) 18 F ~16 >98 0.32 Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG 5 - 6 4 - 10/week Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong><br />

(list)<br />

batch (GBq) production<br />

Ammonia ~1 1-10/month<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

16 13<br />

O(p,a) N Yes No<br />

Yes No<br />

Yes No<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

(list)<br />

<strong>used</strong><br />

Water 3-4 0-40/week<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

COMMENTS: (e.g. you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)<br />

11 C - NNC 112, Dolipram, Tropanes; 18 F Deutero-Altanser<strong>in</strong>e, para fluoro benzylguanid<strong>in</strong>e, Fallypride.<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq


2005 COUNTRY UNITED STATES OF AMERICA USA-69<br />

[1] INSTITUTE: Cyclo-Tech, LLC<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

7650 First Place, Oakwood Village, OH 44146<br />

440-439-5356<br />

mberridge@cyclo-tech.com<br />

440-439-5403<br />

Marc Berridge, Ph.D., President<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

Ken Voelker / VP Cyclotron Eng<strong>in</strong>eer<strong>in</strong>g<br />

NAME/POSITION<br />

Bonnie Benn<strong>in</strong>gton / VP <strong>Production</strong><br />

[3] TYPE OF CYCLOTRON: PET-Trace<br />

YEAR OF:<br />

MANUFACTURER: GE<br />

(I) INSTALLATION:<br />

2002<br />

MODEL:<br />

PETtrace<br />

(II) UPGRADE:<br />

N/A<br />

[4] CYCLOTRON CHARACTERISTICS: 17 MeV proton, 8 MeV deuteron, Negative ion<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He DualBea<br />

Beam energies (MeV) 17 8 na na Yes<br />

Maximum beam available (µA) 60 40<br />

Typical beam employed (µA) 50 20<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong> Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week<br />

radioproduction<br />

ma<strong>in</strong>tenance application<br />

25 21 4 8<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: 0 Radiography: 0<br />

Materials science: 0 Proton therapy: 0<br />

Physics: 0 Neutron therapy: 0<br />

Activation analysis: 0 Other (specify)<br />

[7] Is the cyclotron <strong>used</strong> to produce:<br />

Calibration sources? (specify which & quantity) Yes G No G n<br />

Mössbauer sources? (specify which & quantity) Yes G No G n<br />

X ray sources? (specify which & quantity) Yes G No G n<br />

Intense neutron beam? (specify average En = ?) Yes G No G n<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

I-124, Cu-64<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried out on-<br />

site?<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

Positron emission tomography (PET)<br />

Number<br />

–Cl<strong>in</strong>ical, Small animal, Plant biochemistry 0.1 (Shared Mobile)<br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong> agricultural N<br />

applications such as plant biochemistry/research?<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? N<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Y<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? N<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience?<br />

Y<br />

Y<br />

527<br />

521


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

522 528<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 18<br />

O (p, n) F 2.5 Ci 95 1.3 mL 100g Y<br />

Ne (d, �) 18 F na<br />

16 18<br />

O (�, x) F na<br />

18<br />

F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBqe<br />

18<br />

FDG 50% (uncorr) Y Y na<br />

Fluorocarazolol 40% 1/mo Y Y<br />

fluticasone<br />

propionate<br />

40% 18/mo Y Y<br />

6-FDG 50% 4/mo Y Y etc<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

Topotecan 15% 1/mo Y Y<br />

Nicot<strong>in</strong>e 85% 2/mo Y N<br />

Various Steroids 70% 2/mo Y N<br />

Raclopride 70% 1/mo Y N etc<br />

13<br />

N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on Frequency <strong>of</strong> Nuclear reaction <strong>used</strong> Distribution/ Price/<br />

(list)<br />

batch (GBq) production<br />

sales<br />

GBq<br />

Ammonia 0.8 Ci 20/mo O-16 (p,alpha) Y<br />

Nitrogen 0.8 Ci 1/mo O-16 (p,alpha) N<br />

Yes G No G<br />

15<br />

O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction Price/<br />

(list)<br />

<strong>used</strong><br />

GBq<br />

Water 0.5 Ci N-14 (d,n)<br />

CO 0.5 Ci<br />

Butanol 0.15 Ci<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes G No G Yes G No G<br />

67<br />

Ga Yes G No G Yes G No G<br />

86<br />

Y Yes G No G Yes G No G<br />

94m<br />

Tc Yes G No G Yes G No G<br />

103<br />

Pd Yes G No G Yes G No G<br />

111<br />

In Yes G No G Yes G No G<br />

123<br />

I<br />

Yes G No G Yes G No G<br />

124<br />

I<br />

Yes G No G Yes G No G<br />

201<br />

Tl Yes G No G Yes G No G<br />

211<br />

At Yes G No G Yes G No G<br />

18 O2 (l)


2005 COUNTRY UNITED STATES OF AMERICA USA-70<br />

[1] INSTITUTE: CYCLOTOPE – Accelerated Medic<strong>in</strong>e<br />

8285 El Rio, Suite 160<br />

TELEPHONE NO.:<br />

E-MAIL ADDRESS:<br />

FAX NO.:<br />

[2] PERSON IN CHARGE:<br />

TITLE/POSITION:<br />

OTHER SENIOR STAFF:<br />

NAME/POSITION<br />

[3] TYPE OFCYCLOTRON:<br />

Houston, TX 77054<br />

(713) 747-5686<br />

fdg@cyclotope.com<br />

(713)747-4858<br />

Carlos Gonzalez<br />

President<br />

Roberto Strangis, Cyclotron Eng<strong>in</strong>eer<br />

YEAR OF:<br />

(I) INSTALLATION:<br />

Negative Ion<br />

2002<br />

MANUFACTURER: ACS<br />

MODEL:<br />

TR19/9<br />

(II) UPGRADE:<br />

[4] CYCLOTRON CHARACTERISTICS:<br />

1<br />

H<br />

2<br />

H<br />

3<br />

He<br />

4<br />

He Dual Beams<br />

Beam energies (MeV) 18 9 Yes X No<br />

Maximum beam available (µA) 350 50<br />

Typical beam employed (µA) 100 40<br />

[5] CYCLOTRON OPERATION:<br />

Total hours/ week Hours/week <strong>for</strong> Hours/week <strong>for</strong> research Hours/week <strong>for</strong> Hours/week <strong>for</strong><br />

radioproduction<br />

ma<strong>in</strong>tenance applications<br />

[6] CYCLOTRON APPLICATIONS: Hours/week Hours/week<br />

Radiobiology: Radiography:<br />

Materials science: Proton therapy:<br />

Physics: Neutron therapy:<br />

Activation analysis: Other (specify)<br />

[7] IS THE CYCLOTRON USED TO PRODUCE:<br />

Calibration sources? (specify which & quantity) Yes No X<br />

Mössbauer sources? (specify which & quantity) Yes No X<br />

X ray sources? (specify which & quantity) Yes No X<br />

Intense neutron beam? (specify average En = ?) Yes No X<br />

[8] <strong>Radionuclide</strong>s and radiopharmaceuticals planned to be produced <strong>in</strong> the next 1-3 years (specify):<br />

[9] Do you supply radionuclides to other <strong>in</strong>stitutions?<br />

If yes and available, name <strong>of</strong> <strong>in</strong>stitution/s & how <strong>of</strong>ten?<br />

Yes X No<br />

[10] Are cl<strong>in</strong>ical studies and/or medical research us<strong>in</strong>g cyclotron radiopharmaceuticals carried<br />

out on-site?<br />

Yes No X<br />

[11] Type <strong>of</strong> imag<strong>in</strong>g equipment available on-site<br />

511 KeV co<strong>in</strong>cidence<br />

Gamma camera<br />

S<strong>in</strong>gle photon tomography (SPET)<br />

Positron emission tomography (PET)<br />

– Cl<strong>in</strong>ical<br />

– Small animal<br />

– Plant biochemistry<br />

Number <strong>of</strong><br />

[12] Are cyclotron radionuclides/labelled compounds <strong>used</strong> or planned to be <strong>used</strong> <strong>for</strong><br />

agricultural applications such as plant biochemistry/research?<br />

Yes No X<br />

[13] Is the cyclotron <strong>used</strong> <strong>for</strong> nuclear reaction cross-section measurements? Yes No X<br />

[14] Is the cyclotron <strong>used</strong> <strong>for</strong> targetry development? Yes X No<br />

[15] Is the cyclotron <strong>used</strong> <strong>for</strong> education and tra<strong>in</strong><strong>in</strong>g <strong>in</strong> nuclear sciences, health physics, etc.? Yes X No<br />

[16] Does your <strong>in</strong>stitute accept IAEA research fellows <strong>for</strong> tra<strong>in</strong><strong>in</strong>g/experience? Yes X No<br />

529<br />

523


18 F RADIONUCLIDE PRODUCTION<br />

<strong>Production</strong> Typical<br />

production<br />

yield (GBq)<br />

524 530<br />

% Isotopic<br />

enrichment<br />

18 O <strong>used</strong><br />

Target Volume Usage/year Do you<br />

recycle<br />

18 OH2?<br />

18 OH2<br />

18 O2<br />

18 OH2 (g)<br />

18 O2 (l)<br />

18 O (p, n) 18 F Yes<br />

No<br />

Ne (d, α) 18 F<br />

16 O (α, x) 18 F<br />

18 F RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

18<br />

FDG Daily Yes No X Yes X No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

11<br />

C RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

Yes No Yes No<br />

13 N RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Typical yield on<br />

batch (GBq)<br />

15 O RADIOPHARMACEUTICALS PRODUCED<br />

Name<br />

(list)<br />

Frequency <strong>of</strong><br />

production<br />

Nuclear reaction <strong>used</strong> Distribution/<br />

sales<br />

Yes No<br />

Yes No<br />

Yes No<br />

Typical yield on batch (GBq) Frequency <strong>of</strong> production Nuclear reaction<br />

<strong>used</strong><br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

Price/<br />

GBq<br />

OTHER ISOTOPES PRODUCED<br />

Name<br />

Yield on batch Frequency <strong>of</strong> Used on site Distribution/ Price/<br />

(list)<br />

(GBq)<br />

production<br />

sales<br />

GBq<br />

64<br />

Cu Yes No Yes No<br />

67<br />

Ga Yes No Yes No<br />

86<br />

Y Yes No Yes No<br />

94m<br />

Tc Yes No Yes No<br />

103<br />

Pd Yes No Yes No<br />

111<br />

In Yes No Yes No<br />

123<br />

I<br />

Yes No Yes No<br />

124<br />

I<br />

Yes No Yes No<br />

201<br />

Tl Yes No Yes No<br />

211<br />

At Yes No Yes No<br />

[17] COMMENTS: (e.g., you may add names <strong>of</strong> additional labelled compounds/radiopharmaceuticals be<strong>in</strong>g produced)


531


532<br />

02-31581

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!